Studies towards the synthesis of marine polysulfide natural products by Paul A. Robinson (7166075)
 
 
 
This item was submitted to Loughborough’s Institutional Repository 
(https://dspace.lboro.ac.uk/) by the author and is made available under the 
following Creative Commons Licence conditions. 
 
 
 
 
 
For the full text of this licence, please go to: 
http://creativecommons.org/licenses/by-nc-nd/2.5/ 
 
  
 
 
 
 
 
Studies Towards the Synthesis of Marine Polysulfide 
Natural Products 
 
Paul A. Robinson 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
Abstract 
 
Biologically active compounds isolated from marine sources have had increasing 
interest in recent years with significant research going into the discovery and isolation 
of novel marine polysulfide natural products.  
 
Varacin, probably the most widely studied marine polysulfide to date was the subject 
of much debated structure elucidation attempts, and more recently several successful 
synthetic approaches have been published. The work published aims to increase our 
understanding of marine polysulfide compounds existence in nature and determine the 
origins of their biological activity.  
 
(+)-Aplidium trisulfide which was isolated from Aplidium Sp. D in 1989 by Munro et 
al has been shown to exhibit in vitro antimicrobial, antileukemic and cytotoxic 
properties. These intriguing biological effects have led our work towards developing a 
novel synthetic route toward aplidium trisulfide by both chiral and racemic routes. 
Aplidium trisulfide is of special significance as it is very rare to isolate enantiomeric 
compounds from marine sources.  
 
Two other closely related marine alkaloids fasmerianamine A and B are also of 
synthetic interest to us due to their close resemblance to the structure of aplidium 
trisulfide. The fasmerianamines were isolated by Copp et al from the marine ascidian 
Hypsistozoa fasmeriana in 2001. 
 
 
Keywords: polysulfide, ascidians, aplidium, trisulfide, varacin, fasmerianamine 
 
 
 
 
 
 
 
 
 2
Contents 
 
i. Acknowledgments…………………………………………………………………...4
       
ii. List of abbreviations………………………………………………………………...5
       
1. Introduction………………………………………………………………………..7 
1.1. Ascidians…………………………………………………………………….10 
1.2. Biological activity…………………………………………………………...11 
1.3. Discovery – isolation and characterisation      
1.3.1. Varacin……………………………………………………………….18 
1.3.2. Lissoclinotoxin……………………………………………………….22 
1.3.3. Aplidium trisulfide…………………………………………………...27 
1.3.4. Fasmerianamine……………………………………………………...30 
1.3.5. Polycarpine…………………………………………………………..31 
1.3.6. Lissoclibadin…………………………………………………………33 
1.4. Previous polysulfide synthesis 
1.4.1. Behar and Danishefsky (Varacin)……………………………………37 
1.4.2. Davidson (Varacin)…………………………………………………..41 
1.4.3. Davidson (Lissoclinotoxin A) …………………………………….….43 
1.4.4. Stille and Toste (Varacin)…………………………………………….44 
1.4.5. Novikov (Polycarpine)……………………………………………….46 
 
2. Results and discussion        
2.1. Initial route 
2.1.1. Formation of key secondary alcohols ………………………………..48 
2.1.2. Manganese dioxide oxidations……………………………………….51 
2.1.3. Thioketone formation ………………………………………………..54 
2.1.4. Grignard additions……………………………………………………59 
2.1.5. Functionalising the olefin…………………………………………….61 
2.2. Thiocarbonyl-metal complexes……………………………………………...67 
2.3. Sulfide intermediates 
2.3.1. Retrosynthesis………………………………………………………..70 
 3
2.3.2. Synthon A……………………………………………………………71 
2.3.3. Synthon B…………………………………………………………….74 
2.3.4. Sulfide coupling reaction…………………………………………….77 
2.3.5. Sulfide alkylations……………………………………………………79 
2.3.6. Attempted Synthesis of Cyclic Mono-Sulfide……………………….81 
2.4. Less Hindered Route………………………………………………………...83 
2.5. [3,3] Rearrangements………………………………………………………..93 
2.6. Conclusions………………………………………………………………….96 
   
3. Experimental         
3.1. General information…………………………………………………………98 
3.2. Synthetic procedures………………………………………………………...99 
 
4. References ………………………………………………………………………143 
   
5. Appendices 
5.1. X-ray crystal data and structure refinement for 2-(Benzo[1,3]dioxol-5-yl-tert-
butylsulfanyl-methyl)-1-methyl-1H-imidazole…………………………….147 
5.2. X-ray crystal data and structure refinement for (4-Benzyloxy-3-
methoxyphenyl)-(1H-imidazol-2-yl)-methanone…………………………..154 
5.3. X-ray crystal data and structure refinement for Benzo[1,3]dioxol-5-yl-(1H-
imidazol-2-yl)-methanone………………………………………………….159 
 
 
 
 
 
 
 
 
 
 
 
 
 4
i. Acknowledgments 
 
I would firstly like to thank Dr George W. Weaver for giving me the opportunity to 
carry out my PhD research under his supervision. I would also like to thank him not 
only for his endless advice but also for his enthusiasm and encouragement throughout 
my time at Loughborough University. I would like to thank the EPSRC for sponsoring 
my research as without funding this work wouldn’t have been possible. I would 
finally like to thank the support staff and many friends that I’ve made within the 
chemistry department for their help and advice and for providing an enjoyable place 
to work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5
ii. List of abbreviations 
 
Aq.   -  aqueous 
Bn    - benzyl 
Boc   - t-butoxycarbonyl 
bp   - boiling point 
bs    - broad singlet 
CD   - cyclodextrin 
d   - doublet 
DCM   - dichloromethane 
DDQ   - 2,3-dichloro-5,6-dicyano-benzoquinone  
DEAD   - diethyl azodicarboxylate 
DMAD  - dimethylacetylene dicarboxylate 
DMAP   - 4-dimethylaminopyridine 
DMF   - dimethylformamide 
DMSO   - dimethylsulfoxide 
dd   - doublet of doublets 
EI   - electron ionisation 
ES   - electrospray 
FAB   - fast atom bombardment 
GC   - gas chromatography 
HRMS   - high resolution mass spectrum 
IR   - infrared 
m   - multiplet 
mCPBA  - meta-chloroperbenzoic acid 
mp   - melting point 
NBS   - N-bromosucinimide 
NTS   - N-thiocyanatosuccinimide 
PDC   - pyridinium dichromate 
RBF   - round bottom flask 
s   - singlet 
t   - triplet 
TBAF   - tetra-n-butylammonium fluoride  
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1 - Introduction 
 
Biologically active compounds isolated from marine tunicates have been an area of 
increasing interest since the late 1980’s. It is noteworthy that some 90% of reported 
tunicate secondary metabolites are nitrogenous with many compounds displaying 
remarkable bioactivity.1 For this reason the newly isolated polysulfide secondary 
metabolites are of great biological and synthetic interest. 
 
Although a wide range of marine polysulfides have now been isolated, characterised 
and biologically tested, they were not in fact the first polysulfur containing 
compounds to be studied. 5-Methylthio-1,2,3-trithiane2, 3 (1), 5-carboxyl-1,2,3-
trithiane4 (2), and lenthionine5, 6, 7 (3) are three more basic structure polysulfides 
which have been isolated from less exotic sources. 
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Figure 1: Three naturally occurring polysulfides derivatives 
 
 
5-Methylthio-1,2,3-trithiane (1) has been isolated by gas-phase extraction from the 
green alga Chara globulares and was identified by GC-MS and 1H NMR 
spectroscopy.2 Interestingly, 5-carboxyl-1,2,3-trithiane (2) has been isolated from the 
lower part of the asparagus shoot by extracting with ethanol.4 The 1,2,3,5,6-
pentathiepane lenthionine (3) has been isolated from Shiitake mushrooms and was the 
first cyclic polysulfide to be isolated from an organism. However, in the first reported 
isolation it was suggested that lentionine was not a compound present in Shiitake 
mushroom but was a product of enzyme action on an unknown precursor whilst the 
mushrooms were immersed in water. Further work on this by Chen et al. led to the 
isolation of eighteen different sulphur containing compounds and it is now believed 
these compounds originate from lentinic acid.8 
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In 1989 one of the first marine polysulfide compounds (+)-Aplidium trisulfide (5) was 
isolated from a marine tunicate. (+)-Aplidium trisulfide was isolated from 
methanol/water extracts of Aplidium sp. D found in New Zealand by Munro et al. The 
compound was purified by HPLC and isolated as a yellow gum. Later screening 
showed that Aplidium trisulfide exhibites in vitro antimicrobial, antileukemic and 
cytotoxic properties.9 Enantiomeric compounds from marine sources are very rare, the 
(-)-enantiomer was more recently isolated by Copp et al. from Hypsistozoa 
fasmeriana along with two other novel dithiane alkaloids, fasmerianamine A (6) and 
fasmerianamine B (7).10 
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Figure 2: Varacin, aplidium trisulfide and two novel 1,3-dithiane alkaloids  
 
 
Varacin (4) is another well known marine polysulfide natural product which contains 
a pentathiepin ring and notably has a similar carbon framework to dopamine. Varacin 
was isolated in 1991 by Ireland et al. from the ascidian Lissoclinum vareau collected 
from the Fiji islands. Varacin was screened for biological activity and has shown 
potent antifungal activity as well as cytotoxicity towards human colon cancer 100 
times that of 5-fluorouracil. Varacin was also screened against a range of different cell 
lines, and preliminary results have shown that varacin damages DNA.11 
 
The examples already mentioned are just a few of the many marine polysulfide 
compounds which have now been discovered. Many of the polysulfides isolated 
exhibit some type of biological activity and this is a major reason for our interest in 
this area. The fact that little synthetic work has been carried out on the synthesis of 
marine polysulfide compounds also opens up an area of unexplored research.  
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Most structural, synthetic and biological work that has been carried out to date has 
focused around pentathiepins, and varacin in particular, with several reported 
syntheses.38,50,53 For this reason we planned to investigate a route towards the 
synthesis of Aplidium trisulfide (5), and secondly the two recently discovered 1,3-
dithiane compounds (6) and (7), all of which, to our knowledge have received no 
synthetic interest to date. Another important reason for our search for a total synthetic 
route is that only minute quantities can be isolated from nature by harvesting large 
numbers of tunicates and thus damaging the marine environment.  
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1.1 - Ascidians 
 
Although 70% of our globe is covered by oceans they remain largely untapped in the 
search for new medicinal and pharmacological agents. The oceans are full of living 
organisms and contain more flora and fauna than the land. It is only therefore logical 
that we now turn to marine organisms in the search for more and varied biologically 
active natural products. Throughout the course of evolution marine organisms have 
adapted to harsh environments, which have led to them developing unique metabolites 
to aid their survival. It is such secondary metabolites from ascidians that have now 
come to light in the last 20 years which are of great interest and in particular the 
highly biologically active polysulfide compounds.12 
 
Ascidians, also known more commonly as tunicates 
or sea squirts, are marine filter-feeding animals which 
often go unnoticed. Tunicates are so called due their 
“tunic” like sac which embodies them, and sea squirts 
because of the apparent squirt of water they expel 
when disturbed. The sedentary adult forms can either 
be solitary or colonial. Solitary forms live alone 
whereas colonial ascidians are able to bud off and 
form colonies which are often mistaken for other 
encrusting marine life such as sponges.15 
 
Although many ascidians go unnoticed as they just look like slimy sacs, ascidians are 
actually more closely related to humans than any other invertebrate group.13 Larval 
ascidians have been observed to have chordate structures including; nerve cords 
(primarily in early development), a ‘notochord’ or firm rod of cells beneath the nerve 
cord (similar to a human backbone), a buccal siphon (where water enters) and an atrial 
siphon (where water is expelled). The pharynx which occupies a large part of the body 
has numerous gill slits which act as a sieve for food. Mucus produced allows the 
filtered food to be moved into the upper digestive tract, this movement is aided by 
cilia. Ascidians also have a tubular heart which has been found to contract in dual 
directions.14 
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1.2 – Biological Activity 
 
The use of organosulfur compounds to control infectious disease goes back thousands 
of years, where homeopathic medicine extracts and oils from vegetables such as 
garlic, onions, shallots, chives and scallions, were used successfully to treat bacterial 
infections.16  For example, Allicin (8) has now been identified as the primary agent 
responsible for garlic’s antibacterial properties.17 Allicin has been shown to have 
potent in vitro antibiotic activity against many bacteria including E. coli and S. 
aureus.18 The likely mode of action of Allicin involves reaction of the thiosulfinate 
with cellular thiols to produce a mixed disulfide.19 
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Figure 3: Sulfur containing compounds from garlic 
 
Two other compounds found in garlic, diallyl sulfide (9) and diallyl disulfide (10) 
have been found to exhibit potent activity against methicillin resistant S. aureus 
(MRSA).20 The mechanism of action is not yet fully understood but undoubtedly 
relies on the sulfur functionality.21 
 
It is important to note though, that the presence of sulfur in a biologically active 
molecule may not actually give the compound its biological effects. For example, in 
beta-lactam antibiotics such as amoxicillin (11) and ampicillin (12), the sulfur atom is 
not believed to be involved in the mechanism of action.  
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Figure 4: beta-lactam antibiotics 
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Many marine polysulfide compounds are extremely biologically active and display 
antibacterial, antifungal, or anticancer properties. However, in most cases, the reason 
for their biosynthesis or use within an organism, and the mechanism of their 
biological action remains widely unknown.  
 
Organosulfur compounds which contain thiols are often relatively reactive. Thiols can 
act as strong nucleophiles or reducing agents depending on the electrophile present 
and the reaction environment. Di- and tri-sulfides can act as electrophiles when in the 
presence of thiophilic nucleophiles, resulting in sulfur-sulfur bond cleavage.  
 
It is important to note, that although free thiols can be responsible for biological 
activity, they will also have the potential to dimerise which will reduce their 
biological activity. Metal-thiol coordination can prevent these dimers forming without 
destroying the overall activity of the thiol. 
 
A mechanistically interesting group of biologically active trisulfides which utilise the 
nucleophilic activity are the enediyne antibiotics. Calichemicin (13) and the closely 
related structure of Namenamicin (14) have both been shown to exhibit potent anti-
tumour activity.22, 23 
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Figure 5: Enediyne antibiotics 
 
Both compounds have been shown to undergo a cascade of intramolecular reactions 
resulting in the formation of a highly reactive diradical species (scheme 1). In the first 
step of the process, reaction of the trisulfide group with glutathione generates a free 
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thiolate anion which in turn undergoes a Michael-type addition across the α,β-
unsaturated ketone. This subtle change in hybridization of the carbons allows the 
enediyne to undergo a Bergman cycloaromatization93, producing the phenylene 
diradical. These diradicals are believed to cleave DNA by sequentially stripping off 
hydrogen atoms along the minor grove of the double helix. The sugar radical then 
reacts with O2 to form unstable peroxides.24 
 
O
S
S
S
Me
HO
NH
O
OMe
RO
GSH
O
HS
HO
NH
O
OMe
RO
O
HO
NH
O
OMe
ROS
O
HO
NH
O
OMe
ROS
DNA damaging 
diradical
Scheme 1: Enediyne cascade reaction 
 
Although there are many biologically active compounds with a single sulfur or linear 
chain of sulfur atoms, it is much rarer to find biologically active compounds 
containing a polysulfide ring. One example, leinamycin (15) represents a new class of 
DNA-damaging agents which has an interesting dual mechanism of action.  
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Figure 6: Structure of leinamycin 
 
In 1997 Gates investigated into the biological activity of leinamycin which has been 
shown to exhibit potent antitumour activity. Gates found that leinamycin reacted with 
intercellular thiols yielding an electrophilic oxathiolanone (scheme 2). This is then 
trapped via an intramolecular reaction to yield an episulfonium alkylating species 
which can then alkylate the N7 residue of guanine leading to its cytotoxic behaviour.25 
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Scheme 2: Routes of action of Leinamycin’s Bioactivity 25 
 
Gates also found that polysulfides formed during the formation of the episulfonium 
alkylating species could also produce cell damaging hydroxyl radicals. This led Gates 
to believe that leinamycin’s bioactivity could also be due to a thiol-dependant 
conversion of molecular oxygen to a hydroxyl radical via a trace metal dependant 
Fenton reaction (scheme 3). Leinamycins biological activity is now believed to be due 
to both alkylating and cleaving mechanisms. 
 
O O O O H2O2 + Mn+ H O + M(n+1)+
-
 
 
Scheme 3: Hydroxyl radical produced via a Fenton reaction 
 
Gates’ finding that leinamycin is a thiol-dependant DNA-cleaving agent may also be 
relevant to other polysulfide containing natural products such as varacin, 
lissoclinotoxin and even disulfides such as polycarpine.  
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Gates continued his research into polysulfide activity by examining an analogue of 
varacin, 7-methylbenzopentathiepin (16). Similar cytotoxic results were recorded for 
the analogue as previously found for varacin, reinforcing the idea that 7-
methylbenzopentathiepin is also thiol-mediated in its DNA-cleaving activity.26 
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Scheme 4: Thiol reaction with 7-methylbenzopentathiepin 
 
Additionally Gates found that the reactivity of polysulfide anions (17) generated in 
the reaction with thiols are key intermediates in the generation of the oxygen radicals 
responsible for cleaving DNA. The oxygen radical most likely converts to hydrogen 
peroxide, then forming the highly reactive hydroxyl radical which then leads to either 
sugar-phosphate or sugar-base cleavage. 
 
Recently Greer has produced a theoretical study which investigated a novel S3-
cleavage in the decomposition of pentathiepins. He postulated an inter-conversion 
between the pentathiepin and an open chain polysulfur anion intermediate. Further 
theoretical calculations were performed by Greer, and these provided evidence for an 
open chain polysulfur anion intermediate (18), from which S3 is able to dissociate 
from due to the weak bonds between sulfur four and sulfur five.27 
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Figure 7: Open chained polysulfide before S3 loss 
 
Chan attempted to answer the question of polysulfide bioactivity through the 
effectiveness of converting circular super-coiled DNA into the circular relaxed form. 
His investigation showed that polysulfide compounds such as varacin do indeed 
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cleave DNA, and further investigations into the activation of the compounds showed 
that thiols were necessary to initiate DNA cleaving activity. Chan also investigated 
the effects of pH on the activity and found that at acidic pH the cleaving activity is 
significantly higher than at lower pH levels.29 
 
In an attempt to determine the reactive species involved in the DNA cleavage, Chan 
also observed the effects of a range of nucleophiles and free radical scavengers and 
found that the DNA cleaving reaction was reduced by the addition of superoxide 
radical scavenger dithiothreitol (DTT). Chan also found that the catalase enzyme 
(which reduces H2O2 concentration) exhibited significant inhibitory effects on the 
DNA cleaving reaction, providing a vast amount of evidence that the DNA cleaving 
reaction is indeed radical mediated.30 
 
In 2002 Greer examined the question ‘why are some pentathiepins more biologically 
active than others?’ It was already known that the polysulfide ring is very important 
for the compounds biological activity, but several active compounds also contained a 
remotely bonded amine substituent.28 
 
It had been suggested that the open chain polysulfide was possibly the product of an 
intramolecular ring opening reaction involving the adjacent amine group present on 
varacin. Sato has previously reported that the presence of the amine group does in fact 
enhance the biological activity of the pentathiepin.31 
 
Greer devised a computational study to examine the amines role in the biological 
activity of pentathiepin compounds. The study showed that primary or secondary 
amines were able to allow for an intramolecular addition to the pentathiepin ring near 
to the S1 atom. This leads to nucleophilic attack, followed by sulfur ring opening and 
finally results in the loss of S3 (scheme 5).28 
 
 
 17
NH2
S
S
S S
S
S
S
SSS-
NH
-H+
S-
S
NH
+ S3
 
 
Scheme 5: The role of the amine in the loss of S3 
 
The loss of the S3 had already been reported as being a key intermediate in the 
generation of hydroxyl radicals involved in the cleaving of DNA. Greer was therefore 
able to conclude that amines play an important role in the generation of these 
intermediates and this may have a dramatic affect on the activity of a particular 
polysulfide.  
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1.3 - Discovery: Isolation and Characterisation 
1.3.1 - Varacin 
 
In 1990 Davidson et al. isolated the benzopentathiepin varacin (19) from a sample of 
Lissoclinum vareau, a lavender coloured encrusting species found in the Fiji islands. 
Varacin was isolated by homogenising 55g of freeze dried tissue and using solvent 
partitioning to isolated 360 mg of CHCl3 soluble material. Silica gel column 
chromatography followed by reverse-phase HPLC yielded 40 mg (0.07%) of varacin 
as a light brown glass.11 
S S
S
SS
HN
OMe
MeO
20
O
F
F
F
S S
S
SS
NH2
OMe
MeO
19  
 
Figure 8: Varacin and its trifluoroacetamide derivative  
 
The structure of varacin was first predicted by Davidson to have the formula 
C10H13NO2S5 from the FAB mass spectrum of the trifluoroacetamide protected amine 
(20) which displayed a prominent ion at m/z 435. High resolution electron impact 
ionisation mass spectrometry was used to confirm the accurate mass of 434.9378 for 
C12H12F3NO3S5. Additionally the 13C NMR spectrum showed the expected ten carbon 
signals, including six aromatic. 1H NMR spectroscopy also showed two strongly 
coupled methylene signals at δ 3.15 and 3.25 ppm and a singlet at δ 7.07 ppm for a 
suspected lone proton on the penta-substituted benzene ring. Confirmation of this 
structure was obtained by reducing varacin with tert-butoxy-aluminium hydride, and 
then quenching with methyl iodide to yield (21). 
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Figure 9: Reduced form of varacin 
 
The mass spectrum of the second compound (21) confirmed the loss of three sulphur 
atoms and the addition of four methyl groups, indicating that the structure predicted 
for (19) was indeed correct.  
 
Three structurally similar marine polysulfides varacin A (22), B (23) and C (24) were 
later isolated by Makarieva et al. in 1995 from the ascidian Polycitor Sp. from tissue 
samples collected in the Sea of Japan. Ethanol extraction was carried out on fresh 
tissue samples and the ethanol extract was shown to have potent antimicrobial 
activity.32 
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Figure 10: Varacin’s A-C 
 
The crude extracts were then purified by several stages of silica gel column 
chromatography yielding a mixture of the active components. At this stage 
identification of varacin (19) was carried out using NMR and mass spectrometry 
methods. The acetates of varacin A-C (22a/23a/24a) were then isolated by treatment 
of the crude mixture with Ac2O/pyridine followed by HPLC. The previously 
undescribed acetate of varacin (25) was also isolated and this showed loss of S2 in the 
FABMS giving peaks at both m/z 381 and 317. 
 20
The 1H NMR spectra of (25) and (22a) were very similar apart from the aromatic 
proton signal shifting from 7.13 ppm to 6.49 ppm respectively. This led Makarieva to 
believe that there was a structural difference in the sulfur ring. The NMR data 
gathered together with FABMS and EIMS data allowed Makarieva to conclude that 
the structure of varacin A was indeed (22). 
 
It had previously been reported though that benzopentathiepins are capable of 
decomposing into elemental sulfur and benzotrithioles,33 which meant there were 
some questions over whether varacin A was in fact a natural product. Makarieva 
decided to investigate into this and found that solutions of (19) or (25) would readily 
equilibrate to mixtures of (19) and (22), or (25) and (22a) respectively.32 
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Scheme 6: Benzopentathiepin/benzotrithiole equilibrium 
 
Approximately 10 - 20% conversion of the benzopentathiepin to benzotrithiole was 
detected at room temperature after 100 h in MeOH-d4, and 45% conversion was seen 
after 1 year. Refluxing benzopentathiepin in pyridine for 20 min also yielded around 
45% conversion to the benzotrithiole. Interestingly the addition of S8 to an 
equilibrated mixture under the same conditions would lead to the regeneration of the 
benzopentathiepin and depletion of the benzotrithiole by as much as 10% in 15 min. 
 
The acetates of varacin B (23a) and C (24a) which were also formed were shown by 
EIMS and FABMS to have just the addition of one oxygen atom compared to (22a). 
The EIMS of both varacin B and C showed the loss of one oxygen atom and gave the 
expected peak at m/z 317 suggesting that the two isomers contained an S-oxide.34, 35 
IR spectroscopy also revealed the characteristic absorption of a C-SO-S at 1085 cm-1. 
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Finally, 1H NMR spectroscopy showed that the methylene signals for (23a) were 
shifted downfield, this combined data allowed Makarieva to conclude that varacin B 
was the 3-S-oxide and varacin C was the 1-S-oxide. 
 
Further studies to see whether varacin B and C were formed due to decomposition of 
varacin were carried out in MeOH and Makarieva found that neither compound was 
formed after 1 year. Therefore it is likely that the S-oxides are natural products. 
 
Biological testing which was later carried out on varacin A-C and their acetates 
showed potent in vitro antifungal and antimicrobial activity. This goes against earlier 
suggestions that the amine group side chain is necessary for benzopentathiepins to 
exhibit biological activity.32 
 
In 1994 in their search for new PKC inhibitors, Faulkner and Compagnone discovered 
a range of varacin type compounds isolated from Lissoclinum and Eudistoma sp. 
ascidians. N,N-dimethyl-5-(methylthio) varacin (26) and 5-(methylthio) varacin (27) 
were isolated along with their corresponding trithianes (28) and (29) as reportedly 
inseparable mixtures.36 
 
OMe
MeO
NR2
MeS S S
S
SS
26 = Me
27 = H
OMe
MeO
NR2
MeS
OH
HO
NH2
S S
S
SS
28 = Me
29 = H
30
S
S
S
 
 
Figure 11: Further varacin type structures isolated by Faulkner and Compagnone 36 
 
Although the trithiane and pentathiepin analogues were inseparable, Faulkner and 
Compagnone went on to screen the mixtures for PKC inhibition. The mixture of (27) 
and (29) proved the most potent (IC50 = 0.3 µg/ml) along with another newly isolated 
compound 3,4-desmethyl varacin (30) which had similar activity. 
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1.3.2 - Lissoclinotoxin 
 
In 1991 Guyot and Litaudon reported the isolation of the first lissoclinotoxin, which 
would later be found to be one of a series of different lissoclinotoxin structures. 
Lissoclinotoxin A was isolated from the ascidian Lissoclinum perforatum using 
methanol extraction followed by silica gel chromatography and further preparative 
HPLC purification. Spectral analysis carried out by Guyot and Litaudon led them to 
report the structure of lissoclinotoxin A as (31).37   
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Figure 12: The originally proposed structure for lissoclinotoxin A.37 
 
Davidson et al. lay question to the assigned structure of lissoclinotoxin A whilst 
publishing work on the synthesis of varacin in 1993.38 Davidson originally suggested 
that lissoclinotoxin was more likely to possess the structure (32), but after carrying 
out synthetic work, concluded that it was more likely to be the regioisomer (33). At 
this point Davidson decided to name the synthetic polysulfide (32) 
isolissoclinotoxin.39 
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Figure 13: The newly confirmed structure of lissoclinotoxin (32) and the  
synthetic polysulfide isolissoclinotoxin (33).39 
 
A year later in 1994 Guyot and Litaudon et al. published two further papers, both 
detailing the newly isolated compound lissoclinotoxin B (34), but also confirming the 
revised structure of lissoclinotoxin as (33).40,41 
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Lissoclinotoxin B was isolated as a minor product from the extraction of Lissoclinum 
perforatum as a yellow powder after extensive silica gel chromatographic purification. 
1H NMR spectra showed that lissoclinotoxin B only differed from spectra of 
lissoclinotoxin A in the absence of one aromatic proton suggesting it was likely that B 
was a cyclised derivative of A. Further long-range heteronuclear correlation 
experiments (HMBC) confirmed that lissoclinotoxin B was indeed (34). 
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Figure 14: The structure of lissoclinotoxin B 
 
Later in 1994, Searle and Molinski reported the isolation of lissoclinotoxin A which 
they now reported as being chiral, along with two new natural products, 
lissoclinotoxin C (35) and D (36), isolated from lissoclinum sp. collected near the 
Great Barrier Reef, Australia. Biological screening of the three toxins showed that 
lissoclinotoxin A and D both exhibited antifungal activity against Candida albicans.42 
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Figure 15: The structures of lissoclinotoxin C and D 
 
Lissoclinotoxin C (35) was isolated as it N-trifluoroacetamide as a colourless 
amorphous solid and showed a close structural relationship to lissoclinotoxin A (32). 
High resolution FABMS gave a formula of CllH17NO2S2, (m/z 260.0799, M+H+), 
revealing only two sulfurs and two extra carbons. 1H NMR spectroscopy showed an 
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additional two SCH3 groups when compared to the spectrum of lissoclinotoxin A 
leading to structure (35) being assigned as Lissoclinotoxin C. 
 
Mass spectrometry directly on lissoclinotoxin D was unsuccessful, but by derivatising 
to form the corresponding N-trifluoroacetamide, both positive (M+H+, m/z 651) and 
negative (M-H-, m/z 649) parent ions were observed in the FABMS. The possibility 
of lissoclinotoxin D being a degradation product is ruled out due to the lack of similar 
dimer formation in the FABMS of lissoclinotoxin A’s N-trifluoroacetamide product.  
 
The homo-dimer was assigned due to only a single aryl proton being observed in the 
1H NMR spectrum. The “head-to-tail” structure was assigned due to it being the more 
energetically favourable but Searle and Molinski did not rule out the possibility of a 
“head-to-head” type structure (Figure 16).42 
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Figure 16: The two possible structures of lissoclinotoxin D 
 
As well as the isolation of these two new lissoclinotoxins, Searle and Molinski also 
concluded that lissoclinotoxin A is chiral due to the diastereotopic protons observed 
for the side chain methylene groups in the 1H NMR spectrum. The benzylic H2 signals 
(δ 3.20, ddd, 1H, J = 6.4, 8.4, 13.4 Hz and δ 3.28, ddd, 1H, J = 6.4, 8.4, 13.4 Hz), and 
the vicinal H2 signals (δ 3.55, 1H, m and δ 3.62, 1H, m) were resolved and interpreted 
at 500 MHz. The four mutually coupled protons do not give rise to signals with the 
commonly expected AAXX spin coupling pattern, but appear as an ABXY pattern 
with four distinct chemical shifts and geminal couplings ('J 13.4 Hz).42 
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Searle and Molinski further conclude that it is most likely that chirality is due to a 
high barrier to ring inversion of the pentathiepin ring. The higher barrier of 
approximately 29 kcalmol-1 being due to a unfavourable eclipsing of the sulfur lone 
pairs when passing through the transition state (Figure 17).42 
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Figure 17: Lissoclinotoxin A ring inversion 
 
In 2003, Ireland and co-workers isolated two new natural products lissoclinotoxin E 
(37) and lissoclinotoxin F (38), along with the previously isolated lissoclin 
disulfoxide44 (39) from methanol extracts of the Philippine didemnid ascidian. When 
screened for biological activity, lissoclinotoxin E and F both showed IC50 value of 2.3 
and 1.5 µg/ml respectively towards a PTEN-deficient human breast carcinoma cell 
line.43 
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Figure 18: The structures of lissoclinotoxin E and F, and lissoclin disulfoxide. 
 
The major metabolite lissoclinotoxin E, and minor metabolite lissoclinotoxin F were 
both isolated as a light brown film using solvent partitioning and semi-preparative 
HPLC methods. HRCIMS, and 1H and 13C NMR spectroscopy were predominantly 
used to assign the gross structures. The structure relationship between (37) and (38) 
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was confirmed via a desulfurization method using Raney nickel in methanol at 90oC 
which yielded pure 2-(3,4-dimethoxyphenyl)-N,N-dimethylethanamine (40).45 
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Figure 19: The product of desulfurization of lissoclinotoxin E and F 
 
In order to determine the stereochemistry of lissoclinotoxin E and F, Ireland et al. 
performed a computational study using MacroModel software. The data recorded 
allowed them to assign lissoclinotoxin E (37) and F (38) as the trans and cis isomers 
respectively. Unfortunately though, due to small discrepancies in their data they noted 
that the other three possible isomers could not be excluded. Attempts at gaining 
crystalline material suitable for X-ray crystal analysis also proved unsuccessful, and 
to date there has been no reports of any crystalline derivatives of the lissoclinotoxin 
family.43 
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1.3.3 - Aplidium trisulfide  
 
In 1989 as part of a search for new biologically active compounds from marine 
organisms, Munro et al discovered that methanol-toluene extracts from the ascidian 
Aplidium Sp. D exhibited in vitro antimicrobial, antileukemic and cytotoxic 
properties.9 Purification of a freshly prepared methanol-water extract using reverse 
phase chromatography yielded cis-5-hydroxy-4-(4’-hydroxy-3’-methoxyphenyl)-4-
(2”-imidazolyl)-1, 2, 3-trithiane (5) as a yellow gum (48 mg, 0.05%). 
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Figure 20: The structure of cis-5-hydroxy-4-(4’-hydroxy-3’-methoxyphenyl)-4-(2”-
imidazolyl)-1, 2, 3-trithiane 
 
Interestingly Munro found that the same methanol-water extract when left at room 
temperature for one month did not yield (5), but instead yielded the previously 
reported ketone (41).46 The imidazole containing metabolite (41) had previously been 
isolated by Schmitz and Arabshahi in 1988 from Aplidium pliciferum along with two 
other thiazole containing metabolite (42) and (43). 
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Figure 21:  Three previously isolated metabolites from Aplidium pliciferum46 
 
Attempts by Munro to re-isolate (41) from the freshly prepared ascidian extracts 
failed to yield (41) suggesting that the ketone was not a naturally occurring metabolite 
of Aplidium Sp. D. Further to this Munro found no evidence for the occurrence of the 
thiazole containing metabolites. 
 28
Munro decided to investigated further the stability of Aplidium trisulfide (5) and he 
found that although (5) was stable for one month in acidic solution (4% TFA in 
CD3OD), a change occurred over a period of weeks in slightly alkaline (0.02% NaOH 
w/v in CD3OD) or neutral conditions giving a mixture of (5) and two new compounds 
(44) and (45). 
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Figure 22: The two products of the decomposition of (5) in neutral or basic 
conditions 
 
Compound (44) was characterised as an isomer of (5) due to it possessing the same 
1H-13C long range couplings as determined by HMBC, as well as showing the same 
LRMS and HRMS data. Comparison of 1H and 13C NMR data of (5) with (44) 
showed that the two compounds differed by stereochemical inversion at C-4. 
 
Further nOe experiments showed that the naturally occurring trithiane (5) exists as a 
skewed boat conformation in solution and is assigned as 4R, 5S, where as (44) exists 
as a 4S, 5S structure. 
 
The second compound formed through the storage of (5) in neutral or alkaline 
CD3OD was noted as having very similar 1H and 13C NMR data as of that of the 
ketone (41), suggesting the presence of a conjugated electron withdrawing group at C-
1. Munro found that upon acidification of this solution to stop further decomposition, 
signals from the new compound diminished and new signals from the ketone (41) 
appeared. The transformation to (41) was complete after 2 days at room temperature. 
All attempts at utilising HPLC separation to isolate the transient intermediate 
proposed as (45) proved unsuccessful, only yielding further ketone. This is consistent 
with the instability of the thione in aqueous acidic solution. 
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Later in 2001 Copp and co-workers discovered that extracts from the delicate pink 
stalked ascidian Hypsistozoa fasmeriana found off the coast of New Zealand 
exhibited a wide range of biological activities. Specimens of H. fasmeriana were 
collected by scuba from Leigh Harbour and Tutukaka, and kept freeze dried until use. 
The freeze dried samples were extracted with MeOH and CH2Cl2 and the crude 
extract partitioned between water and CH2Cl2. C18 Flash chromatography and semi 
preparative HPLC were used to isolate (-)-(5) as a TFA salt (8mg, 0.18%).10 
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Figure 23: Both (+) and (-) enantiomers of the trisulfide now isolated 
 
All spectral data obtained for the (-) enantiomer were identical to that previously 
report for the (+) enantiomer except the chiroptical properties which were equal in 
magnitude but opposite in sign at every wavelength measured.  
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1.3.4 - Fasmerianamine 
 
In 2001, as well as isolating the newly discovered (-) enantiomer of the aplidium 
trisulfide Copp and co-workers also discovered two entirely new dithiane alkaloids 
(46) and (47) from Hypsistozoa fasmeriana.10 Unfortunately neither of the dithianes 
were found to exhibit biological activity but never the less they represent an 
interesting and novel class of enantiomeric marine polysulfides. 
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Figure 24: The structure of fasmerianamine A (46), and fasmerianamine B (47) 
 
Several features of the fasmerianamines 1H NMR spectra were similar to those of 
aplidium trisulfide (5), which aided structural elucidation. The dithianes were isolated 
as a 2:1 mixture (A:B), and characterised by NMR spectroscopy and mass 
spectrometry. A molecular formula of C26H24N4O6S2 was established for (46) using 
HRFABMS. Extensive NMR spectroscopy allowed Copp to assign the relative 
stereochemistry of (46) as (8α, 10β, 11β)-methyl-2-[3-[11-hydroxy-10-(22-hydroxy-
21-methoxyphenyl)-10-(18H-imidazol-14-yl)-9,13-dithian-8-yl]-1H-indol-2-yl]-2-
oximoacetate. 
 
The 1H NMR data for (47) was almost identical to that of (46) apart from the absence 
of a methyl singlet at δ 4.02. This was replaced by a broad resonance at δ 13.10 which 
suggested the presence of a carboxylic acid functionality. 
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1.3.5 - Polycarpine 
 
Polycarpine was first isolated by Fenical in 1996 when investigating the ascidian 
Polycarpa clavata. Fenical had originally investigated Polycarpa clavata in 1990, 
which had resulted in the isolation of polycarpamines A-E. These unusual, bioactive 
metabolites contained a high percentage of sulfur and novel functional groups. To 
further explore these interesting metabolites a full exploration was undertaken in 
1996, leading, ultimately to the isolation of the novel dimeric disulfide alkaloid, 
polycarpine dihydrochloride (48).  
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Figure 25: The structure of polycarpine 
 
Isolation of polycarpine dihydrochloride was achieved by extraction of the crude plant 
material with 70 % MeOH/CH2Cl2, followed by partitioning of the extract into 
hexane, ethyl acetate, n-butanol and water. Gel-filtration of the n-butanol fraction, 
followed by mild chromatography yielded polycarpine hydrochloride as the sole 
metabolite. Fenical found that if silica gel was used to perform the chromatography 
polycarpine was isolated as the free base (49), with three other degradation products 
(50-52), though this was later over come by using silica flash chromatography and 
reversed phase HPLC. 
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50 – R = OMe, X = S 
51 – R = OH, X = S 
52 – R = OMe, X = O    
Figure 26: Polycarpine: products of degradation 
 
The pure polycarpine hydrochloride was isolated as orange rods, with a melting point 
of 201-203 °C. The molecular formula C22H24N6O2S2 was established using 
HRFABMS and the isotope cluster which was observed confirmed that only two 
sulphur atoms were present. The symmetry element was confirmed by 13C NMR 
where only 11 carbon atoms were observed rather than the expected 22. 
 
The dicationic nature of the metabolite was confirmed by exposure to acetate salts in 
water, which led to the formation of (52), which contained two acetate counter ions. 
 
The remaining structural assignments were achieved by using combined spectral 
methods. In particular 2D-NMR hetero-correlation methods and nOe experiments. 
HMBC correlations were able to link the aromatic proton at C-7 to that at C-5, and 
correlation of the C-11 N-methyl protons to C-1 and C-3.  
 
To meet the requisite molecular formula, a disulfide bridge linking two identical 
halves is required to be positioned at C1 and C1’, resulting in structure (48) as the 
only reasonable candidate. 
 
The free base of polycarpine was isolated as an orange non-crystalline solid, and was 
similar in NMR and mass spectrum to the dihydrochloride form. However, only seven 
resonances were observed in the carbon spectrum, and the proton spectrum had a 
significant broadening of the resonances seen at 3.14 and 7.37, suggesting the 
compound actually exists as a tautomeric mixture in solution. 
 
Polycarpine dihydrochloride has been found to be cytotoxic toward the human colon 
tumor cell line HCT-116 at 0.9 μg/ml. 
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1.3.6 - Lissoclibadin 
 
To date, seven lissoclibadins have been isolated from various ascidians. Lissoclibadin 
1 (53) was the first of these to be isolated and characterised when found in the ethanol 
extract of the ascidian Lissoclinium sp. by Namikoshi et al.47 
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Lissoclibadin 1 was isolated as the tris-TFA salt, with the molecular weight 887 and 
formula (C39H57N3O6S7) being deduced from HRFABMS. The 1H and 13C spectra 
indicated the presence of three identical aromatic amine moieties. By subtracting the 
sum of the three aromatic moieties from the molecular formula of (53), Namikoshi 
was able to ascertain that the compound must contain four additional sulfur atoms, 
and from this, that the aromatic moieties were joined by one disulphide bond and two 
sulphide bonds, giving a 10 membered polysulfide ring. 
 
Later in 2005, Namikoshi, when continuing to investigate extracts from the ascidian 
Lissoclinium sp, isolated Lissoclibadins 2 (54) and 3 (55) from the n-BuOH layer.48 
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Figure 27: The structures of Lissoclibadin 2 and 3. 
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Both lissoclibadin 2 and 3 were isolated as bis-TFA salts. Interestingly, lissoclibadin 2 
was found to have the same molecular formula and weight as lissoclinotoxin F (37), 
and lissoclibadin 3 was found to have the same molecular formula and weight as 
lissoclinotoxin E (38).48 Spectral analysis of each compound showed that both 
lissoclibadin 2 and 3 contained two aromatic amine moieties with the same formula as 
in lissoclibadin 1, and lissoclinotoxins E and F. However, lissoclinotoxin F, shows 
symmetric 1H and 13C signals in relation to the aromatic amine units, whereas 
lissoclibadin 2 shows two sets of signals corresponding to each of the moieties 
indicating the molecule is not of a symmetrical shape. Further, lissoclibadin 2 showed 
an nOe correlation between the OMe of one moiety and the NMe2 of the other, 
proving the compound must be of unsymmetrical shape and enabling the structure of 
lissoclibadin 2 to be correctly assigned. In the case of lissoclibadin 3, 1H and 13C data 
showed only one set of signals corresponding to the aromatic amine units, indicating 
that unlike lissoclibadin 2, lissoclibadin 3 had a symmetric structure. This posed an 
interesting problem, as lissoclinotoxin E had also previously been assigned the same 
symmetrical structure, yet the data for the two compounds was not identical.  
Namikoshi used the nOe correlation between the OMe and NMe found in 
lissoclibadin 3 as evidence that the aromatic amine moieties in lissoclibadin 3 had to 
have a trans orientation, resulting in the structure of lissoclinotoxin E being assigned 
the cis orientation.     
 
In 2006, four further lissoclibadins were isolated by Nakazawa et al.49 This time from 
the ascidian Lissoclinum cf. badium.. The four new compounds Lissoclibadin 4 (56), 
5 (57), 6 (58) and 7 (59) were isolated in Manado, Indonesia, from ethanol extracts.   
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Figure 28: The structures of Lissoclibadin 4-7. 
 
The four new lissoclibadin compounds were all isolated as the bis-TFA salt. In all 
cases the molecular weights and formulas were deduced from HRFABMS and NMR 
studies.  
 
Lissoclibadin 4 gave a molecular weight of 482 and formula of C22H30N2O4S3. As 
with lissoclibadin 2 (54), 1H and 13C spectra showed the existence of two identical 
aromatic amine moieties, however in the case of lissoclibadin 4, the aromatic moieties 
were substituted slightly differently to lissoclibadin 2, with an OH in place of an OMe 
group and a proton replacing the SMe group. Subtraction of these units from the total 
molecular formula of the compound left three sulphur atoms, indicating that the units 
were connected as in lissoclibadin 2, with one disulphide bond and one sulphide bond, 
and as in the case of lissoclibadin 2, the asymmetric structure indicated by the NMR 
data meant that only antiparallel orientation could be possible, leading to the structure 
being assigned as shown. Similar structural analysis on lissoclibadins 5-7 lead to their 
structures also being assigned as shown.  
 
All of the isolated lissoclibadins 1 to 7 have shown various bioactivities, such as 
antifungal activity, antibacterial activity and inhibition of protein kinase C.  
 
For example Namikoshi found that lissoclibadin 1 (53) inhibited the growth of the 
marine bacterium R. atlantica strain TUF-D11 (15.2mm at 20 µg/disk) but 
interestingly was not active against E. coli IAM 12119T, S. aureus IAM 12544T, S. 
cerevisiae IAM 1438T, M. hiemalis IAM 6088 at 50 µg/disk. 
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Namikoshi also found that lissoclibadins 1 to 3 showed cytotoxicity against the 
human leukemia cell line HL-60 at IC50 values of 0.37 (0.33), 0.21 (0.13), and 5.5 
(3.16) µM (µg/mL), respectively. 
 
Whereas, the more recently discovered lissoclibadins 4-7 (56-59) did show weak 
antibacterial activity against S. aureus and E. coli, two of the dimeric lissoclibadins 
compounds (57) and (58) also showed modest anti-yeast activity against S. cerevisiae. 
Nakazawa postulated that it was possible that the phenol group in (57) and (58) may 
mediate their antimicrobial activity but as yet no actual mechanism of action has been 
proposed for these compounds.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 37
1.4 - Previous Polysulfide Synthesis 
1.4.1 - Behar and Danishefsky (varacin) 
 
Behar and Danishefsky50 presented the first publication on their attempted synthesis 
of varacin in May 1993. Their work was spurred on by their broader interest in 
polysulfide containing anti-tumour antibiotics, but it was necessary to overcome 
several problems during the synthesis. Most noticeably were the problems of 
interaction between the primary amino and pentathiepin groups, which had previously 
been documented as incompatible, and the actual incorporation of the pentathiepin 
ring onto an aromatic ring was to prove a challenge. 
 
The synthesis (scheme 7) began with a Diels-Alder reaction between 2, 3-dimethoxy-
1, 3-butadiene (61) and dimethylacetylene dicarboxylate (62) (DMAD). The product 
was immediately oxidized with DDQ to yield diester (63). Treatment of the diester 
(63) with nitronium tetrafluoroborate (NO2BF4) in sulfolane (tetramethylene sulfone) 
yielded the corresponding nitrodiester (64). At this point it was necessary to 
distinguish between the methyl ester groups to continue the synthesis. This was 
accomplished by hydrolyzing the less hindered methyl ester group to yield the 
carboxylic acid (65), and then converting this to its corresponding acid chloride. This 
could then be treated with excess diazomethane to yield the diazoketone (66). Silver 
benzoate was then used to promote a Wolff rearrangement to first yield the methyl 
ester (67) and then the acid (68). Reduction with borane followed by reaction with 
LiOH provided the required benzyl ester (69), silylation of the primary alcohol and 
hydrogenation of the nitro and benzyl ester yielded the protected anthranilic acid (70).  
 
Once the formation of the acid had been completed, the next step was the 
incorporation of sulphur into the molecule.  To achieve this, the previously 
synthesized acid compound (70) was reacted with isoamyl nitrite in the presence of 
carbon disulphide and isoamyl alcohol. The compound was then directly subjected to 
thermal decomposition under the assumption that the previous reaction would have 
yielded the diazonium carboxylate salt. This assumption proved to be correct when 
thermal decomposition yielded the expected compound (71) in 40% yield. The 
installation of the nitrogen substituents was achieved in two steps by removal of the 
silyl protecting group to yield the alcohol, and then a subsequent Mitsunobu reaction 
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using phthalimide to yield (73). It was found to be necessary to be able to remove the 
amino protecting group with mild acidic conditions, as harsher conditions resulted in 
decomposition of the pentathiepin ring, as such the tert-butyl carbamate protecting 
group was used (73).  
 
The pentathiepin ring posed the most unique problem. Behar and Danishefsky found a 
solution to this synthetic step by the treatment of (73) with S2Cl2 which resulted in 
both the removal of the ortho ester and the formation the pentathiepin ring (74). 
Finally removal of the nitrogen protecting groups was performed using methanolic 
HCl. The resulting compound was then purified using reversed-phase HPLC to yield 
the trifluoroacetate salt of varacin (75). However, the actual synthesis of free varacin 
(76) was found to pose a further problem due to the aforementioned interaction 
between the amino group and the pentathiepin ring. All the desalting techniques used 
resulted in rapid decomposition, thought to be initiated by the free amino group 
attacking the pentathiepin ring. This led Behar to believe that varacin is only stable at 
physiological pH as it is able to exist in protonated form.   
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Scheme 7: (a) PhMe, CHCl3, Reflux; (b) DDQ, PhMe [78% for 2 steps] (c) 
NO2BF4, sulfolane [77%]; (d) LiOH, THF, H2O [quantitative]; (e) PhMe, 
(COCl)2, cat.DMF; (f) excess CH2N2, Et2O [79% from 65]; (g) Silver Benzoate, 
TEA, MeOH [76%]; (h) BH3.THF, THF; (i) BnBr, NaHCO3, TBAI, DMF (92% 
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from 68); (j) TBDPSCl, TEA, DMAP, DCM [90%]; (k) H2, Pd(OH)2, THF; H2, 
Pd-C, EtOH [94%]; (l) isoamyl nitrate, isoamyl alcohol, CS2, 1,2-dichloroethane, 
75oC [40%]; (m) TBAF, THF [93%]; (n) phthalimide, DEAD, PPh3, THF; (o) 
hydrazine, EtOH; (p) (Boc)2O, DMAP, DCM [55% from 72]; (q) S2Cl2, THF; (r) 
MeOH, HCl [46% from 73] 
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1.4.2 - Davidson (varacin) 
 
Before the synthesis of varacin by Behar and Danishefsky50 and Davidson,38 there 
was much discussion over the actual structure of varacin because the structure had 
been assigned purely on spectroscopic data, and there remained the question of if the 
compound existed solely as a pentathiepin compound or as a mixture of pentathiepin 
and trithiane ring systems. Davidson decided that a total synthesis of varacin would 
provide a definitive answer to this question.  
 
Davidson’s approach was to form the pentathiepin ring via the addition of sulfur 
monochloride (S2Cl2) to an appropriate pre-constructed dithiol or dithiolate 
precursor.38 To arrive at the dithiolate precursor Davidson used a route in which 
vanillin (77) was converted to 2,3-dibromoveratraldehyde (78) in three steps, this was 
found to be more efficient than using a single step process. To incorporate the sulphur 
into the compound the aldehyde (78) was treated with cuprous n-butylmercaptide in 
quinoline/pyridine to yield a mixture of (79) and the two possible monodemethylated 
compounds. The aldehyde (79) was methylated and then treated with nitromethane in 
HOAc/NH4OAc to give the nitro compound (80), which was subsequently reduced 
with LiAlH4 to give the phenethylamine side chain, which was protected with a β-
(trimethylsilyl)ethoxycarbonyl group to yield (81). Removal of the n-butyl groups to 
yield the dithiolate compound was effected by treating compound (81) with Na/NH3. 
The addition of S2Cl2 to the dithiolate yielded two products (82) and (83). Separation 
of these compounds was achieved using flash-chromatography or reversed phase 
HPLC. Compounds (82) and (83) were found to give very similar NMR spectra, 
however, Davidson was able to identify some significant differences which enabled 
each compound to be identified. From these Davidson was able to indentify 
compound (82) as the benzopentathiepin and (83) as the benzotrithiane.  
 
Exposure of (82) to TFA in chloroform provided the trifluoroacetate salt of varacin 
(84) and the spectroscopic data matched that reported for the natural product. 
Davidson obtained further confirmation of the presence of a pentathiepin ring by the 
conversion of the TFA salt of varacin into the N-trifluoroacetamide (85) with TFAA. 
HRMS of this compound gave a molecular ion consistent with the formula 
C12H12F3NO3S5. However, despite repeated attempts Davidson also found that 
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deprotection of (82) to yield free varacin resulted in rapid decomposition into several 
uncharacterisable products.  
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Scheme 8: Davidson’s synthesis of varacin 
 
 
 
 
 
 
 
 
 
 
 
 43
1.4.3 - Davidson (isolissoclinotoxin A) 
 
During his synthesis of varacin, Davidson also examined structure of lissoclinotoxin 
A by the synthesis of isolissoclinotoxin A.39 The Davidson’s synthesis of 
isolissoclinotoxin A follows the same synthetic route as that used in the previous 
synthesis of varacin up to compound (79) where instead of methylating the free 
alcohol a MOM group was used instead. This enables the protecting group to be 
easily removed to yield the required compound. The MOM protected compound (86) 
was then treated with nitromethane in HOAc/NH4OAc to give the nitro compound 
(87), which was subsequently reduced with LiAlH4 to give the phenethylamine side 
chain, which was protected with a β-(trimethylsilyl)ethoxycarbonyl group to yield 
(88). As in the previous synthesis of varacin the SBu groups were reduced using 
Na/NH3 which was followed directly with treatment of the dithiolate groups with 
S2Cl2 resulting in the formation of a 3:2 mixture of compounds (89) and (90). These 
compounds where found to have many of the spectral characteristic observed in the 
varacin intermediates (82) and (83), enabling Davidson to postulate that (89) 
contained a pentathepin ring and (90) a trithiane ring. Further evidence of this was 
obtained by the conversion of (89) to the TFA salt (91), which was then further 
reacted with TFAA to yield the N-trifluoroacetamide derivative (92). HRMS of 
compound (92) was found to show that the compound had a molecular formula of 
C11H10F3NO3S5, consistent with the presence of a pentathiepin ring. 
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1.4.4 - Still & Toste (varacin) 
 
Still and Toste53 in their attempts to synthesis the polysulfide varacin decided on an 
approach that introduced only a single sulphur using S2Cl2 in a method first reported 
by Chenard and co-workers. This system was initially investigated using the model 
system shown in scheme 8, where p-toluenethiol (93) is doubly lithiated and then S8 is 
used to yield 7-methylbenzopentathiepin (94) in 56% yield. However, due to 
contamination of 7-methylbenzopentathiepin via this method, a more reliable route 
was devised in which the lithiated p-toluenethiol is treated with di-tert-butyl disulfide 
and then treated with S2Cl2 to yield 7-methylbenzopentathiepin (94) in 86% yield 
after purification via chromatography.  
 
SH
CH3
BuLi (2.0 eq.), TMEDA (2.0 eq)
C6H12, 0oC to 25oC, 20h
S-
Li
CH3
SH
StBu
CH3
S
S
SS
S
CH3
S2Cl2 (2.1 eq)
THF
S8 (4.0 eq)
tBuSStBu (2.3 eq)
-10oC, 8h
93
94  
 
Scheme 9: Initial test reaction 
 
With these encouraging results in hand a full synthesis of varacin was then attempted 
using 3,4-dimethoxyphenethylamine (95) as the starting material. After protection of 
the NH2 group, the compound was thiocyanated using an electrophilic thiocyanation 
procedure developed by Toste et al.,54 which used NTS, to yield the thiocyanate (96). 
This was then converted to tert-butyl sulphide (97) using But2Cu(CN)Li2 in a ligand 
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exchange reaction also developed by Toste and co workers. Lithiation and reaction 
with di-tert-butyl disulfide yielded the desired bisulfide (98) in good yield. Initially 
the key step of the reaction, the formation of the pentathiepin ring, proved 
problematic, however the synthesis was finally achieved by the addition of BaCO3 to 
the reaction with S2Cl2 to yield the Boc-protected compound (99) in 59% yield after 
chromatography. The reaction gave an overall yield of 18%. 
 
 
MeO
MeO
NH2 MeO
MeO
NHBoc
SCN
MeO
MeO
NHBoc
StBu
MeO
MeO
NHBoc
StBu
MeO
MeO
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But2Cu(CN)Li2 (3 eq.)
-78oC, 4 h, THF
 tBu-S-S-tBu (5 eq.)
S2Cl2 (5 eq.) 
THF, BaCO3
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BuLi (4 eq.) 
TMEDA (4 eq.)
i) Boc2O, TEA
 
Scheme 10: Still & Toste’s route 
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1.4.5 –  Novikov (polycarpine) 
 
Bis[2-amino-4-(4-methoxyphenyl)-1-methyl-5-imidazolyl]disulfide dihydrochloride 
(100) (polycarpine) was recently isolated from Polycarpa aurata from the Pacific 
ocean by Novikov,86 and has also been found more recently in Polycarpa clavata in 
the Indian Ocean, Western Australia by Fenical and Kang.85 
 
NH2 NH2
NN NN
S S
Me Me
OMe OMe
100 
 
Figure 29: Structure of polycarpine 
Polycarpine is interesting as it presents both high biological activity and a new 
structural type of alkaloid from ascidians. However, to date only one synthetic 
approach has been published. Novikov et al.86 decided to investigate polycarpines 
structure-activity relationship by developing a simple and general synthesis to it and 
other related compounds using a key intermediate (103). Polycarpine was prepared in 
three steps from commercially available p-methoxyphenacyl bromide (101) in 57% 
overall yield (Scheme 11). 
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Scheme 11: Synthesis of polycarpine 
 
Nucleophilic substitution of the bromine was performed using a large excess of 
MeNH2 to yield the amine, though due to the instability of the free base the compound 
was isolated as the HCl salt (102). Conversion of the salt to the aminoimidazole (103) 
was achieved using S-ethylthiourea in water in the presence of NaOH. The final step 
used S2Cl2 in acetic acid to couple the two molecules of (103) via a disulfide bridge. 
Six other analogues were also prepared in a similar manner. 
 
All of the disulfides prepared were tested in-vitro against 60-75 lines of cancer cells, 
with polycarpine (100) showing significant anti-tumour activity. 
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2 - Results and Discussion 
2.1 - Initial route 
2.1.1 - Formation of the key secondary alcohols 
 
The goal of synthesising the naturally occurring Aplidium trisulfide (4R, 5S) initially 
in racemic form was approached firstly by attempting to construct the non-sulfur 
containing section of the molecule. It was thought by introducing the main imidazole 
and benzene segments first that the labile sulfur ring would then be able to be formed 
in a later step limiting the chances of damaging the ring with harsh reagents and 
conditions. 
OMe
HO
S
SS
OH
NHN
4
5
 
 
It was therefore set out to form the alcohol (104) from the cheap and commercially 
available starting materials of vanillin and imidazole. Before we proceeded with the 
coupling of imidazole and vanillin it was necessary to use two different protection 
groups to prevent side reactions or other by-products forming. The hydroxyl group on 
vanillin was therefore protected using both benzyl (105) and TBDMS (106) protection 
groups, and imidazole was protected as shown in scheme 11 with the 
dimethylaminomethyl group. This group was used due to its ability to coordinate to 
the lithium cation and stabalise the imidazole carbanion, as well as the ease of 
deprotection during a later step. 
 
P1O
O
OMe
N
N+
MeO
N
HN
OH
P1O
n-BuLi (1.1eq)
[-78oC-RT, 24 h]
THF/ N2
105. P1 = Bn
106. P1 = TBDMS
107. P = CH2NMe2 104
P
 
Scheme 12: Synthesis of key secondary alcohols 
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All protection steps gave near quantitative yields but as was later found the benzyl 
protection of the alcohol was favourable over the TBDMS protection. This was due to 
the fact that the benzyl protected products yielded a highly crystalline sample 
allowing simple and easy purification via recrystalisation. It was also observed that 
the TBDMS protection was labile on a flash silica column, leading to reduced yields. 
 
N
N
N
Me
Me
N
H
N
H H
O
Water, HCl (pH~5)
Dimethylamine hydrochloride
[RT, 24 h]
107  
Scheme 12: Imidazole protection 
 
The addition of (107) to the aldehyde was carried out using n-BuLi in hexane (2.5M) 
to deprotonate the imidazole at the 2-position. This was then reacted with the 
aldehyde forming the secondary alcohol (104). The formation of (104) was confirmed 
by 1H NMR as the spectrum showed a new signal at 5.8ppm for the CHOH proton. 
The IR spectrum also showed a new hydroxyl stretch at 3190cm-1, as well as the 
absence of an aldehyde signal confirming the formation of a secondary alcohol.  
 
A range of other interesting secondary alcohol structures were also sythesised using 
both N-methylimidazole and thiazole in place of (107). Different functionalities were 
also introduced onto the benzene moiety yielding several other secondary alcohols 
with dimethoxy- and 1,3-dioxole-analogues, these are tabulated below. 
 
 
Secondary Alcohol 
 
Yield (%) 
TBDMSO
OMe
N
H
N
OH
108 
82 
       
BnO
OMe
N
H
N
OH
109 
73 
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N
Me
N
MeO
OMe
OH
110 
98 
     
N
S
MeO
OMe
OH
111 
95 
         
N
Me
N
OH
O
O 112 
92 
       
N
H
N
OH
O
O 113 
88 
      
N
S
OH
O
O 114 
70 
 
Table 1: Yields of key secondary alcohols 
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2.1.2 - Manganese Dioxide Oxidation 
 
As the secondary alcohol was of limited use for the addition of a further carbon atom 
to form the necessary quaternary centre it was decided to firstly oxidise the alcohol to 
the corresponding ketone (115). This would then allow us to introduce a nucleophilic 
source of carbon and form the desired quaternary centre. The oxidation was achieved 
by refluxing the corresponding secondary alcohol with 5 equivalents of MnO2 in 
methanol for 24 h. The resulting black mixture is then simply filtered through a pad of 
celite giving the corresponding ketone on evaporation of the filtrate.  
 
OH
PO
OMe
N
NP1
O
PO
OMe
N
NP1MnO2, MeOH
[Reflux, 24 h]
115  
Scheme 13: General reaction for MnO2 oxidation 
 
This procedure proved to be very reproducible giving good yields of a range of 
different ketones. The ketones needed no further purification and could be used 
directly in further reaction steps. A range of ketones were synthesised and these are 
tabulated below. 
 
 
Ketone 
 
Yield (%) 
     
N
S
O
O
O  116 
95 
N
Me
N
O
MeO
OMe 117 
97 
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N
HN
O
O
O
118 
90 
TBDMSO
MeO
N
HN
O
119 
93 
        
N
H
N
O
O
O     120 
96 
    
BnO
MeO
N
HN
O
  121 
 
84 
 
 
Table 2: Range of ketones and their yields 
 
The formation of the ketones was confirmed by IR spectra where a strong carbonyl 
stretch was observed for each compound around 1650 cm-1. Further evidence was 
obtained from the X-ray crystal structure of the piperonal (Figure 30) and benzyl 
protected (Figure 31) derived ketones. 
 
 
Figure 30: Crystal structure of benzo[1,3]dioxol-5-yl-(1H-imidazol-2-yl) 
-methanone (120) 
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Figure 31: Crystal structure of (4-Benzyloxy-3-methoxyphenyl)- 
(1H-imidazol-2-yl)-methanone (121) 
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2.1.3 - Thioketone Formation 
 
With a range of ketones in hand we wanted to investigate forming the previously 
reported thioketone (122) which had been isolated from extracts of the Aplidium sp. 
D. There were two main reasons for this suggested next step, firstly the thioketones 
would offer a interesting set of new compounds which would be challenging to make, 
and secondly this step may offer a novel way of introducing sulfur into the structure at 
an early stage which may prove useful when going forward towards the synthesis of 
aplidium trisulfide.   
 
O
N
H
N
OMe
HO
Thionation Reagent
S
N
H
N
OMe
HO
122  
Scheme 14: General thionation reaction 
 
Although this seemed a relatively simplistic target it is known that thiocarbonyl 
compounds can be inherently unstable as they photo-oxidise in air to give the 
corresponding ketone, sulfur and sulfoxide94, as well as being hydrolytically unstable. 
It was therefore decided to firstly use benzophenone as a test ketone as it is cheap and 
comercially available and this would not involve using up our own sythesised ketone 
product. Benzophenone is also known to yield a bright blue thioketone which is 
reasonably stable compared to less bulky thioketones, and the highly unstable 
thioaldehydes.95 
P
S
P
SS
S
OMe
MeO  
 
Figure 32: Structure of Lawesson’s reagent 
 
Lawesson’s Reagent  was firstly used to do the conversion using toluene as a solvent 
and refluxing the reaction mixture for 12 h. This yielded a blue solid in 88% crude 
yield, but the IR spectrum suggested small amounts of ketone were still present due to 
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a weak carbonyl stretch. The 1H NMR also revealed a number of aromatic containing 
impurities which we expected had come from the degraded Lawesson’s reagent. 
Column chromatography was therefore attempted to purify the thioketone but this 
yielded benzophenone starting material and a small amount of an unidentifiable 
aromatic mixture. 
 
As purification by column chromatography resulted in the thioketone decomposing 
we decided to try other methods which may not require further purification. P4S10 had 
previously been used to form thioketones88 and more recently it has been coupled 
with other reagents such as NaHCO357 and Al2O358 in attempts to try and increase 
yields and allow reactions to be conducted at room temperature. Previously the draw 
back of using P4S10 as a thionation reagent has been that a large excess has had to be 
used to achieve moderate conversion to the thioketone. We therefore decided to try a 
range of solvents and conditions using benzophenone before going on to try and form 
(66). Acetonitrile was initially used as a solvent  due to the reported success of Nivard 
et al57 in forming thiocarbonyl compounds much faster in polar solvents compared 
with widely used toluene. 
 
Reagent/s Solvent Temp. (oC) Time (hrs) Yield (%) 
P4S10 CH3CN 25oC 24 93*  
P4S10 DMF 25oC 24 87* 
P4S10/Al2O3 CH3CN 25oC 24 94* 
P4S10/Al2O3 Dioxane Reflux 1 Complex mixture 
P4S10/NaHCO3 CH3CN 25oC 24 78* 
P4S10/NaHCO3 DMF 25oC 24 91* 
P4S10/NaHCO3 Toluene Reflux 48 89* 
Al2S3 Toluene 25oC 24 Starting material 
Al2S3 Toluene Reflux 72 Starting material 
Al2S3 THF Reflux 72 Starting material 
 
Table 3: Range of conditions used in forming the thioketone (*crude yields.) 
 
When using P4S10 and acetonitrile as a solvent thiobenzophenone was formed in a 
good crude yield which was comparable to Nivard’s yields of ~90%. We also found 
that the corresponding thioacetamide was formed as had previously been reported in 
the literature by Nivard. The thioacetamide was observed in the 1H NMR spectra with 
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a peak at 1.1ppm. This by-product was also formed when using P4S10/Al2O3 and 
P4S10/NaHCO3 with acetonitrile. Interestingly Kaushik58 did not report the formation 
of thioacetamide during his work using P4S10/Al2O3 reagents. Due to the presence of a 
carbonyl peak in the IR spectrum of the crude product purification by column 
chromatography was attempted to yield the pure thioketone. Attempts using light 
petroleum/ethyl acetate eluent on silica gel yielded further samples contaminated with 
ketone. Purification was therefore put on hold in hope of a better conversion process. 
 
Due to the incomplete reaction and formation of thioacetamide we decided to try a 
different solvent. Dioxane was chosen as a readily available dry solvent, but due to 
the insolubility of the reagents it was decided to reflux the mixture to increase 
solubility. This unfortunately led to the reaction mixture turning into a solid which 
was insoluble in both organic solvents and water. A sample of the material formed 
was submitted for mass spectrometry but the results proved inconclusive. We were 
therefore unable to conclude what reaction had taken place but we postulate that the 
mixture underwent a complex polymerisation involving ring opening of dioxane. 
 
DMF was another readily available polar solvent which we next trialled. This gave the 
characteristic bright blue thiobenzophenone, but an inability to remove the high 
boiling point residual DMF without destroying the thioketone meant that this was not 
the best solvent to use.  
 
Using P4S10/NaHCO3 and refluxing in toluene also led to the formation of 
thiobenzophenone in good crude yield with the only impurity being a small amount of 
benzophenone. This was the most promising procedure so far for the formation of 
thioketone. 
 
We also wanted to experiment into other sources of sulfur which may facilitate the 
conversion of ketones to thioketones. To our knowledge aluminium sulfide had not 
been used before so we tried reacting this with benzophenone using toluene then THF 
as the solvent. Unfortunately even after refluxing a mixture of benzophenone and 
aluminium sulfide for extended durations no reaction was observed and only starting 
material was recovered. From this brief work it appears that aluminium sulfide is not 
a reactive enough form of sulfide to undergo this type of reaction. 
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Reactions with no solvents also interested us due to the previously observed problems 
of P4S10 reacting with acetonitrile and dioxane, and also the environmental benefits of 
solvent-less reactions. Therefore we went ahead and stirred our test substrate, 
benzophenone, with 2 equivalents of the reagents at room temperature for either 24 or 
72 h (table 4). Reagents were pre-ground in a pestle and mortar for 10 minutes as 
suggested in Kaushik’s paper, before being stirred in a round bottom flask with a 
magnetic stirrer bar for the remainder of the reaction time. The solid was then 
extracted with small portions of DCM. 
 
Solid state reactions (No Solvent) 
Ketone Substrate  Reagent/s Time (hrs) Yield (%) 
Benzophenone P4S10 24 84 
Benzophenone P4S10/Al2O3 (1:1) 24 87 
Benzophenone Al2S3 72 SM 
 
Table 4: Solid state reaction conditions 
 
Both P4S10 and P4S10/Al2O3 yielded the bright blue thiobenzophenone in good yields, 
although the 1H NMR spectra revealed that there was again benzophenone impurity in 
the samples and this continued to be a problem as column chromatography led to 
further decomposition of the thioketone. Al2S3 gave no reaction under these 
conditions and work up yielded the starting material benzophenone. 
 
At this stage it was decided to try our most successful method, P4S10/NaHCO3 
refluxing in toluene, on our own pre-synthesised ketone and hopefully forming the 
corresponding thioketone (123). 
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O
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O
P4S10/NaHCO3
[Toluene, reflux, 24 h]
123  
Scheme 15: Attempted formation of Benzo[1,3]dioxol-5-yl-(1-methyl-1H- 
imidazol-2-yl)methanethione 
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A difficulty in determining whether any thioketone was forming was a major 
problem. Thin layer chromatography showed no evidence of product forming and 
there was no observed colour change as with the thiobenzophenone formation. Upon 
workup the reaction yielded only starting material and no thioketone was observed. 
Several further attempts were made to repeat the reaction using the other pre-
synthesised ketone analogues but in all cases no desired product could be isolated. 
Attempts were also made to use GC-MS to analyse the reaction mixture to see if small 
quantities of the thioketone were formed in-situ but only the ketone was observed in 
the mass spectrum.  
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2.1.4 - Grignard Addition 
 
Due to the problems in forming the thioketone intermediates it was decided to 
continue toward the synthesis of Aplidium trisulfide by using a Grignard addition to 
the previously formed ketone intermediates. A Grignard addition was first attempted 
using commercially available vinyl magnesium bromide (2.5M in THF). It was 
quickly observed that the commercially available Grignard gave poor yields, typically 
around 40-50% so it was decided that making the fresh Grignard in situ using an alkyl 
or alkenyl bromide and magnesium may be more effective. 
 
Formation of the Grignard was achieved by refluxing vinyl bromide with excess 
magnesium turnings and a crystal of iodine in THF for 30 min. At this stage the 
reaction was cooled to room temperature and the ketone was added in THF and the 
reaction mixture stirred for 24 h. Formation of the tertiary alcohol was confirmed by a 
strong hydroxyl stretch in the IR spectra ~3100cm-1 and later by 1H and 13C NMR 
spectroscopy. A range of tertiary alcohols (124-126) were isolated in good yields. 
O
N
X
OH
NX
OR1
R2O
R2O
OR1
i) VinylMgBr, I2, Mg, reflux, 30 min
ii) ketone added, RT, 24 h
124. X = NH, R1/R2 = OCH2O (76% yield)
125. X = S, R1/R2 = OCH2O (80% yield)
126. X = NMe, R1 = R2 = OMe (89% yield) 
Scheme 16: Vinyl Grignard addition products 
 
The Grignard addition proved to be a reliable reaction and gave us a simple route to 
create the new quaternary centre. Although the new quaternary centre is formed as a 
racemate due to optically inactive reagents being used, other concurrent work was 
investigating an alternative asymmetric route toward aplidium trisulfide and this will 
be discussed later. 
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OH
NMeN
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R1O
R1O
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i) AllylBr, I2, Mg, reflux, 30 min
ii) ketone, RT, 24 h
OH
O
NMeN
R1O
OR2
127. R1 = R2 = Me
128. R1/R2 = -OCH2O-
5
 
 
Scheme 17: Allyl Grignard addition product 
 
Due to the ease of carrying out the vinyl Grignard additions to the ketone 
intermediates it was decided to make some other interesting analogues containing the 
allyl group (127) and (128) instead of the vinyl group. It was thought that these 
compounds may also be useful in synthesising simplified trisulfide structures which 
did not contain the additional hydroxyl group at the 5-position, as is present in the 
structure of aplidium trisulfide. It was also thought that the allyl group may later be 
converted to an aldehyde group by osonolysis as shown in scheme 17. 
 
Compound Yield (%) 
 
NMeN
OMe
MeO
OH
127 
82 
  
O
O
OH
NMeN
  128 
49 
 
Table 5: Allylmagnesium bromide addition products 
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2.1.5 - Functionalising the Olefin 
 
Now that we had completed the synthesis of the main carbon back-bone with the 
imidazole group present, our next step would have to allow us to introduce some 
functionality to the terminal alkene. The new functionality would have to allow 
further steps in order to form the trisulfide ring via the addition of sulfur, and also 
allow the formation of a secondary alcohol at the 5 position. The compound (129) was 
therefore targeted as a useful intermediate. Creating a t-butyl thioether (130) at the 
terminal carbon was important as this could be deprotected at a later stage and reacted 
with S2Cl2 to form a range of different sized sulfur containing rings (131). 
 
OH
NMeN
MeO
OMe
OH
NMeN
MeO
OMe
StBuOH
StBu
NMeN
MeO
OMe
StBuPGO
NMeN
MeO
OMe
S
SnS
PGO
i) tBu Deprotection
ii) SnCln
i) Protect 2ry OH
ii) tBuSH, H+, CHCl3
129
130131  
 
Scheme 18: Possible functionalisation of the olefin 
 
Firstly we decided that forming the epoxide (132) on the terminal alkene would 
generate a useful synthetic intermediate. It was hoped that the epoxide could be 
formed in a good yield by using mCPBA. The epoxide could then be opened with a 
nucleophilic source of sulfur in a later step, giving the secondary alcohol (133), and a 
terminal thio- group on work up.  One possible problem with this synthetic route is 
the ring opening step. In our perceived reaction the sulfur nucleophile would need to 
attack at the epoxides terminal carbon. The alternative is that the epoxide opens at the 
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non-terminal carbon giving the product (134). We consider this a less likely product 
due to it being sterically less favourable to open in this way. 
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NMeN
OH
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MeO
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SROH
OMe
BnO
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NaSH or 
NaStBu
-SH
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OHSR
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133134
DESIRED PRODUCT
UNDESIRED
 
Scheme 19: Possible epoxide formation and ring opening with a nucleophilic  
source of sulfur 
 
The epoxidation was attempted on the N-methylimidazole derivative (126), scheme 
20, by carrying out the addition of 2 equivalents of mCPBA (77%) in DCM at 0oC 
and then allowing the reaction to warm to 25oC over 4 hours. The reaction yielded a 
dark orange oil which was unidentifiable by 1H NMR spectroscopy. Column 
chromatography on silica gel was attempted to purify the mixture but none of the 
desired product (135) was isolated. 
 
OH
NMeN
MeO
OMe
OH
NMeN
MeO
OMe
O
mCPBA (2 eq.)
0oC-RT (4 hrs)
DCM
126 135  
 
Scheme 20: mCPBA epoxidation of terminal alkene 
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Possible reasons for the reaction yielding an inseparable mixture of products could be 
either that the tertiary alcohol ring opened the epoxide or the imidazole double bond 
could also have reacted with the excess mCPBA. For this reason the reaction was 
repeated with a single equivalent of mCPBA to determine if the ring opening was 
occurring, and if so could we isolate this product.  
 
The reaction was repeated and monitored closely by TLC. After 4 hours some starting 
material was still observed on the TLC plate but there were several new spots 
apparent. Work up followed by preparative TLC was carried out in attempts to isolate 
the major products. Despite repeated attempts to identify the products using 1H NMR 
spectroscopy our efforts proved inconclusive. 
 
A second attempt at epoxidising the alkene was tried using the well known Sharpless 
asymmetric epoxidation method discovered by Sharpless and Katsuki in 1980.59 The 
procedure which requires 10 mol% Ti(i-OPr)4, 1.1 eq. tBuOOH and one optical 
isomer of diethyl tartrate only works for allylic alcohols. The method was therefore 
trialled on the allylic alcohol substrates (127) and (128). Unfortunately in each case 
the reaction only yielded ca. 65-70% recovery of starting material after column 
chromatography.  
 
A hydroboration/oxidation reaction was next tried using both THF.BH3 (Scheme 21) 
and separately 9-BBN. The BH3 method had the advantages that it will react with 
three equivalents of the alkene to yield the trialkylborane, together with the ease in 
handling the reagent as a 1M solution in THF. Hydroboration/oxidation was 
envisaged as a useful step in forming the desired primary alcohol (136). Both sources 
of borane were trialled but unfortunately only starting material was recovered from 
the reactions.  
OH
NMeN
O
O
OH
NHN
O
O
OH
i) BH3. THF, (0oC-RT, 5 h)
ii) NaOH (3 M), H2O, H2O2
            (0oC, 1 h)
136128  
Scheme 21: Attempted hydroboration/oxidation reaction 
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Ozonolysis of pre-synthesised allyl containing substrates such as (127) was another 
possible reaction which we could utilise in order to functionalise the terminal alkene. 
This was carried out using two different methods show in scheme 22. The reaction 
mixture from the first attempted ozonolysis was quenched with DMS in order to try 
and form the aldehyde. Unfortunately the reaction yielded a complex mixture of 
products as was observed in the 1H NMR spectrum. Although several aldehyde peaks 
were present at ~9.5ppm no products could be isolated after column chromatography. 
 
NMeN
OMe
MeO
OH
NMeN
MeO
OH
O
NMeN
OMe
MeO
OH
OH
i) O3, DCM, -78oC, 10 min
ii) DMS, 30 min, RT
i) O3, DCM, -78oC, 2 min
ii) NaBH4, 2 h, RT
OMe 137
138
127
 
Scheme 22: Ozonolysis and reductive ozonolysis reactions 
 
We thought the reason for the ozonolysis yielding a complex mixture of products may 
have been due to two reasons. One possibility being that the aldehyde formed maybe 
unstable or could have also reacted further with itself. Another problem could be that 
ozonolysis of the imidazole ring is occurring and forming other reactive or unstable 
aldehydes. For this reason a second method was tried with a shortened ozonolysis 
period of just 2 min. The reaction was then quenched with NaBH4 in an attempt to 
form the terminal hydroxyl containing compound (138). Unfortunately this gave a 
similar complex mixture as previously seen in the 1H NMR spectra. Therefore it was 
decided to discontinue the ozonolysis work on this type of substrate as it was most 
likely that we would be unable to limit the amount of ozone present so not to 
ozonolyse the imidazole group. 
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As the attempted methods so far to functionalise the olefin had proven quite harsh, 
with the ozonolysis possibly breaking open the imidazole ring, and the mCPBA 
epoxidation possibly forming the imidazole N-oxide it was decided to look for a 
milder reaction. In one particular paper by Rao et al they explored the use of β-CD in 
a new and environmentally benign procedure that formed β-hydroxysulfides 
efficiently and in good yields.56 We thought this type of reaction would allow us to 
form some very useful intermediates so we set about their method on our own 
substrate to try and form compound (139).  
 
NS
OH
NS
OH
t-BuSH (1eq), O2
ß-CD (1mmol in 15ml H2O)
139
OH StBuO
O
O
O
 
Scheme 23: Attempted β-hydroxysulfides formation 
 
At first the reaction was attempted at room temperature stirring for 24 hours but this 
yielded only starting material. We then considered two ways to possibly make the 
reaction proceed; raising the temperature to speed up the reaction, and by using more 
equivalents of the thiol. Although there were no problems envisaged by increasing the 
equivalents of thiol, apart from odour, raising the temperature of a reaction containing 
volatile t-butyl thiol may lead to less thiol in the reaction mixture. With the boiling 
point of t-butyl thiol being 62-65°C it was decided to carry out the reaction in a closed 
flask with minimal headspace when using the thiol at elevated temperatures. Several 
substrates were trialled containing both the imidazole and thiazole groups as well as 
attempts at changing the thiol to thio-phenol (Table 6). Unfortunately we could not 
replicate Rao’s success and no reaction with any of our substrates was observed. 
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Alkene Thiol Eq. of thiol Temp. (oC) Yield (%) 
NS
OH
O
O  
t-butyl 1 25 SM 
NS
OH
O
O  
t-butyl 2 25 SM 
OMe
MeO
NMeN
OH
 
t-butyl 2 60 SM 
NS
OH
O
O  
phenyl 2 60 SM 
OMe
MeO
NMeN
OH
 
t-butyl 5 25 SM 
 
Table 6: The range of substrates and reaction conditions trialled for attempted 
formation of corresponding β-hydroxysulfide 
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2.2 – Thiocarbonyl-metal complexes 
 
Due to the previous problems associated with forming a stable thioketone 
intermediate, another area of interest to us was in forming thiocarbonyl-metal 
complexes as had previously been reported by Reid64 and Gingerich.65 Their work was 
of interest to us for two main reasons, firstly this may allow us to form a more stable 
thiocarbonyl species, and secondly that the complexes previously reported may allow 
further work into ligand exchange and the possibility of an asymmetric route  towards 
aplidium trisulfide using sterically hindered ligands. If this was possible it would be 
envisaged that a nucleophile would have a preferential side of attack. 
 
S
MOCOC CO
CO
CO
N
HN
OMe
OH
S
MOCOC
CO
N
HN
OMe
OH
Sterically Bulky Ligand
Nu-
 
 
Scheme 24: Proposed route for asymmetric work 
 
Reid’s method of forming a reactive metal complex species involved using 
tetrabutylammonium iodide and chromium or tungsten hexacarbonyl, heating in 
diglyme and then filtering the mixture to yield the corresponding salt.  
 
This procedure was carried out under nitrogen using both the tungsten and chromium 
hexacarbonyl starting materials and successfully yielded the corresponding salts. 
Confirmation of the iodo-metal complex formation was observed by the characteristic 
C=O stretches present in the IR spectra. Reaction of the iodo-tungsten and iodo-
chromium complexes with benzophenone was attempted in-situ due to the instability 
of the complexes. Reactions were carried out in THF at room temperature but no new 
products were observed when using either of the complexes, and as Gingerich’s 
procedure seemed more promising at the time no further work was carried out to 
study the reactivity of these iodo-metal complexes. 
 
 68
On the other hand Gingerich had initially formed a reactive mononuclear salt 
containing the species [M(CO)5(SH)]- using metal hexacarbonyl’s (scheme 25). 
Several analogue compounds were prepared containing tungsten, chromium and 
molybdenum metal centres. 
 
M(CO)6 + [(Ph3P)2N]SH [(Ph3P)2N][M(CO)5(SH)] + CO 
 
Scheme 25: Angelici and Gingerich’s previous work 
 
Gingerich found that the tungsten analogue could be isolated as a solid in good yield 
of 93% where as the yellow chromium analogue discoloured in air after 4 hours. The 
molybdenum analogue was reportedly too unstable to isolate pure. For these reasons 
the thio-tungsten complex was chosen for further reactivity studies. Further research 
showed that [W(CO)5SH]- could be reacted with sterically unhindered ketones such as 
acetone and methylethylketone as well as a range of para-substituted benzaldehyde 
compounds to form tungsten-thiocarbonyl complexes such as (140-144). A reduction 
in yield was noted when using sterically hindered carbonyl substrates. 
 
S
WOCOC CO
CO
CO
R3
S
R2
WOCOC CO
CO
CO
R1
140. R1, R2 = Me
141. R1 = Me, R2 = Et
142. R3 = NMe2
143. R3 = OMe2
144. R3 = Me  
 
Figure 33: Previous thiocarbonyl products 
 
We decided to initially try and repeat Gingerich’s work on less sterically demanding 
aldehydes before attempting to form a thiocarbonyl-metal complex containing our 
pre-synthesised ketones.  
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The thio-tungsten salt was initially formed following Gingerich’s procedure achieving 
a comparible yield of 84% of a yellow solid. IR bands at 2052, 1932(vs), 1851 were 
used to confirm the products formation.  
 
Next, we decided to trial one of Gingerich’s reported reactions using readily available 
anisaldehyde as a substrate. The corresponding thioaldehyde-tungsten complex was 
isolated as a purple oil in 6% yield after column chromatography, much lower than 
the reported 32% yield.  
 
Although this was a poor yield we decided that it would be worthwhile to attempt the 
formation of a thioketone-tungsten complex. This was initially attempted using 
benzophenone as a substrate.  The reaction yielded 2% of a bright purple compound 
after column chromatography. The compound showed a strong carbonyl absorption at 
1932cm-1 in the IR spectrum, and a shift at δ 206.9 in the 13C NMR spectrum, 
characteristic of a C=S carbon. HRMS confirmed the product as C18H10SO5W (M+) 
m/z 521.9755.  
 
[(Ph3P)2N][W(CO)5(SH)] S
WOCOC CO
CO
CO
O
+
Triflic acid (1.1eq.)
THF
 
 
Scheme 26: Formation of [W(CO)5{S=C(C6H5)2}] 
 
Despite several attempts using fresh batches of the tungsten salt and freshly distilled 
THF the reaction could not be repeated on our own ketone substrates (116-121). This 
is possibly due to steric hinderance.  
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2.3 – Key sulfide intermediates 
2.3.1 – Retrosynthesis 
 
Due to the difficulties with introducing functionality to the terminal alkenes as 
previously discussed, it was decided that a more convergent synthesis was needed 
where functionality could be incorporated during the addition of the C5/C6 unit. 
 
OH
5 6
NHN
MeO
OMe  
 
Figure 34: Vinyl containing substrate difficult to functionalise 
 
Retrosynthetically it was still thought that forming the 1,2,3-trithiane should be the 
final synthetic step due to the expected instability of the trithiane ring, therefore we 
decided the first disconnections should be at S1-S2 and S2-S3 (Scheme 27). The 
presence of di-t-butyl groups would allow for a protected thiol to be deprotected and 
ring closed using sulfur monochloride. 
 
NMeN
OMe
MeO
S3
S2S1
OH
145
NMeN
OMe
MeO
StBu
StBu
OH
146
NMeN
OMe
MeO
StBu
Synthon A
StBu
OH
Synthon B 
 
Scheme 27: Retrosynthesis to give synthon A and B 
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2.3.2- ‘Synthon A’ 
 
Compound (147) was chosen as the synthetic equivalent to synthon A. We thought 
that by using a strong enough base this was a viable deprotonation due to the 
stabilising effect of the neighbouring sulfur, although it was hoped that the carbanion 
would still exhibit reasonable nucleophilicity. 
 
NMeN
OMe
MeO
StBu
'Synthon A'
StBu
N
Me
N
H
MeO
OMe
147
Base
 
 
Forming the sulfide (147) was first attempted via a Mitsunobu type reaction (Scheme 
28) using a presynthesised secondary alcohol. 
 
StBu
N
Me
N
147
OH
N
Me
N
DIAD, PPh3, THF
tBuSH
[0oC-RT, 24 h]OMe
MeO MeO
OMe
 
Scheme 28: Mitsunobu reaction to form sulfide 
 
The reaction yielded a dark orange oil which was purified by silica column 
chromatography using a light petroleum: ethyl acetate (10:1) eluent. Unfortunately 
this only led to the recovery of the starting material (80%). The same procedure was 
also repeated using n-butylthiol in place of t-butylthiol, as it was thought that the n-
butyl chain may be less sterically demanding allowing the reaction to proceed. This 
was not the case though and again the starting material (76%) was recovered. 
 
At this stage it became apparent that there was a more fundamental reaction which we 
could try. A simple nucleophilic substitution reaction using acid to aid the loss of 
water and form the corresponding sulfide was a possibility (Scheme 29). 
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StBu
N
Me
N
OH
N
Me
N
O
O
O
O
t-BuSH, TFA, CHCl3
Reflux, 24 h
148  
Scheme 29: Acid catalysed SN1 reaction to form sulfide 
 
This reaction worked well using TFA and gave (148) as an orange oil in 90% yield. 
The crude product was also clean and needed no purification. Confirmation that the 
sulfide had formed was evident in the IR spectra where the hydroxyl peak in the 
starting material was now absent. 1H NMR spectroscopy also confirmed that the 
product had been formed due to the 1H, s, CHOH shifting form 5.85ppm in the 
starting material to 5.26ppm in the product. Final confirmation of the structure was 
achieved when after long term storage several small crystals formed in the storage 
tube. Utilising single crystal X-ray diffraction allowed us to elucidate the crystal 
structure (Figure 35). 
 
Figure 35: X-ray crystal structure of 2-(Benzo[1,3]dioxol-5-yl-tert-butylsulfanyl-
methyl)-1-methyl-1H-imidazole 
 
Following this success the same procedure was repeated with several other secondary 
alcohols to give a range of interesting sulfide analogues (149-154) (Table 7). Each 
new compound was isolated as a yellow-orange oil, as was found with the original 
product. Due to the possibility of gaining further X-ray crystal structures of these 
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novel sulfides a range of recrystallisation techniques were carried out in attempt to 
gain crystals but unfortunately no further crystals were isolated.  
 
Alcohol 
Thiol 
(2 eq) 
Solvent
Time 
(h) 
Sulfide 
Yield 
(%) 
OH
N
Me
N
O
O  
t-BuSH CHCl3 24 
S
N
Me
N
O
O     149
90 
OH
N
S
OMe
MeO
 
n-BuSH CHCl3 24 
S
N
S
OMe
MeO
150
96 
OH
N
Me
N
OMe
MeO
 
t-BuSH CHCl3 24 
S
N
Me
N
OMe
MeO
  151
99 
OH
N
Me
N
OMe
MeO
 
n-BuSH CHCl3 24 
 
S
N
Me
N
OMe
MeO
 152
95 
OH
N
S
OMe
MeO
 
t-BuSH CHCl3 24 
S
N
S
OMe
MeO
 153
98 
OH
N
Me
N
O
O  
n-BuSH CHCl3 24 
S
N
Me
N
O
O   154
92 
Table 7: The range of sulfides formed from their corresponding secondary alcohols 
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2.3.3 – ‘Synthon B’ 
 
Once we had formed compound (148) and a range of analogues (149-154) we decided 
to investigate possible synthetic equivalents to ‘synthon B’ which could be used to 
complete the main carbon backbone structure of Aplidium trisulfide. There were 
several immediate options (155-157) and each compound had positives and negatives 
for their formation and use in the coupling reaction. 
 
O
OEt
SStBu
OH
=
O
Cl
S
O
S
or or
155 156 157
_
 
 
Figure 36: Synthetic equivalents to synthon B 
 
The ester was foreseen as the easiest synthetic target due to its chemical stability but 
probably the most un-reactive due to the non-favourable loss of EtO- in the coupling 
reaction. Although this compound could prove to be less reactive at a later stage, due 
to the straight forward synthesis we went ahead and made a small batch of the β-t-
butylsulfide ester (155) and also the n-butylsulfide analogue (158). 
 
O
OEt
S
155
O
OEt
Br tBuSH, NaH (1.5eq)
O
OEt
S
158
DMF, 0oC, 24 h
n-BuSH, NaH (1.5eq)
DMF, 0oC, 24 h
O
OEt
Br
 
 
Scheme 30: Formation of two different β-sulfide esters 
 
The esters (155) and (158) were isolated as light yellow oils in good yields of 99 and 
95% respectively. The crude product appeared clean in the 1H NMR spectrum so no 
further purification was carried out. 
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Formation of the acid chloride (160) was not quite as simple as forming the esters, but 
we managed to synthesise the acid chloride in two steps from bromoacetic acid as 
shown in scheme 31 via the corresponding carboxylic acid (159). 
 
O
OH
S
160
O
OH
Br
tBuSH, NaH (2.2eq)
DMF, 0oC, 24 h
O
Cl
S
SOCl2
reflux, 30 min
159bromoacetic acid
 
 
Scheme 31: Formation of acid chloride via corresponding carboxylic acid 
 
Formation of the acid chloride was confirmed by IR spectroscopy when the carbonyl 
band shifted from 1710 cm-1 to 1793 cm-1 indicative of the acid chloride carbonyl. 1H 
NMR spectroscopy also confirmed the acid chloride had been formed, but we were 
unable to obtain a clean 13C NMR spectrum and mass spectra due to the acid chloride 
hydrolysing back to the carboxylic acid.  
 
Formation of the β-sulfide aldehydes proved to be challenging targets. One possible 
starting material was chloro-acetaldehyde but this was only available commercially in 
aqueous solution. Extraction of the acetaldehyde was carried out into chloroform and 
the extraction was confirmed by 1H NMR spectroscopy. Transformation of the chloro-
acetaldehyde into the β-sulfide aldehydes was then attempted using NaH (1.1eq) and 
thiol (1eq) but this failed to yield the desired product.  
 
O
Cl
t-BuSH, NaH
CHCl3, RT, 24 h
BuS
O
t-
 
 
Scheme 32: Attempted formation of the β-sulfide aldehyde 
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Instead of the desired product a complex mixture was isolated which we were unable 
to purify by silica gel chromatography. We were therefore unable to determine what 
type of reaction had occurred but due to the large multiplet in the 1H NMR spectra at 
0.9 - 1.2 ppm characteristic of a t-butylsulfide, it led us to believe that a possible 
polymerisation had occurred between sulfide anions and other units of the reactive 
aldehyde. 
 
tBuS
O
tBuS
O
OH
StButBuS
O tBuS
O
Further Polymerisation
Dimer Formation
excess NaH
 
 
Scheme 33: Possible polymerisation of sulfides 
 
At this stage we thought it maybe sensible to look at using a protected form of the 
aldehyde as the aldehyde it self seemed to be too reactive. 2-Bromo-1,1-dimethoxy-
ethane was commercially available so we decided to work on this building block. As 
previous, we used both n-BuSH and t-BuSH in the nucleophilic substitution. The 
substitutions were carried out giving good yields of compounds (161) and (162), in 
79% and 97% respectively. 
O
BuS
H2O, H+
OMe
OMe
Br
H2O, H+
t
O
BuSn-
BuS
OMe
OMe
OMe
OMe
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DMF
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Scheme 34: Sulfide acetal formation and attempted Deprotection 
 
Deprotection of the acetal was attempted using aq.HCl in MeOH but the reaction 
yielded a complex mixture of products. Silica gel column chromatography was carried 
out but unfortunately none of the desired product could be isolated. 
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2.3.4 – Convergent Step 
 
Now that we had a range of synthetic equivalents it was decided to attempt the 
possible coupling reactions to complete the main carbon backbone structure of 
aplidium trisulfide. 
 
The first attempted convergent step was between the imidazole containing sulfide and 
the t-butylsulfide ethyl ester. The formation of the anion was carried out using n-BuLi 
(2.5 M, 1.1eq) in THF at -78oC. The ester was then added and the reaction mixture 
was allowed to return to room temperature and stirred overnight. The reaction yielded 
a crude orange oil which was purified by silica gel column chromatography. 
Unfortunately, even though TLC suggested the presence of new products, attempts at 
isolating these proved unsuccessful and only the aromatic containing sulfide was re-
isolated. 
 
S
N
Me
N
O
O
O
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n-BuLi (2.5 M), THF
-78oC-RT, 24 h
 
Scheme 35: Attempted coupling of the sulfide anion with sulfide ester 
 
This work was repeated several times taking care to ensure anhydrous conditions 
while using a range of the previously synthesised analogue compounds but again no 
new products could be isolated in any case.  
 
We thought the possible low reactivity of the ester may be a reason for the reaction 
not yielding the clean desired product so we next decided to react the acid chloride 
containing sulfide with the carbanion in the hope that this would be much more 
reactive and form the desired product. 
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The reaction was carried out in the same way as previously attempted using a slight 
excess of n-BuLi to form the carbanion and then adding the acid chloride while 
stirring at -78oC. At this stage we were very keen to form compound (163) as this 
would be an exciting and key step towards synthesising aplidium trisulfide.  
 
S
N
Me
N O
Cl
S
+
NMeN
S
SO
n-BuLi (2.5 M), THF
-78oC-RT, 24 hMeO
OMe MeO
OMe
163
Scheme 36: Attempted acid chloride coupling 
 
To our disappointment only the aromatic containing sulfide was recovered but no 
other products were isolated even after careful column chromatography. This led us to 
believe that either the anion wasn’t being formed, or stabilisation of the anion meant 
that this was not a reactive intermediate. Further work would need to determine if this 
carbanion could be formed. 
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2.3.5 – Sulfide Alkylation 
 
As the convergent synthesis was not proceeding as we had hoped it was decided to 
investigate some other interesting alkylations on the proposed sulfide anion (Scheme 
37). Methyl iodide seemed an obvious way to determine whether or not the anion was 
being formed, as well as demonstrating the carbanion reactivity.  
S
N
Me
N
+
NMeN
S
n-BuLi (2.5 M), THF
-78oC-RT, 24 h
MeO
OMe
MeO
OMe
R
R-X
 
Scheme 37: Sulfide anion alkylation 
 
We therefore attempted to create the anion in exactly the same way as previously 
discussed, but this time we reacted the anion with methyl iodide. To our surprise the 
reaction yielded the desired product on our first attempt in 90% yield. The product 
displayed a new 3H, s at δ 2.17 in the 1H NMR spectrum. HRMS confirmed the 
product as C18H27N2O2S m/z 335.1788. 
 
The methyl iodide reaction was repeated on the piperonal derived substrate and 
yielded 70% product. Further reactions were carried out using allyl bromide and 
benzyl bromide to investigate how sterics would affect the carbanions reactivity. This 
allowed us to form a range of novel compounds (Table 8).  
 
Unfortunately both the benzyl bromide and allyl bromide additions yielded crude 
mixtures which appeared impure by 1H NMR spectroscopy. Column chromatography 
was therefore carried out to isolate the pure compounds and further characterise the 
products. This led to poor yields for both products. 
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Compound Yield (%) 
  
NMeN
OMe
MeO
S
164 
90 
       
NMeN
S
O
O 165 
70 
NMeN
OMe
MeO
S
166 
11 
NMeN
OMe
MeO
S
167 
8 
Table 8: Sulfide alkylation products and their yields 
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2.3.6 – Attempted Synthesis of Cyclic Mono-Sulfide 
 
Another interesting synthetic step that we wanted to investigate was the use of an 
intramolecular cyclisation reaction to form cyclic monosulfides such as (169). We 
attempted to make the target compound by firstly synthesising (168) using 3-
chloropropane-1-thiol and our previously developed procedure for forming sulfides. 
The sulfide (168) was isolated in 85% yield after silica gel column chromatography. 
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Scheme 38: Attempted formation of cyclic mono-sulfide 
 
Cyclisation was then attempted using n-BuLi (2.5 M, 1.1eq) to deprotonate at -78oC. 
The reaction was then allowed to warm to room temperature and stirred for a further 
24 h. On work up the reaction yielded a dark orange oil which appeared to be a mix of 
many different products visible by TLC and 1H NMR spectroscopy. Column 
chromatography proved challenging as the separation between spots was minimal. 
Repeat work was attempted increasing the solvent volume and adding the n-BuLi 
dropwise over 1 hour. This again yielded a complex mixture and after several 
attempts at purification this was discontinued as no clean products could be isolated.    
 
Two further compounds (170) and (171) were synthesised in an attempt to study the 
cyclisation further. It was thought that the phenylethanol derived substrate (170) may 
undergo the cyclisation faster due to less steric hindrance, and the diphenylmethanol 
 82
substrate may further show us the effects of anion delocalisation. It was found that 
neither compound readily cyclised when using n-BuLi to deprotonate, this could 
possibly be due to the delocalisation of the anion once formed around the benzene 
ring.  
S Cl S
Cl
170 171  
  Figure 36: Two further chloropropanethiol compounds 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 83
2.4 - Less Hindered Route 
 
Due to the previously discussed problems with introducing functionality at the C5 and 
C6 positions of the tertiary alcohol, it was decided that other possible synthetic routes 
may prove more fruitful. 
5
OH
6
NMeN
MeO
OMe  
 
Whilst looking through the literature a paper by Hibert87 described how a Friedel-
Craft Acylation could be carried out to form the ketone (174). This type of 
intermediate would be useful for our synthesis of aplidium trisulfide analogues. It 
could be envisaged that chlorine would be substituted for a sulfide group using 
tBuSH, and that an imidazole nucleophile could be added to the ketone forming the 
tertiary alcohol (172) with a new quaternary centre. The tertiary alcohol (172) would 
be absent of any functionality at the 5-position where the hydroxyl group is present in 
aplidium trisulfide), but this route may allow us to investigate the trisulfide forming 
step before having the additional consideration of the 5-hydroxy group. 
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Figure 37: Proposed new route to key intermediate (172) 
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The Friedel-Craft acylation was not as straight forward to carry out as we had hoped. 
Reacting the acid chloride and veratrole at 50oC for 2 hours gave just 51% yield of 
product (174) upon work up.  We suspected the reaction yield was low due to a dark 
black sticky residue which coated the reaction flask making it difficult to handle and 
extract.  
 
The reaction was repeated at 100oC for 5 hours to determine whether a better yield 
could be gained.  Unexpectedly, workup of the reaction mixture yielded 90% of the 
closely related para-demethylated product (175). This was evident due to the O-H 
stretch in the IR spectrum at 3392cm-1 and the absence of a CH3 peak at δ ~3.7 in the 
1H NMR spectrum. HRMS confirmed the loss of a single methyl group C10H11ClO3 
found m/z 214.0391. 
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Scheme 39: Friedel-Craft Acylation products 
 
Due to the much improved yield of (175) we decided to carry this product through our 
originally devised route. It was first necessary to carry out protection on the para-
alcohol. A benzyl protection was chosen as this had previously been carried out using 
readily available benzylbromide, potassium carbonate as a base and refluxing in 
acetone for 24 hours. 
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Scheme 40: Unexpected benzyl protection product (177) 
 
Work up of the reaction yielded a mixture of products as visible by 1H NMR 
spectroscopy. Column chromatography was carried out on silica gel using a light 
petroleum: ethyl acetate (10:1) eluent. This yielded the enone (177) in 27% yield. This 
once again was not our intended product but led us to rethink our synthetic route. It 
was therefore decided to attempt a Sharpless dihydroxylation on the enone. The 
reaction was attempted using the commercially available AD-mix beta which is 
required at 1.4g per mmol of substrate. One equivalent of methanesulfonamide was 
also added to aid the hydrolysis step. 
 
BnO
OMe
O
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BnO
OMe
O
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tBuOH/H2O (1:1)
 
Scheme 41: Sharpless dihydroxylation 
 
Upon workup the reaction yielded a crude mixture which was purified by column 
chromatography on silica gel. This yielded the dihydroxylated product in 22% yield. 
The dihydroxylated product showed a strong broad absorbance at 3389cm-1 in the IR 
spectrum and the expected 3 protons at δ 3.6, 3.9 and 5.0 ppm in the 1H NMR 
 86
spectrum in place of the previously observed vinyl protons. HRMS confirmed the 
product as C17H18O5 with m/z 302.1151.  
 
BnO
OMe
O
177 (27%)
BnO
OMe
O
178 (22%)
OH
OH
AD-mix beta
Methanesulfonamide (1eq)
tBuOH/H2O (1:1)
O
Cl
HO
OMe
175 (90%)
BnBr (1eq), K2CO3 (0.5eq)
Acetone, Reflux, 24 h
MeO
OMe
Cl
O
Cl
+AlCl3 (2eq)
100oC, 5 h
 
 
Scheme 42: Three step synthesis of dihydroxylated product 
 
The three step process was repeated in attempts to form more of (178). The plan was 
then to carry out a diol protection and investigate whether an imidazole anion would 
attack the carbonyl group as previously demonstrated for aldehydes. It was found that 
the dihydroxylation step was very unrepeatability and due to the low yields of the 
dihydroxylated product using the three step process (Scheme 42) a more efficient 
route was sought.  
 
Direct formation of the enone was next investigated using the benzo[1,3]dioxole 
analogue and reacting with 1 equivalent of  acryloyl chloride. 
O
O
O
179
O
O
Cl
O AlCl3 (1.5 eq)
0oC - RT, 12 h
 
Scheme 43: Friedel-Craft enone formation 
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The addition of AlCl3 to the reaction mixture was this time carried out at 0°C, and 
then the reaction was allowed to warm to RT overnight. This method worked much 
better than the previously used refluxing methodology and upon workup yielded the 
desired product in 91% yield. Recrystallisation of the product in diethyl ether 
removed low level impurities that were present in the 1H NMR spectrum. The product 
exhibited a strong carbonyl stretch at 1737 cm-1 in the IR spectrum.   
 
As small amount of dihydroxylation product had been previously been isolated it was 
decided to briefly repeat this work on the enone substrate (179). This was 
unsuccessful and resulted in reisolation of the starting material as had been the case 
with repeat attempts at forming (178).  
 
Another well known method of forming diols is the Prévost reaction.89 2 Equivalents 
of silver carboxylate is needed to form the trans dicarboxylate which can then 
hydrolysed to the trans-1,2-diol under basic conditions. This was therefore attempted 
on the enone (179) using the readily available reagents iodine and silver benzoate in 
toluene. 
O
O
O
179
O
O
O
180
i) I2 (1.1 eq)
   C6H5CO2Ag (2.2 eq)
ii) NaHCO3 aq.
OH
OH
 
Scheme 44: Attempted Prévost reaction 
 
Unfortunately the reaction yielded quantitative recovery of the starting material. The 
Woodward-Brutcher modification of the Prévost reaction90 was also attempted with 
the addition of aqueous acetic acid. It was thought that this method may be more 
reproducible and less dependant on dry reaction conditions. The modification also has 
the benefit of only requiring 1 equivalent of silver benzoate as the orthocarboxylate is 
directly hydrolysed to give a cis-1,2-diol. Unfortunately the modified conditions also 
led to recovery of starting material. 
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At the same time as studying reactions of the electron deficient olefin in the enone 
system we decided to investigate reactions of allylic alcohols. This would allow us to 
understand whether certain reactions attempted on the tertiary alcohol substrates could 
be carried out on less hindered allylic systems. The allylic alcohols (105) and (106) 
were therefore synthesised from the corresponding aldehydes using a Grignard 
reaction in good yields of 95 and 89% respectively.  
 
181: R = R' = Me (95%)
182: R + R' = -CH2- (89%)
O OH
BrMgCH=CH2
RO
OR'
RO
OR'
THF, -78oC
 
Scheme 45: Grignard to form allylic alcohol 
 
Epoxidation of the alkene was attempted using mCPBA as had previously been 
performed on the tertiary more hindered alcohols. The mCPBA reaction was carried 
out under the exact same conditions as previously used. It was again found that the 
reaction yielded a complex mixture of products as observed by 1H NMR 
spectroscopy. Purification by silica gel chromatography was attempted but this led to 
further impure uncharactorisable fractions. It was postulated that the epoxidation 
reaction was occurring but the hydroxyl group may be further reacting via a Payne 
type rearrangement or undergoing further intermolecular reactions with other epoxide 
containing molecules to form a complex mixture of products.  
 
A further reaction which was therefore tried was a multiple oxidation using sodium 
hypochlorite solution. This was carried out using excess oxidising agent in 
acetonitrile. This was to aid the solubility of the substrate. Upon work up the reaction 
yielded the epoxy-ketone (183) in 71% yield. 
O
O
182
O
O
O
183 (71%)
O
OH
NaOCl (excess)
Acetonitrile
 
Scheme 46: Sodium hypochlorite oxidation 
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Oxidation of the allylic alcohol to the epoxide was confirmed by 1H NMR 
spectroscopy where the expected protons at. 2.9 (1H, dd, J = 2.6, 6.4 Hz, CHCHH), 
3.0 (1H, dd, J = 4.6, 6.4 Hz, CHCHH), 4.1 (1H, dd, J = 2.6, 4.6 Hz, CHCH2) were 
clearly observed. Oxidation of the hydroxyl group was confirmed by IR spectroscopy 
as the product showed a strong carbonyl stretch at 1678 cm-1. Final confirmation was 
obtained from the FAB-HRMS with a peak observed at m/z 210.0759 corresponding 
to C10H12NO4 the M+NH4+ ion. 
 
O
O
O
183
O
184
O
O
O
StBu
OH
tBuSH (1.1 eq)
NaH (1.5 eq)
THF, 0oC
 
Scheme 47: Attempted epoxide opening reaction 
 
Attempt at ring opening the epoxide proved challenging. The chosen conditions used 
sodium hydride to firstly deprotonate the t-butyl thiol in a solution of THF at 0°C. The 
keto-epoxide (183) was then added drop wise in a solution of THF and the reaction 
mixture allowed to warm to RT. Work up yielded a mixture of products as visible by 
1H NMR spectroscopy. Attempts to isolate a major product using column 
chromatography and preparative TLC proved unsuccessful. A possible problem with 
this reaction may be the reactivity of the sulfur anion which was formed, which could 
have either reacted with the epoxide as we had hoped, or possibly the ketone group. 
The epoxide could also have ring opened at the terminal or secondary site giving 
further mixtures of products.  
 
Another reaction of interest to us was in using a bromination agent to form a 
bromonium ion from an alkene. Carrying the reaction out in alcohol can reportedly 
yield the corresponding alkoxybromide.82 This was initially attempted using N-
bromosucinimide on a styrene substrate with methanol/water (4:1) as a mixed solvent. 
185
OMe
BrNBS (2 eq)
MeOH/H20 (4:1)
 
Scheme 48: Methoxybromide formation from styrene 
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The reaction afforded an 80% yield of the desired methoxybromide which was 
confirmed by comparable data to that previously reported by Phukan.82 
Disappointingly repeating the exact procedure on the allylic alcohol (181) only 
yielded starting material. This reaction was repeated to confirm our findings but this 
time carrying out the reaction over an extended period of 24 hours instead of the 2 
hours used for the styrene substrate. Unfortunately only starting material was 
recovered confirming this allylic alcohols low reactivity to NBS. 
 
181
NBS (2 eq)
MeOH/H20 (4:1)
OH
MeO
OMe
OH
MeO
OMe
Br
OMe
186  
Scheme 49: Attempted methoxybromide formation 
 
Ozonolysis had previously been attempted on the tertiary alcohol structure with little 
success. This was assumed to be due to the compatibility of the imidazole group when 
trying to oxidise only the terminal alkene. To study this further we synthesised the 
alcohol (187) from the corresponding aldehyde using allylmagnesium bromide. This 
was achieved in a good yield of 79%. 
 
187
OH
188
OH
O
MeO
OMe
MeO
OMe
O3
DCM
 
Scheme 50: Ozonolysis of the allyl Grignard product 
 
The ozonolysis reaction was then carried out in DCM. It was found to be difficult to 
control the amount of O3 entering the reaction flask by tuning the flow rate as a 
theoretical stoichiometric amount of O3 yielded starting material. For this reason the 
second reaction was left running for 5 minutes before quenching with DMS and 
carrying out TLC analysis on the mixture. The TLC plate was visualised under a UV 
light source where the mixture now appeared as a long streak running 2/3rds the 
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length of the plate. As there were no identifiable spots present it was decided not to 
attempt column chromatography purification.  
 
A recent paper by Lin et al91 demonstrated the anti-Markovnikov addition of thiols to 
vinyl ethers. This was of interest to us for introducing sulfur into the carbon backbone 
structure in the proposed reaction scheme 51. 
 
OH
OEt
NMeN
O
O
anti-Markovnikov addition
solvent/catalyst free 30-60oC
OH
OEt
NMeN
O
O
StBu
189 190  
Scheme 51: anti-Markovnikov thiol addition 
 
Compound (189) was therefore targeted as a useful synthetic intermediate although 
the initially trial reactions were carried out on piperonal and benzophenone substrates. 
One equivalent of t-BuLi (1.7 M) was used to form the ethylvinyl ether anion at -78°C 
in THF. Addition of the carbonyl compound was carried out at -78°C before allowing 
the reaction mixture to gradually warm back to room temperature. The reaction of 
both the piperonal and benzophenone substrates proceeded well using this procedure 
yielding the corresponding alcohols in 61% (191) and 77% (192) yield respectively.  
O
O
O
O
O
OH
OEttBuLi (1.7 M)
THF, -78oC
EtO
191
tBuLi (1.7 M)
THF, -78oC
EtO
192
O
OH
OEt
 
Scheme 52: Ethylvinyl ether additions 
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Following the successful ethylvinyl ether additions on both an aldehyde and ketone 
substrate we were relatively confident that the reaction would proceed on our 
imidazole containing ketone substrates. We carried out the reaction under the same 
pre-determined conditions in an attempt to form the target compound (189) but after 
the initial work up it was evident from the 1H NMR spectrum that the reaction had not 
proceeded as cleanly as previously observed. 
 
The crude mixture was therefore purified by silica gel column chromatography using 
light petroleum:ethyl acetate (10:1) eluent. This afforded a trace yield of a colourless 
oil. Interestingly, IR spectroscopy suggested the presence of a hydroxyl group due to 
a stretch at 3482cm-1, and 1H NMR spectroscopy suggested the presence of a t-butyl 
group due to the peak at 1.18 ppm which integrated to approximately 9 protons.  Due 
to the presence of the correct number of aromatic protons we tentatively assign the 
structure of the t-butyl addition product (193). 
tBuLi (1.7 M)
THF, -78oC
EtO
189
OH
OEt
NMeN
O
O
O
N
Me
N
O
O
193 (trace yield)
OH
NMeN
O
O
 
Scheme 53: Attempted ethylvinyl ether addition to an imidazole containing ketone 
 
Unfortunately time did not allow for an investigation into thiol additions to the earlier 
synthesised vinyl ethers (191) and (192) as planned due to more promising work in 
the area of sulfur containing [3,3] sigmatropic rearrangement. 
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2.5 - [3,3] Rearrangements 
 
The Claisen rearrangement23 is well known as one of the most powerful reactions for 
the stereoselective formation of carbon-carbon bonds. Although the Claisen 
rearrangement has been widely studied, the thio-Claisen rearrangement has had 
limited attention since it was first reported in 1962 by Kwart and Hackett.92 We 
decided to investigate the use of a thio-Claisen rearrangement as a practical tool for 
introducing sulphur to an allylic alcohol substrate.  
 
Our investigation initially began using the widely available reagent thiocarbonyl 
diimidazole (TCDI) as a source of sulfur. The corresponding allylic alcohol was 
stirred with an excess of TEA in chloroform before adding the TCDI. It was found 
that at room temperature the reaction yielded starting material after 48 hours, but 
when the reaction was refluxed for 24 hours a distinct product spot was observed on 
the TLC plate. Aqueous work-up was followed by silica gel column chromatography 
yielding a yellow solid with a mp = 184-185°C. The new product exhibited a new 
carbonyl stretch at 1600cm-1 in the IR spectrum and the absence of the original O-H 
was also noted. 1H NMR spectroscopy suggested the formation of (195) due to two 
new alkene protons present at 6.04 and 6.55 ppm. A coupling constant of 15.6Hz 
indicated that the transalkene had been formed. One anomaly that was noticed in the 
NMR spectra of the product was that no imidazole protons or carbons were observed, 
suggesting that the imidazole group may not be present in the product. We therefore 
eagerly awaited the mass spectrometry results which we hoped would help deduce the 
structure. Unfortunately mass spectrometry results proved inconclusive and a major 
ion was not observed. We therefore postulate that the reaction went via the 
thionocarbamate intermediate (194) and we tentatively assign the product as (195).  
195
OH
O
O
O
O
O
S
N
N
O
O
SO
N
N
TCDI (1.5eq)
TEA (1.5eq)
CHCl3
194  
Scheme 54: thio-Claisen reaction using TCDI 
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A similar reaction utilising an isothiocyanate was also carried out. This was initially 
attempted using the same TEA/chloroform procedure as previously used but this was 
unsuccessful and yielded starting material even after 48 hours refluxing. We were 
intrigued as to why the reaction would not precede using an isothiocyanate under 
these conditions so attempted a further reaction using sodium hydride to deprotonate 
the allylic alcohol in THF at 0°C. The isothiocyanate was then added and the reaction 
allowed to return to room temperature overnight. An aqueous work up followed by 
recrystallisation yielded a white solid with mp = 239-241°C. The 1H NMR spectrum 
exhibited a NH proton at 6.95 ppm as a broad singlet. The two alkene protons were 
again observed at 6.00 and 6.40 ppm with a 15.6 Hz coupling constant. HRMS 
confirmed the product as having the formula C18H18NO4S and m/z 344.0948 leading 
us to assign the structure (197).  
196
OH
O
O
O
O
O
S
NH
O
O
SO
NH
NaH (2 eq)
THF
N
C
S
OMe
MeO MeO
197  
Scheme 55: thio-Claisen rearrangement using isothiocyanate 
 
One final reaction that was attempted was the rearrangement of a similar carbonic 
acid intermediate (198). It was thought that this may undergo a similar rearrangement 
through a cyclic transition state to form the transalkene (199). The rearrangement was 
attempted using Boc2O and both the previously used reaction conditions. 
Unfortunately in both cases the suggested intermediate was isolated and the 
rearrangement to form (199) was not observed.  
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198
O
O
O
MeO
OMe
OH
MeO
OMe
O
O
O
MeO
OMe
199
Method A: TEA, Boc2O, CHCl3
Method B: NaH, Boc2O, THF
 
Scheme 56: Attempted carbonic acid rearrangment 
 
The thio-Claisen rearrangement had worked and sulfur had been successfully 
incorporated forming (197). Further work to functionalise the new double bond in 
(197) is needed to develop the synthesis further. It is not clear why the attempted 
Claisen rearrangement of (198) failed, but it may be due to the higher stability of the 
C=O bond in the carbonate ester compared to the relatively weak C=S bond in the 
thionocarbamate (196). 
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2.6 - Conclusions 
 
Throughout this research the most challenging aim has been to work towards the total 
synthesis of aplidium trisulfide. Although the complete total synthesis was not 
achieved I believe the research carried out has made a real advancement toward this 
previously unattempted target molecule.  
 
The work initially afforded a catalogue of key secondary alcohol compounds 
containing the imidazole group and aromatic substituents present in aplidium 
trisulfides structure. These compounds were successfully oxidised using a manganese 
dioxide procedure which proved to be high yielding and a reproducible process which 
led to the synthesis of a variety of closely related ketones. A Grignard reaction was 
then utilised to form a range of allylic alcohols. This step demonstrated the formation 
of the hindered quaternary carbon centre which is present in the main carbon 
backbone structure of aplidium trisulfide. 
 
OH
NMeN
MeO
OMe
S
N
S
OMe
MeO
NMeN
OMe
MeO
S
 
Figure 38: Synthetic advancements toward aplidium trisulfide  
 
Difficulties in the synthesis arose when attempting to functionalise the olefin of the 
carbon backbone structure. This proved to be a major hurdle and we are unable to 
report an effective way to gain functionality at this site. Whilst the initial proposed 
route became hampered due to unsuccessful attempts at functionalisation, this led to a 
number of new and diverse ideas.  
 
Going back to the secondary alcohol stage allowed us to rethink our proposed 
synthesis. At this stage we came up with a more convergent synthesis towards 
aplidium trisulfide and this led us to introduce sulfur into the structure at an earlier 
stage. A range of butylthioether compounds were synthesised. The presence of the 
butylthioether was to facilitate the formation of the trisulfide ring during the proposed 
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final step.  t-Butylthioether groups have previously been shown to react with a range 
of sulfur chlorides and form polysulfide ring. So the introduction of a thioether was a 
key synthetic step.  
 
Synthesis of both ester and acid chlorides containing a thioether group was completed 
successfully and these compounds were necessary for the convergent step. 
Unfortunately the proposed convergent step proved unsuccessful which was 
disappointing due to the highly desired product. 
S
N
Me
N O
Cl
S
+
NMeN
S
SO
n-BuLi (2.5 M), THF
-78oC-RT, 24 hMeO
OMe
MeO
OMe  
Figure 39: Unsuccessful convergent step 
 
More successful work followed where we demonstrate that a carbanion can be formed 
adjacent to the sulfur atom and a range of alkylhalides could be reacted with the anion 
to form a quaternary centre. We discovered that steric hindrance had a large effect, 
reducing the yield of sterically demanding products.  
 
Problems were also encountered when attempting to form thioketone compounds due 
to their inherently instability. This led us to investigate the use of organometallic 
chemistry in forming stabilised thioketone metal complexes. Isolation of the bright 
purple thiobenzophenone-tungsten complex was successful and proved that hindered 
ketones could be used in this type of reaction, but due to the extremely poor yields our 
direction moved away from this exciting avenue of research.  
 
Finally we embarked upon a new “less hindered” synthetic route. This was designed 
to get around the problems previously encountered when trying to functionalise a 
sterically hindered olefin. At this stage of the research time was short and many 
reactions were tried unsuccessfully without further repeat work or optimisation. This 
would be an area where further research may prove fruitful. Ethylvinyl ether additions 
to benzaldehyde type compounds were not fully utilised and it would be interesting to 
investigate the use of thiol additions to vinyl ether containing compounds.  
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Experimental 
3.1 - General Information 
 
 
Infrared spectra were obtained using a Perkin-Elmer Paragon 1000 FT-IR 
spectrometer. Thin film spectra were recorded using dichloromethane to load the 
samples onto a sodium chloride plate. 1H and 13C NMR spectra were recorded at 400 
MHz and 100 MHz respectively using a Bruker DPX 400MHz instrument using 
CDCl3 as the solvent unless otherwise stated. 1H and 13C NMR shifts are reported in 
ppm using tetramethylsilane as the internal reference. Mass spectra were recorded 
using a Jeol-SX102 instrument, using electron impact (EI) or fast atom bombardment 
(FAB) techniques, or by the EPSRC national mass spectrometry service at the 
University of Wales, Swansea, using electrospray (ES) techniques. Melting points 
were recorded using an Electrothermal-IA 9100 melting point instrument. 
Chromatographic purification was carried out using Merk-Kieselgel 60H silica gel as 
the absorbent. Reactions were monitored using thin layer chromatography (TLC) on 
aluminium backed plates and were observed under UV radiation of wavelength 254 
nm or via staining with a solution of phosphomolybdic acid (PMA) in ethanol and 
then drying. Reactions requiring anhydrous conditions were carried out using 
glassware dried overnight at 130oC, freshly distilled solvents and done under an 
atmosphere of nitrogen unless otherwise stated. Light petroleum was distilled from 
calcium chloride. Dichloromethane and ethanol were distilled from calcium hydride. 
Tetrahydrofuran (THF) was distilled from sodium using benzophenone as an 
indicator. All other solvents were used as obtained. Aqueous work-ups were carried 
out using de-ionised water. 
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3.2 – Synthetic Procedures 
Preparation of benzo[1,3]dioxole-4-carbaldehyde 60 
 
O
O
O  
 
Piperonyl alcohol (7.61 g, 50 mmol) and PDC (9.41 g, 25 mmol) were stirred in DCM 
(100 ml) at 25oC for 24 h. Diethyl ether (100 ml) was then added and the solution 
filtered through a pad of celite which was further washed with diethyl ether (2 x 50 
ml). The organic filtrate was then evaporated to dryness yielding 6.13 g (82%) of a 
white solid; mp = 34-35 oC (lit.1 mp = 36 oC); νmax(film)/cm-1 1668 (C=O), 1621, 
1597, 1494, 1447, 1417, 1273, 1094, 1034, 927, 864, 811, 785; δH (400 MHz CDCl3) 
5.96 (2H, s, CH2), 6.85 (1H, d, J = 8.0 Hz, CHarom), 7.24 (1H, d, J = 1.6 Hz, CHarom), 
7.32 (1H, dd, J =  1.6, 8.0 Hz, CHarom), 9.72 (1H, s, CH); δC (100 MHz CDCl3) 102.1 
(CH2), 106.9 (CH), 108.4 (CH), 128.7 (CH), 131.9 (quat), 148.7 (quat), 153.1 (quat), 
190.4 (CO). 
 
 
Preparation of imidazol-1-ylmethyldimethylamine 61 
 
N
N
NMe2  
 
Imidazole (17.02 g, 250 mmol) and dimethylamine hydrochloride (20.64 g, 250 
mmol) were dissolved in water (50 ml). Conc. HCl was added to achieve pH~4. Aq. 
formaldehyde (22.3 ml, 300 mmol) was then added and the reaction was stirred for 24 
h. The mixture was then basified with 20% KOH solution and extracted with DCM (3 
x 100 ml). The combined organic layers were then dried over MgSO4 and evaporated 
to dryness yielding 26.78 g (86%) of a colourless oil; νmax (film)/cm-1 3107, 2942, 
2831, 1504, 1455, 1214, 1074, 1050 cm-1; δH (400 MHz CDCl3) 2.17 (6H, s, 2 x 
CH3), 4.56 (2H, s, CH2), 6.88 (1H, t, J = 1.2 Hz, CH), 6.95 (1H, t, J = 1.2 Hz, CH), 
 100
7.40 (1H, s, CH); δC (100 MHz CDCl3) 41.8 (2 x CH3), 69.2 (CH2), 119.8 (CH), 128.9 
(CH), 137.6 (CH). 
 
 
Preparation of 4-(tert-butyldimethylsilanyloxy)-3-methoxybenzaldehyde 62 
 
O
O
OMe
Si
 
 
Vanillin (7.61 g, 50 mmol) and imidazole (5.11 g, 75 mmol) were dissolved in DCM 
(75 ml) and stirred for 15 min. TBDMSCl (9.80 g, 65 mmol) in DCM (40 ml) was 
then added and the reaction was stirred at room temperature for 24 h. Water (75 ml) 
was added and the reaction extracted with DCM (3 x 75 ml). The combined organic 
layers were dried over MgSO4 and evaporated to dryness yielding 12.83 g (96%) of a 
clear yellow oil; νmax(film)/cm-1 2929, 2856, 1697 (C=O), 1592, 1504, 1289, 1152; δH 
(400 MHz CDCl3) 0.01 (6H, s, Si(CH3)2), 0.81 (9H, s, C(CH3)3), 3.66 (3H, s, OCH3), 
6.76 (1H, d, J = 8.0 Hz, CHarom), 7.17 (2H, m, 2 x CHarom), 9.65 (1H, s, CH); δC (100 
MHz CDCl3) -3.6 (2 x CH3), 18.0 (quat), 25.7 (3 x CH3), 56.1 (CH3), 109.0 (CH), 
114.6 (CH), 127.7 (CH), 129.6 (quat), 147.5 (quat), 152.2 (quat), 191.2 (CO). 
 
 
Preparation of 4-benzyl-3-methoxybenzaldehyde 63 
 
O
O
OMe  
 
Vanillin (7.61 g, 50 mmol) and potassium carbonate (8.29 g, 60 mmol) in acetone 
(300 ml) were placed in a round bottomed flask. Benzyl bromide (8.55 g, 50 mmol) 
was then added slowly and once the addition was complete the reaction mixture was 
refluxed for 24 h. Water (200 ml) was then added, and the mixture extracted with 
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ethyl acetate (3 x 100 ml). The combined organic layers were then dried over MgSO4 
and evaporated to dryness yielding a yellow solid. This was then recrystallised from 
DCM-light petroleum to yield 11.02 g (91%) of a white powder; νmax (film)/cm-1 
2936, 1681 (C=O), 1585, 1507, 1268, 1135, 1030; δH (400 MHz CDCl3) 3.91 (3H, s, 
OCH3), 5.21 (2H, s, CH2), 6.97 (1H, d, J = 8.0 Hz, CHarom), 7.37 (7H, m, 7 x CHarom), 
9.80 (1H, s, CHO); δC (100 MHz CDCl3) 55.0 (CH3), 70.9 (CH2), 109.3 (CH), 112.3 
(CH), 113.8 (CH), 117.8 (CH), 126.7 (CH), 127.2 (CH), 128.2 (CH), 128.8 (CH), 
130.3 (quat), 136.0 (quat), 150.0 (quat), 153.6 (quat), 191.0 (CO). 
 
 
General Procedure for the Formation of Key Secondary Alcohols 
 
The corresponding imidazole/thiazole (10 mmol) was stirred in THF (10 ml) at -78oC 
under an atmosphere of nitrogen. n-BuLi in hexane (2.5 M, 12 mmol) was then added 
drop-wise and the reaction mixture stirred for 15 min. The required aldehyde (10 
mmol ) was then added and the reaction was allowed to return to room temperature 
and stirred for 24 h. The reaction was then quenched with water (25 ml) and extracted 
with ethyl acetate (3 x 25ml). The organic fractions were then combined, dried over 
MgSO4 and evaporated to dryness yielding the crude secondary alcohol. Silica 
column chromatography was carried out using petrol:ethyl acetate (10:1) eluent 
affording the pure product. 
 
 
[4-(tert-Butyldimethylsilanoxy)-3-methoxyphenyl]-(1H-imidazol-2-yl)-methanol  
 
O
MeO
N
H
N
OH
Si
 
 
Prepared as general procedure for the synthesis of key secondary alcohols using pre-
synthesised 4-(tert-butyldimethylsilanyloxy)-3-methoxybenzaldehyde (2.66 g, 10 
mmol) and imidazol-1-ylmethyldimethylamine (1.25 g, 10 mmol) yielding 2.75 g 
(82%) of a white powder; mp 226-227 oC; νmax(film)/cm-1 3300 (O-H), 2953, 2357, 
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1667, 1513, 1462, 1283, 1075; δH (400 MHz DMSO) 0.01 (6H, s, Si(CH3)2), 0.84 
(9H, s, C(CH3)3), 3.63 (3H, s, OCH3), 5.65 (1H, s, CHOH), 6.68 (3H, m, 3 x CHarom), 
6.89 (1H, s, C=NCH), 6.99 (1H, d, J = 2.0Hz, NHCH) [OH and NH not observed]; δC 
(100 MHz CDCl3) 4.7 (2 x CH3), 18.1 (quat), 25.5 (3 x CH3), 55.2 (CH3), 69.4 (CH), 
110.6 (CH), 115.9 (CH), 118.6 (CH), 119.7 (CH), 126.7 (CH), 137.0 (quat), 143.1 
(quat), 150.0 (quat), 150.3 (quat); HRMS [ES] (M+H+), C17H27N2O3Si requires m/z 
335.1712, found m/z 335.1785. 
 
 
(4-Benzyloxy-3-methoxyphenyl)-(1H-imidazol-2-yl)-methanol 
 
BnO
MeO
N
H
N
OH
 
 
Prepared as general procedure for the synthesis of key secondary alcohols using pre-
synthesised 4-benzyl-3-methoxybenzaldehyde (2.42 g, 10 mmol) and Imidazol-1-
ylmethyl-dimethyl-amine (1.25 g, 10 mmol), yielding 2.26 g (73%) of a white 
powder; mp 189-190 oC; νmax(film)/cm-1 3190 (O-H), 1589, 1514, 1457, 1415, 1229, 
1135, 1071cm-1; δH (400 MHz CDCl3) 3.77 (3H, s, OCH3), 5.04 (2H, s, CH2), 5.75 
(1H, s, CHOH), 6.76 (2H, m, 2 x CHarom), 6.86 (2H, s, NHCHCH), 6.90 (1H, s, 
CHarom), 7.21 (5H, m, 5 x CHarom) [OH and NH not observed]; δC (100 MHz CDCl3) 
55.5 (CH3), 69.4 (CH2), 69.9 (CH), 110.4 (CH), 113.1 (CH), 118.3 (CH), 127.6 (2 x 
CH), 127.7 (3 x CH), 128.3 (2 x CH), 136.2 (quat), 137.2 (quat), 146.7 (quat), 148.7 
(quat), 150.3 (quat); HRMS [EI] (M+), C18H18N2O3 requires m/z 310.1322, found m/z 
310.1317. 
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(3,4-Dimethoxyphenyl)-(1-methyl-1H-imidazol-2-yl)-methanol 
 
N
Me
N
MeO
OMe
OH
 
 
Prepared as general procedure for the synthesis of key secondary alcohols using 3,4-
dimethoxybenzaldehyde (16.62 g, 100 mmol) and 1-methylimidazole (8.21 g, 100 
mmol) yielding 24.18 g (98%) of a yellow oil; νmax(film)/cm-1 3187 (O-H), 1593, 
1512, 1456, 1439, 1297, 1271, 1083; δH (400 MHz CDCl3) 3.31 (3H, s, NCH3), 3.69 
(3H, s, OCH3), 3.75 (3H, s, OCH3), 5.81 (1H, s, CHOH), 6.61 (1H, s, CHarom), 6.65 
(3H, s, CHarom and NCHCHN), 6.87 (1H, s, CHarom) [OH and NH not observed]; δC 
(100 MHz CDCl3) 33.2 (CH3), 55.8 (2 x CH3), 68.6 (CH), 109.3 (CH), 110.7 (CH), 
118.1 (CH), 122.0 (CH), 125.9 (CH), 134.2 (quat), 148.1 (quat), 148.8 (quat), 149.3 
(quat); HRMS [EI] (M+), C13H16N2O3 requires m/z 249.1234, found m/z 249.1235. 
 
 
(3,4-Dimethoxyphenyl)-thiazol-2-yl-methanol  
 
N
S
MeO
OMe
OH
 
 
Prepared as general procedure for the synthesis of key secondary alcohols using 3,4-
dimethoxybenzaldehyde (4.15 g, 25 mmol) and thiazole (2.13 g, 25 mmol) yielding 
5.99 g (95%) of a yellow oil; νmax(film)/cm-1 3203 (O-H), 2963, 2397, 1515, 1503, 
1481, 1260, 1024; δH (400 MHz CDCl3) 3.80 (3H, s, OCH3), 3.81 (3H, s, OCH3), 5.95 
(1H, s, CHOH), 6.80 (1H, d, J = 8.0 Hz, CHarom), 6.94 (2H, m, 2 x CHarom), 7.25 (1H, 
d, J = 3.2 Hz, SCH), 7.68 (1H, d, J = 3.2 Hz, NCH) [OH not observed]; δC (100 MHz 
CDCl3) 13.1 (quat), 21.3 (quat), 54.8 (2 x CH3), 52.8 (CH), 108.4 (CH), 109.9 (CH), 
118.1 (CH), 118.7 (CH), 132.9 (quat), 141.3 (CH), 148.2 (quat); HRMS [EI] (M+H+), 
C12H14NO3S requires m/z 252.0689, found m/z 252.0693. 
 104
Benzo[1,3]dioxol-5-yl-(1-methyl-1H-imidazol-2-yl)-methanol  
 
N
Me
N
OH
O
O  
 
Prepared as general procedure for the synthesis of key secondary alcohols using 
piperonal (3.75 g, 25 mmol) and 1-methylimidazole (2.05 g, 25 mmol) yielding 5.36 g 
(92%) of a white solid; mp = 109-112oC; νmax(film)/cm-1 3113 (O-H), 1549, 1482, 
1456, 1437, 1287, 1251, 1103; δH (400 MHz CDCl3) 3.34 (3H, s, NCH3), 5.73 (1H, s, 
CHOH), 5.85 (2H, s, OCH2O), 6.67 (3H, m, 3 x CHarom), 6.74 (1H, d, J = 1.2 Hz, 
NCH3CH), 6.77 (1H, d, J = 1.2 Hz, C=NCH) [OH not observed]; δC (100 MHz 
CDCl3) 33.1 (CH3), 68.8 (CH), 101.0 (CH2), 107.0 (CH), 108.0 (CH), 119.7 (CH), 
122.1 (CH), 126.2 (CH), 135.0 (quat), 147.0 (quat), 147.8 (quat), 149.1 (quat); HRMS 
[EI] (M+H+), C12H13N2O3 requires m/z 233.0921, found m/z 233.0921. 
 
 
Benzo[1,3]dioxol-5-yl-(1H-imidazol-2-yl)-methanol  
 
N
H
N
OH
O
O  
 
Prepared as general procedure for the synthesis of key secondary alcohols using 
piperonal (0.75 g, 5 mmol) and pre-synthesised imidazol-1-ylmethyldimethylamine 
(0.63 g, 5 mmol) yielding 0.96 g (88%) of a yellow oil; νmax(film)/cm-1 3195 (O-H), 
2891, 2579, 1548, 1504, 1486, 1442, 1362, 1301, 1263, 1235, 1183, 1101, 1038, 933; 
δH (400 MHz DMSO-d6) 5.69 (1H, s, CHOH), 6.03 (2H, s, CH2), 6.19 (1H, bs, OH), 
6.76 (2H, s, 2 x CHarom) 6.89 (1H, s, CHarom) [imidazole protons not observed]; δC 
(100 MHz DMSO-d6) 69.3 (CH), 100.7 (CH2), 106.8 (CH), 107.6 (CH), 119.5 (CH), 
137.4 (quat), 146.1 (quat), 146.9 (quat), 150.2 (quat) [NCHCH not observed]; HRMS 
[EI] (M+), C11H10N2O3 requires m/z 218.0691, found m/z 218.0695. 
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Benzo[1,3]dioxol-5-ylthiazol-2-ylmethanol  
 
N
S
OH
O
O  
 
Prepared as general procedure for the synthesis of key secondary alcohols using 
piperonal (0.88 g, 5.9 mmol) and thiazole (0.50 g, 5.9 mmol) yielding 0.97 g (70%) of 
a orange oil; νmax(film)/cm-1 3311 (O-H), 2928, 1681, 1603, 1502, 1496, 1442, 1246, 
1094, 1038, 929; δH (400 MHz CDCl3) 5.88 (3H, m, CH2 and CHOH), 6.71 (1H, d, J 
= 7.6 Hz, CHarom), 6.86 (2H, m, 2 x CHarom), 7.21 (1H, d, J = 3.2 Hz, SCH), 7.62 (1H, 
d, J = 3.2 Hz, NCH) [OH not observed]; δC (100 MHz CDCl3) 73.6 (CH), 101.2 
(CH2), 107.1 (CH), 108.3 (CH), 119.6 (CH), 120.4 (CH), 135.5 (quat), 142.3 (CH), 
147.7 (quat), 148.0 (quat), 174.5 (quat); HRMS [EI] (M+), C11H9NO3S requires m/z 
235.0303, found m/z 235.0306. 
 
 
General Procedure for MnO2 Oxidation of Secondary Alcohols 
 
The pre-synthesised secondary alcohol (4 mmol) and activated MnO2 (20 mmol) were 
refluxed in methanol (10 ml) for 24 h. The mixture was then filtered warm through a 
pad of celite and the solids further washed with chloroform (3 x 25 ml). The 
combined organic filtrate was then evaporated to dryness yielding the corresponding 
ketone. 
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Benzo[1,3]dioxol-5-yl-thiazol-2-ylmethanone  
 
N
S
O
O
O  
 
Prepared as general procedure for the MnO2 oxidation of secondary alcohols using 
benzo[1,3]dioxol-5-ylthiazol-2-ylmethanol (0.90 g, 3.8 mmol) and MnO2 (1.66 g, 
19.2 mmol) yielding 0.85 g (95%) of a yellow oil; νmax(film)/cm-1 2359, 1639 (C=O), 
1599, 1499, 1478, 1438, 1388, 1352, 1297, 1264, 1241, 1117, 1077, 1035, 926; δH 
(400 MHz CDCl3) 6.01 (2H, s, OCH2O), 6.86 (1H, d, J = 8.4 Hz, CHarom), 7.62 (1H, 
d, J = 3.0 Hz, SCH), 7.91 (1H, d, J = 1.6 Hz, CHarom), 8.01 (1H, d, J = 3.0 Hz, NCH), 
8.26 (1H, dd, J = 8.4, 1.6 Hz, CHarom); δC (100 MHz CDCl3) 101.9 (CH2), 108.1 
(CH), 110.7 (CH), 125.9 (CH), 128.4 (CH), 129.5 (quat), 144.6 (CH) [4 x quat not 
detected]; HRMS [ES] (M+H+), C11H8NO3S requires m/z 234.0217, found, 234.0219.  
 
 
(4-Benzyloxy-3-methoxyphenyl)-(1H-imidazol-2-yl)-methanone  
 
BnO
MeO
N
H
N
O
 
 
Prepared as general procedure for the MnO2 oxidation of secondary alcohols using (4-
benzyloxy-3-methoxyphenyl)-(1H-imidazol-2-yl)-methanol (0.62 g, 2 mmol) and 
MnO2 (0.87 g, 10 mmol), yielding 0.52 g (84%) of a yellow solid; mp 172-174 oC; 
νmax(film)/cm-1 1633, 1624, 1511, 1463, 1327, 1310, 1253, 1173, 1150 ; δH (400 MHz 
CDCl3) 3.99 (3H, s, OCH3), 5.28 (2H, s, OCH2Ph), 6.97 (1H, d, J = 8.5 Hz, CHarom), 
7.25-7.45 (7H, m, 5 x CHarom and NHCHCHN), 8.10 (1H, d, J =1.4 Hz, CHarom), 8.50 
(1H, dd, J = 8.5 and 1.4 Hz, CHarom) [NH not observed]; δC (100 MHz CDCl3) 56.1 
(CH3), 70.8 (CH2), 112.2 (CH), 113.1 (CH), 119.7 (CH), 126.6 (CH), 127.2 (2 x CH), 
128.1 (CH), 128.6 (2 x CH), 128.7 (quat), 131.6 (CH), 136.3 (quat), 145.5 (quat), 
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149.2 (quat), 152.9 (quat), 179.9 (quat). HRMS [EI] (M+), C18H16N2O3 requires m/z 
308.1157, found  m/z 308.1161. 
 
 
Benzo[1,3]dioxol-5-yl-(1H-imidazol-2-yl)-methanone  
 
N
H
N
O
O
O
 
 
Prepared as general procedure for the MnO2 oxidation of secondary alcohols using 
benzo[1,3]dioxol-5-yl-(1H-imidazol-2-yl)-methanol (0.87 g, 4 mmol) and MnO2 (1.74 
g, 20 mmol), yielding 0.77 g (90%) of a yellow solid; mp 182-185oC; νmax(film)/cm-1 
3280, 2361, 1623, 1594, 1442, 1395, 1249, 1121; δH (400 MHz CDCl3) 6.07 (2H, s, 
OCH2O), 6.93 (1H, d, J = 8.0 Hz, CHarom), 7.29 (1H, s, NHCH), 7.38 (1H, s, 
C=NCH), 8.06 (1H, d, J = 1.6 Hz, CHarom), 8.49 (1H, dd, J = 1.6, 8.0 Hz, CHarom) 
[NH not observed]; δC (100 MHz CDCl3) 101.8 (CH2), 108.1 (CH), 110.5 (CH), 119.7 
(CH), 128.3 (CH), 129.9 (quat), 131.6 (CH), 147.9 (quat), 152.3 (quat) [2 x quat not 
detected]; HRMS [ES] (M+H+), C11H9N2O3 requires m/z 217.0608, found m/z 
217.0608. 
 
 
[4-(tert-Butyldimethylsilanoxy)-3-methoxyphenyl]-(1H-imidazol-2-yl)-methanone 
 
TBDMSO
MeO
N
H
N
O
 
 
Prepared as general procedure for the MnO2 oxidation of secondary alcohols using [4-
(tert-butyldimethylsilanoxy)-3-methoxyphenyl]-(1H-imidazol-2-yl)-methanol (0.50 g, 
1.4 mmol) and MnO2 (0.61 g, 7.0 mmol), yielding 0.43 g (93%) of a orange oil; 
νmax(film)/cm-1 2958, 1681, 1587, 1514, 1462, 1416, 1259, 1096; δH (400 MHz 
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DMSO-d6) 0.01 (6H, s, Si(CH3)2), 0.85 (9H, s, SiC(CH3)3), 3.75 (3H, s, OCH3), 6.81 
(1H, d, J = 8.4 Hz, CHarom), 6.98 (1H, s, NHCH), 7.17 (1H, s, C=NCH), 8.02 (1H, d, 
J = 2.0 Hz, CHarom), 8.21 (1H, dd, J = 2.0, 8.4 Hz, CHarom) [NH not observed]; δC 
(100 MHz DMSO-d6) -4.1 (2 x CH3), 25.5 (3 x CH3), 55.5 (CH3), 113.8 (CH), 114.8 
(CH), 121.1 (CH), 126.2 (CH), 127.2 (quat), 130.6 (CH), 145.1 (quat), 147.1 (quat), 
151.9 (quat), 178.9 (quat) [1 x quat not detected]; HRMS [EI] (M+), C17H24N2O3Si 
requires m/z 332.1556, found  m/z 332.1559. 
 
 
Benzo[1,3]dioxol-5-yl-(1-methyl-1H-imidazol-2-yl)-methanone 
 
N
Me
N
O
O
O  
 
Prepared as general procedure for the MnO2 oxidation of secondary alcohols using 
benzo[1,3]dioxol-5-yl-(1-methyl-1H-imidazol-2-yl)-methanol (2.32 g, 10 mmol) and 
MnO2 (4.35 g, 50 mmol), yielding 2.20 g (96%) of a white solid; mp = 295-297 oC; 
νmax(film)/cm-1 2358, 1766, 1633 (C=O), 1598, 1440, 1396, 1357, 1257, 1234, 1094, 
1036; δH (400 MHz CDCl3) 3.97 (3H, s, NCH3), 5.97 (2H, s, OCH2O), 6.82 (1H, d, J 
= 8.0 Hz, CHarom), 7.01 (1H, s, CH3NCH), 7.12 (1H, s, C=NCH), 7.72 (1H, d, J = 1.6 
Hz, CHarom), (1H, dd, J = 1.6, 8.0 Hz, CHarom); δC (100 MHz CDCl3) 36.4 (CH3), 
101.7 (CH2), 107.8 (CH), 110.6 (CH), 126.5 (CH), 127.8 (CH), 129.0 (CH), 131.6 
(quat), 143.2 (quat), 147.6 (quat), 151.7 (quat), 182.2 (quat); HRMS [ES] (M+H+), 
C12H11N2O3 required 231.0764, found 231.0764. 
 
 
 
 
 
 
 
 
 109
(3,4-Dimethoxyphenyl)-(1-methyl-1H-imidazol-2-yl)-methanone 
 
N
Me
N
O
MeO
OMe  
 
Prepared as general procedure for the MnO2 oxidation of secondary alcohols using 
(3,4-dimethoxyphenyl)-(1-methyl-1H-imidazol-2-yl)-methanol (1.24 g, 5 mmol) and 
MnO2 (2.17 g, 25 mmol), yielding 1.19 g (97%) of a white solid; mp = 172-173 oC; 
νmax(film)/cm-1 1631 (C=O), 1582, 1508, 1446, 1416, 1263, 1226, 1075, 1020, 768; 
δH (400 MHz CDCl3) 3.84 (3H, s, OCH3), 3.87 (3H, s, OCH3), 3.97 (3H, s, NCH3), 
6.86 (1H, d, J = 8.4 Hz, CHarom), 7.01 (1H, s, CH3NCH), 7.12 (1H, s, C=NCH), 7.77 
(1H, d, J = 2.0Hz, CHarom), 8.08 (1H, dd, J = 2.0, 8.4 Hz, CHarom); δC (100 MHz 
CDCl3) 35.3 (CH3), 54.9 (2 x CH3), 108.9 (CH), 111.6 (CH), 125.4 (2 x CH), 127.9 
(CH), 128.9 (quat), 142.3 (quat), 147.5 (quat), 152.2 (quat), 181.5 (quat); HRMS [EI] 
(M+), C13H14N2O3 requires m/z 246.1004, found m/z 246.1004. 
 
 
Preparation of [W(CO)5I] [N(Bu)4] 64 
 
Tetrabutylammonium iodide (0.50 g, 1.4 mmol) was heated with an excess of 
tungsten hexacarbonyl (1.00 g, 2.8 mmol) in diglyme (20 ml) at 120oC for 4 h. The 
mixture was filtered hot under N2, and addition of hexane to the filtrate afforded 0.85 
g (91%) of a yellow solid. IR spectra were recorded to confirm the carbonyl stretches 
and then the product was carried through without further purification. νmax(film)/cm-1 
2058, 1909, 1836. 
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Preparation of [Cr(CO)5I] [N(Bu)4] 64 
 
Tetrabutylammonium iodide (0.50 g, 1.4 mmol) was heated with an excess of 
chromium hexacarbonyl (1.00 g, 4.5 mmol) in diglyme (20 ml) at 120oC for 4 h. The 
mixture was filtered hot under N2, and addition of hexane to the filtrate afforded 0.72 
g (95%) of a yellow solid. IR spectra were recorded to confirm the carbonyl stretches 
and then the product was carried through without further purification. νmax(film)/cm-1 
2055, 1914, 1849. 
 
 
Preparation of [W(CO)5SH] [(Ph3P)2N] 65 
 
Sodium hydrosulfide (0.15 g, 2.7 mmol) and bis(triphenylphosphoranylidene)-
ammonium chloride (1.15 g, 2.0 mmol) were dissolved in ethanol (10 ml). The 
mixture was stirred at RT for 1.5 h and then the volatile components were removed 
under vacuum. THF (20 ml) and tungsten hexacarbonyl (0.74 g, 2.1 mmol) were then 
added and the mixture refluxed for 1.5 h. The mixture was then filtered under N2 and 
the resulting filtrate reduced under vacuum yielding 1.51 g (84%) of a yellow solid; 
mp 115-117oC (lit. mp65 = 116 – 119 oC); νmax(film)/cm-1 2052, 1932(vs), 1851. 
 
 
Preparation of [W(CO)5{S=C(C6H4)OMe}] 65 
 
[(Ph3P)2N][W(CO)5SH] (1.79 g, 2.0 mmol) and p-anisaldehyde (0.27 ml, 2.2 mmol) 
were stirred in THF (10 ml) with an excess of magnesium sulphate. Triflic acid (0.19 
ml, 2.2 mmol) was then added dropwise to the reaction during which the solution 
turned a deep purple. The mixture was then reduced under vacuum and the resulting 
residue was purified via column chromatography eluting with light petroleum: ethyl 
acetate (99:1) to afford 0.057 g (6%) of the title compound as a purple oil; 
νmax(film)/cm-1 2067, 1919(vs), 1592, 1262, 1162; δH (400 MHz CDCl3)  3.92 (3H, s, 
OCH3), 6.94 (2H, dd, J 2.6, 9.4 Hz, 2 x CHarom), 7.83 (2H, dd, J 2.6, 9.4 Hz, CHarom), 
9.89 (1H, s, S=CH); HRMS [EI](M+), C13H8SO6W requires m/z 473.9524, found m/z 
473.9530. 
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Preparation of [W(CO)5{S=C(C6H5)2}] 
 
[(Ph3P)2N][W(CO)5SH] (1.79 g, 2.0 mmol) and benzophenone (0.40 g, 2.2 mmol) 
were stirred in THF (10 ml) with an excess of magnesium sulphate. Triflic acid (0.19 
ml, 2.2 mmol) was then added dropwise to the reaction during which the solution 
turned a deep purple. The mixture was then reduced under vacuum and the resulting 
residue was purified via column chromatography eluting with light petroleum: ethyl 
acetate (99:1) to afford 0.021 g (2%) of the title compound as a purple oil. 
νmax(film)/cm-1 2067, 1932(vs); δH (400 MHz CDCl3)  7.12 - 7.64 (8H, m, 8 x 
CHarom), 7.80 - 7.83 (2H, m, 2 x CHarom); δC (100MHz CDCl3) 128.3, 128.9, 130.1, 
132.4, 171.2 (C=O), 206.9 (C=S); HRMS [EI](M+), C18H10SO5W requires m/z 
521.9753, found m/z 521.9755. 
 
 
Preparation of 1,1-diphenyl-prop-2-en-1-ol 66 
 
OH
 
 
An excess of magnesium turnings were stirred vigorously overnight under N2 to give 
a clean reaction surface. THF (10 ml) was then added to the flask along with a crystal 
of iodine. Vinyl bromide solution (1M in THF, 2.4 ml, 2.4 mmol) was then added 
dropwise and the mixture was refluxed for 30 min. Benzophenone (0.40 g, 2.0 mmol) 
was then added and the solution was stirred for 12 h then quenched with ice. The 
resulting mixture was extracted with DCM (3 x 25 ml) and the combined organic 
fractions then washed with water (50 ml) and brine (50 ml). The organic was then 
evaporated to dryness yielding a white solid, 0.37 g (87%); mp = 68-70oC (lit. mp67 = 
72-73oC); νmax(film)/cm-1 3468 (O-H), 3057, 1597, 1446, 1318, 1276, 1176, 1072, 
1029, 920; δH (400 MHz CDCl3) 2.25 (1H, s, OH), 5.29 (2H, m, CH=CH2), 6.49 (1H, 
dd, J = 8.8, 16.2 CH=CH2) 7.16 - 7.31 (10H, m, 10 x CHarom); δC (100 MHz CDCl3) 
79.4 (quat), 113.9 (CH2), 127. 1 (4 x CH), 127.3 (2 x CH), 128.2 (4 x CH), 143.5 
(CH), 145.7 (2 x quat). 
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Preparation of 1-benzo[1,3]dioxol-5-yl-1-(1H-imidazol-2-yl)-prop-2-en-1-ol 
 
O
O
OH
NHN
 
 
Vinyl bromide solution (1 M in THF, 0.46 ml, 0.46 mmol) was added dropwise to an 
excess of magnesium turnings in THF (5 ml) and the solution refluxed for 1 h. 
Benzo[1,3]dioxol-5-yl-(1H-imidazol-2-yl)-methanone (0.050 g, 0.23 mmol) in THF 
(5 ml) was then added and the reaction was stirred for 12 h. Ice was then added to 
quench the reaction and the resulting mixture was extracted with DCM (3 x 20ml). 
The organic fractions were combined, dried over MgSO4 and evaporated to dryness 
yielding 39 mg (76%) of a yellow oil; νmax(film)/cm-1 3149 (O-H), 2923, 1502, 1484, 
1434, 1240, 1162, 1094, 1039; δH (400 MHz CDCl3) 5.20 – 5.25 (2H, m, CHCH2), 
5.86 (2H, s, OCH2O), 6.42 (1H, dd, J = 10.4, 17.2 Hz, CHCH2), 6.66 (1H, d, J = 8.4 
Hz, CHarom), 6.75 (1H, dd, J = 1.6, 8.4 Hz, CHarom), 6.83 (1H, d, J = 1.6 Hz, CHarom), 
6.88 (2H, s, NCHCH) [OH and NH not observed]; δC (100 MHz CDCl3) 100.2 (CH2), 
106.3 (CH), 106.9 (CH), 113.7 (CH2), 118.8 (CH), 119.6 (CH), 122.3 (CH), 136.3 
(quat), 140.3 (CH), 146.2 (quat), 146.7 (quat), 149.9 (quat) [1 x quat not detected]; 
HRMS [EI] (M+), C13H12N2O3 requires m/z 244.0848, found. m/z 244.0849. 
 
 
Preparation of 1-benzo[1,3]dioxol-5-yl-1-thiazol-2-yl-prop-2-en-1-ol 
 
O
O
OH
NS
 
 
Vinyl bromide solution (1 M in THF, 1.2 ml, 1.2 mmol) was added dropwise to an 
excess of magnesium turnings in THF (5 ml). The mixture was then refluxed for 1 h 
and then allowed to cool. Benzo[1,3]dioxol-5-yl-thiazol-2-yl-methanone (0.23 g, 1 
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mmol) was then added in THF (5 ml) and the reaction was stirred for 12 h. An 
aqueous work up was carried out extracting with DCM (3 x 25 ml). The combined 
organic fractions were further washed with water (25 ml) and brine (25 ml). The 
organic was then dried over MgSO4, evaporated to dryness giving 0.21 g (80%) of an 
orange oil; νmax(film)/cm-1 3165 (O-H), 2931, 1507, 1498, 1478, 1253, 1123, 1099, 
1027; δH (400 MHz CDCl3) 5.27 (2H, dd, J = 10.4, 17.2 Hz, CHCH2), 5.85 (2H, s, 
OCH2O), 6.45 (1H, dd, J = 10.4, 17.2, Hz, CHCH2), 6.67 (1H, d, J = 12.4 Hz, 
CHarom), 6.84 (1H, dd, J = 1.6, 12.4 Hz, CHarom), 6.89 (1H, d, J = 1.6 Hz, CHarom), 
7.19 (1H, d, J = 3.4 Hz, SCH), 7.63 (1H, d, J = 3.4 Hz, NCH) [OH not observed]; δC 
(100 MHz CDCl3) 77.5 (quat), 100.3 (CH2), 106.8 (CH), 107.2 (CH), 114.1 (CH2), 
118.3 (CH), 118.8 (CH), 136.8 (quat), 140.5 (CH), 141.4 (CH), 146.2 (quat), 146.7 
(quat), 175.4 (quat); HRMS [ES] (M+H+), C13H12NO3S requires m/z 262.0532, found 
m/z 262.0529. 
 
 
General Procedure (A) for the synthesis of sulfides 
 
The corresponding thiol (6 mmol) was stirred in DMF (5 ml) under an atmosphere of 
nitrogen at 0 oC. NaH (9 mmol) was added and the mixture was stirred for 10 min. 
The bromoacetate/acetal (6 mmol) was then added and the reaction stirred at room 
temperature for 24 h. Water (25 ml) was added to quench, and then extraction was 
carried out with diethyl ether (3 x 25 ml). The combined organic fractions were 
washed with water (25 ml) then dried over MgSO4. Evaporation to dryness yielded 
the clean crude product. 
 
 
n-Butylsulfanylacetic acid ethyl ester 68 
 
O
O
S  
 
Prepared as general procedure (A) for the synthesis of sulfides using n-butylthiol 
(0.54 g, 6 mmol) and ethyl bromoacetate (1.00 g, 6 mmol), yielding 1.01 g (95%) of a 
yellow oil; νmax(film)/cm-1 2957, 2929, 2871, 1734 (C=O), 1464, 1411, 1379, 1365, 
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1272, 1203, 1131, 1030; δH (400 MHz CDCl3) 0.84 (3H, t, J = 4.8 Hz, S(CH2)3CH3), 
1.19 (3H, t , J = 7.2 Hz, OCH2CH3), 1.35 (2H, m, SCH2CH2CH2), 1.53 (2H, m, 
SCH2CH2CH2), 2.57 (2H, t, J = 7.6 Hz, SCH2CH2CH2), 3.14 (2H, s, CH2C=O), 4.13 
(2H, q, J = 7.2 Hz, OCH2CH3); δC (100 MHz CDCl3) 12.7 (CH3), 13.2 (CH3), 20.8 
(CH2), 30.3 (CH2), 31.3 (CH2), 32.7 (CH2), 60.2 (CH2), 169.6 (quat). 
 
 
tert-Butylsulfanylacetic acid ethyl ester 69 
 
O
O
S
 
 
Prepared as general procedure (A) for the synthesis of sulfides using tert-butylthiol 
(0.54 g, 6 mmol) and ethyl bromoacetate (1.00 g, 6 mmol), yielding 1.05 g (99%) of a 
yellow oil; νmax(film)/cm-1 2960, 2864, 1734 (C=O), 1460, 1365, 1271, 1201, 1133, 
1031; δH (400 MHz CDCl3) 1.19 (3H, t, J = 7.2 Hz, OCH2CH3), 1.27 (9H, s, 
C(CH3)3), 3.21 (2H, s, CH2C=O), 4.12 (2H, q, J = 7.2 Hz, CH2CH3); δC (100 MHz 
CDCl3) 14.1 (CH3), 30.6 (3 x CH3), 31.8 (CH2), 42.9 (quat), 61.2 (CH2), 171.1 (quat). 
 
 
2-(2,2-Dimethoxyethylsulfanyl)-2-methylpropane 70 
 
S
OMe
OMe
 
 
Prepared as general procedure (A) for the synthesis of sulfides using t-butylthiol (0.54 
g, 6 mmol) and 2-bromo-1,1-dimethoxyethane (1.01 g, 6 mmol), yielding 0.85 g 
(79%) of a yellow oil; νmax(film)/cm-1 2958, 2828, 1459, 1363, 1163, 1060, 980, 964; 
δH (400 MHz CDCl3) 1.24 (9H, s, C(CH3)3), 2.67 (2H, d, J = 5.6 Hz, SCH2), 3.29 
(6H, s, 2 x OCH3), 4.43 (1H, t, J = 5.6 Hz, CH(OCH3)2); δC (100 MHz CDCl3) 29.8 (3 
x CH3), 29.9 (quat), 40.9 (CH2), 52.2 (2 x CH3), 102.9 (CH). 
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1-(2,2-Dimethoxyethylsulfanyl)-butane 71 
 
S
OMe
OMe 
 
Prepared as general procedure (A) for the synthesis of sulfides using n-butylthiol 
(0.54 g, 6 mmol) and 2-bromo-1,1-dimethoxyethane (1.01 g, 6 mmol), yielding 1.03 g 
(97%) of a yellow oil; νmax(film)/cm-1 2955, 2927, 2871, 2828, 1464, 1366, 1222, 
1190, 1120, 1058, 985, 965; δH (400 MHz CDCl3) 0.86 (3H, t, J = 4.8 Hz, 
S(CH2)3CH3), 1.34 (2H, m, SCH2CH2CH2), 1.49 (2H, m, SCH2CH2CH2), 2.51 (2H, t, 
J = 7.2 Hz, SCH2CH2CH2), 2.61 (2H, d, J = 5.6 Hz, SCH2CH), 6.09 (6H, s, OCH3), 
4.42 (1H, t, J = 5.6 Hz, CH(OCH3)2); δC (100 MHz CDCl3) 11.2 (CH3), 21.6 (CH2), 
31.8 (CH2), 32.5 (CH2), 34.4 (CH2), 53.7 (2 x CH3), 104.5 (CH). 
 
 
Preparation of tert-butylsulfanyl-acetic acid 72 
 
OH
O
S
 
 
tert-Butylthiol (0.496 g, 5.5 mmol) and bromoacetic acid (0.695 g, 5.0 mmol) were 
stirred in DMF (5 ml) at 0oC. NaH (60%, 0.440 g, 11.0 mmol) was then added and the 
reaction stirred at room temperature overnight. Water (25 ml) was added to quench 
the reaction and then the mixture was acidified to ~pH 5 with aq.HCl. The mixture 
was then extracted with diethyl ether (3 x 25 ml). The combined organic fractions 
were further washed with water (3 x 25 ml) to remove residual DMF. The organic was 
then dried over MgSO4, filtered and reduced to dryness yielding 0.639 g (97%) of a 
yellow oil; νmax(film)/cm-1 2924, 1710 (C=O), 1459, 1420, 1365, 1296, 1160, 933; δH 
(400 MHz CDCl3) 1.28 (9H, s, C(CH3)3), 3.26 (2H, s, SCH2) [OH not observed]; δC 
(100 MHz CDCl3) 30.6 (3 x CH3), 31.2 (CH2), 43.4 (quat), 177.6 (quat); HRMS [EI] 
(M+), C6H12O2S requires m/z 148.0558, found m/z 148.0555. 
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Preparation of tert-butylsulfanylacetyl chloride 73 
 
Cl
O
S
 
 
tert-Butylsulfanyl-acetic acid (0.10 g, 0.68 mmol) was stirred in SOCl2 (1 ml) at 60 oC 
for 1 hour. The mixture was then cooled and the excess SOCl2 was removed under 
pressure on a rotary evaporator yielding 0.098 g (88%) of an orange oil; 
νmax(film)/cm-1 2922, 1793 (C=O), 1457, 1375, 1168, 1007, 961; δH (400 MHz 
CDCl3) 1.27 (9H, s, C(CH3)3), 3.69 (2H, s, CH2). [13C NMR and HRMS - not 
recorded due to the unstable nature of the acid chloride.] 
 
 
General Procedure (B) for the synthesis of sulfides  
 
The corresponding pre-synthesised secondary alcohol (5 mmol), thiol (10 mmol) and 
TFA (10 mmol) were refluxed in CHCl3 (20 ml) for 24 h. The reaction was then 
basified with aqueous NaHCO3 and extracted into CHCl3 (3 x 25 ml). The organic 
fractions were combined, washed with water (25 ml) and dried over MgSO4. 
Evaporating the organic to dryness yielded the clean crude product. 
 
 
2-[tert-Butylsulfanyl-(3,4-dimethoxy-phenyl)methyl]-thiazole 
 
S
N
S
OMe
MeO
 
 
Prepared as general procedure (B) for the synthesis of sulfides using tert-butylthiol 
(1.80 g, 20 mmol), TFA (2.28 g, 20 mmol) and (3,4-dimethoxyphenyl)-thiazol-2-yl-
methanol (2.51 g, 10 mmol), yielding 3.17 g (98%) of a dark orange oil; 
νmax(film)/cm-1 2956, 2358, 1590, 1513, 1462, 1416, 1263, 1140, 1026; δH (400 MHz 
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CDCl3) 1.22 (9H, s, C(CH3)3), 3.78 (3H, s, OCH3), 3.81 (3H, s, OCH3), 5.41 (1H, s, 
(CH3)3CSCH), 6.73 (1H, d, J = 8.4 Hz, CHarom), 6.92 (1H, dd, J = 2.0, 8.4 Hz, 
CHarom), 6.96 (1H, d, J = 2.0 Hz, CHarom), 7.18 (1H, d, J = 3.6 Hz, SCHCH), 7.62 (1H, 
d, J = 3.6 Hz NCH); δC (100 MHz CDCl3) 30.7 (3 x CH3), 45.4 (quat), 49.3 (CH), 
55.8 (2 x CH3), 111.1 (CH), 118.1 (CH), 119.8 (CH), 120.2 (CH), 133.7 (quat), 142.6 
(CH), 148.4 (quat), 149.1 (quat), 174.9 (quat); HRMS [ES] (M+H+), C16H22NO2S2 
requires m/z 324.1086, found m/z 324.1088. 
 
 
2-[n-Butylsulfanyl-(3,4-dimethoxyphenyl)methyl]-thiazole 
 
S
N
S
OMe
MeO
 
 
Prepared as general procedure (B) for the synthesis of sulfides using n-butylthiol 
(1.80 g, 20 mmol), TFA (2.28 g, 20 mmol) and (3,4-dimethoxyphenyl)-thiazol-2-yl-
methanol (2.51 g, 10 mmol), yielding 3.09 g (96%) of a orange oil; νmax(film)/cm-1 
2954, 1590, 1513, 1462, 1416, 1262, 1139, 1026, 764; δH (400 MHz CDCl3) 0.87 
(3H, t, J = 7.2 Hz, S(CH2)3CH3), 1.40 (2H, m, SCH2CH2CH2), 1.58 (2H, m, 
SCH2CH2CH2), 2.52 (2H, m, SCH2CH2CH2), 3.87 (3H, s, OCH3), 3.88 (3H, s, 
OCH3), 5.42 (1H, s, CH2SCH), 6.82 (1H, d, J = 8.0 Hz, CHarom), 7.01 (1H, dd, J = 2.0, 
8.0 Hz, CHarom), 7.06 (1H, d, J = 2.0 Hz, CHarom), 7.28 (1H, d, J = 3.2 Hz, SCHCH), 
7.71 (1H, d, J = 3.2 Hz, NCH); δC (100 MHz CDCl3) 13.7 (CH3), 21.9 (CH2), 31.1 
(CH2), 32.4 (CH2), 51.3 (CH), 55.9 (2 x CH3), 111.0 (CH), 111.1 (CH), 119.9 (CH), 
120.5 (CH), 132.0 (quat), 142.6 (CH), 148.7 (quat), 149.1 (quat), 173.1 (quat); HRMS 
[ES] (M+H+), C16H22NO2S2 requires m/z 324.1086, found m/z 324.1088. 
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2-[tert-Butylsulfanyl-(3,4-dimethoxyphenyl)-methyl]-1-methyl-1H-imidazole 
 
S
N
Me
N
OMe
MeO
 
 
Prepared as general procedure (B) for the synthesis of sulfides using tert-butylthiol 
(0.90 g, 10 mmol), TFA (1.14 g, 10 mmol) and (3,4-dimethoxyphenyl)-(1-methyl-1H-
imidazol-2-yl)-methanol (1.24 g, 5 mmol), yielding 1.58 g (99%) of a orange oil; 
νmax(film)/cm-1 2955, 1589, 1513, 1462, 1411, 1363, 1334, 1262, 1235, 1139, 1026; 
δH (400 MHz CDCl3) 1.18 (9H, s, C(CH3)3), 3.46 (3H, s, NCH3), 3.77 (6H, s, 2 x 
OCH3), 5.34 (1H, s, (CH3)3CSCH), 6.70 (2H, m, 2 x CHarom), 6.86 (2H, m, CHarom and 
CH3NCH), 6.97 (1H, d, J = 2.0 Hz, NCH); δC (100 MHz CDCl3) 31.1 (3 x CH3), 33.4 
(CH3), 43.7 (CH), 44.5 (quat), 55.9 (2 x CH3), 110.6 (CH), 111.4 (CH), 119.7 (CH), 
121.6 (CH), 127.2 (CH), 131.7 (quat), 147.5 (quat), 148.1 (quat), 148.9 (quat); HRMS 
[ES] (M+H+), C17H25N2O2S requires m/z 321.1631, found m/z 321.1629. 
 
 
2-[n-Butylsulfanyl-(3,4-dimethoxyphenyl)-methyl]-1-methyl-1H-imidazole 
 
S
N
Me
N
OMe
MeO
 
 
Prepared as general procedure (B) for the synthesis of sulfides using n-butylthiol 
(0.90 g, 10 mmol), TFA (1.14 g, 10 mmol) and (3,4-dimethoxyphenyl)-(1-methyl-1H-
imidazol-2-yl)-methanol (1.24 g, 5 mmol), yielding 1.51 g (95%) of a orange oil; 
νmax(film)/cm-1 2953, 1602, 1512, 1464, 1419, 1338, 1261, 1234, 1140, 1026; δH (400 
MHz CDCl3) 0.75 (3H, t, J = 7.2 Hz, S(CH2)3CH3), 1.23 (2H, m, SCH2CH2CH2), 1.44 
(2H, m, SCH2CH2CH2), 2.37 (2H, m, SCH2CH2CH2), 3.39 (3H, s, NCH3), 3.74 (3H, 
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s, OCH3), 3.79 (3H, s, OCH3), 5.12 (1H, s, SCH), 6.68 (2H, m, CHarom and CH3NCH), 
6.82 (1H, ddd, J = 0.4, 2.0, 8.4 Hz, CHarom), 6.88 (1H, d, J =  1.2 Hz, C=NCH), 6.91 
(1H, d, J =  2.0 Hz, CHarom); δC (100 MHz CDCl3) 13.5 (CH3), 21.6 (CH2), 31.1 
(CH2), 31.3 (CH2), 33.2 (CH3), 45.8 (CH), 55.9 (2 x CH3), 110.4 (CH), 111.2 (CH), 
120.3 (CH), 121.7 (CH), 127.2 (CH), 130.8 (quat), 146.5 (quat), 148.3 (quat), 149.1 
(quat); HRMS [ES] (M+H+), C17H25N2O2S requires m/z 321.1631, found m/z 
321.1629. 
 
 
2-(Benzo[1,3]dioxol-5-yl-tert-butylsulfanylmethyl)-1-methyl-1H-imidazole 
 
S
N
Me
N
O
O  
 
Prepared as general procedure (B) for the synthesis of sulfides using t-butylthiol 
(0.090 g, 1 mmol), TFA (0.114 g, 1 mmol) and benzo[1,3]dioxol-5-yl-(1-methyl-1H-
imidazol-2-yl)-methanol (0.116 g, 0.5 mmol), yielding 0.14 g (90%) of a orange oil; 
νmax(film)/cm-1 2956, 1682, 1608, 1501, 1442, 1364, 1281, 1246, 1159, 1123, 1096, 
1037, 928, 793, 739; δH (400 MHz CDCl3) 1.10 (9H, s, C(CH3)3), 3.45 (3H, s, NCH3), 
5.26 (1H, s, SCH), 5.82 (1H, d, J = 1.6 Hz, OCHHO), 5.83 (1H, d, J = 1.6 Hz, 
OCHHO), 6.70 (1H, d, J = 1.2 Hz, CH3NCH), 6.71 (1H, d, J = 8.0 Hz, CHarom), 6.74 
(1H, ddd, J = 0.8, 2.0, 8.0 Hz, CHarom), 6.84 (1H, d, J = 1.2 Hz, C=NCH), 6.94 (1H, d, 
J = 2.0 Hz, CHarom); δC (100 MHz CDCl3) 29.9 (3 x CH3), 32.4 (CH3), 42.5 (CH), 
43.6 (quat), 100.1 (CH2), 105.9 (CH), 106.7 (CH), 120.1 (CH), 120.7 (CH), 126.6 
(CH), 132.1 (quat), 145.9 (quat), 146.2 (quat), 146.8 (quat); HRMS [ES] (M+H+), 
C16H21N2O2S requires m/z 305.1318, found m/z 305.1320. 
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2-(Benzo[1,3]dioxol-5-ylbutylsulfanylmethyl)-1-methyl-1H-imidazole 
 
S
N
Me
N
O
O  
 
Prepared as general procedure (B) for the synthesis of sulfides using n-butylthiol 
(0.180 g, 2 mmol), TFA (0.150 g, 1 mmol) and benzo[1,3]dioxol-5-yl-(1-methyl-1H-
imidazol-2-yl)-methanol (0.232 g, 1 mmol), yielding 0.28g (92%) of a orange oil; 
νmax(film)/cm-1 2956, 1723, 1486, 1243, 1037, 931, 794; δH (400 MHz CDCl3) 0.81 
(3H, t, J = 7.4 Hz, S(CH2)3CH3), 1.28 (2H, m, SCH2CH2CH2), 1.45 (2H, m, 
SCH2CH2CH2), 2.38 (2H, m, SCH2CH2CH2), 3.44 (3H, s, NCH3), 5.11 (1H, s, SCH), 
5.87 (1H, d, J = 1.6 Hz, OCHHO), 5.88 (1H, d, J = 1.6 Hz, OCHHO), 6.67 (1H, d, J = 
8.0 Hz, CHarom), 6.74 (2H, m, CHarom and CH3NCH), 6.91 (2H, m, CHarom and 
C=NCH); δC (100 MHz CDCl3) 12.6 (CH3), 20.9 (CH2), 30.1 (CH2), 30.4 (CH2), 32.2 
(CH), 44.8 (CH3), 100.1 (CH2), 106.8 (CH), 107.7 (CH), 120.4 (CH), 120.7 (CH), 
126.1 (CH), 131.1 (quat), 145.3 (quat), 145.9 (quat), 146.9 (quat); HRMS [ES] 
(M+H+), C16H21N2O2S requires m/z 305.1318, found m/z 305.1320. 
 
 
Preparation of 2-[1-tert-butylsulfanyl-1-(3,4-dimethoxyphenyl)-ethyl]-1-methyl-
1H-imidazole 
NMeN
OMe
MeO
S
 
 
2-[tert-Butylsulfanyl-(3,4-dimethoxyphenyl)-methyl]-1-methyl-1H-imidazole (0.160 
g, 0.5 mmol) was stirred at -78oC in THF (5 ml). n-BuLi (2.5 M in hexane, 0.24 ml, 
0.6 mmol) was added dropwise and the mixture stirred for 15 min. Methyl iodide 
(0.085 g, 0.6 mmol) was added and the reaction allowed to warm to room temperature 
and stir for 24 h. Water (25 ml) was then added and the mixture extracted with DCM 
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(3 x 25 ml). The combined organic layers were further washed with water (25 ml), 
dried over MgSO4 then evaporated to dryness yielding 0.151 g (90%) of a yellow oil; 
νmax(film)/cm-1 2958, 2358, 1506, 1456, 1258, 1143, 1082, 1026, 804; δH (400 MHz 
CDCl3) 1.07 (9H, s, C(CH3)3), 2.17 (3H, s, SCCH3), 3.26 (3H, s, NCH3), 3.75 (3H, s, 
OCH3), 3.79 (3H, s, OCH3), 6.60 (1H, dd, J = 2.0, 8.4 Hz, CHarom), 6.69 (1H, d, J = 
8.4 Hz, CHarom), 6.74 (1H, d, J = 2.0 Hz, CHarom), 6.78 (1H, d, J = 1.2 Hz, CH3NCH), 
6.93 (1H, d, J = 1.2 Hz, C=NCH); δC (100 MHz CDCl3) 30.4 (3 x CH3), 34.1 (CH3), 
34.3 (CH3), 46.2 (quat), 51.2 (quat), 54.7 (CH3), 54.9 (CH3), 108.1 (CH), 109.7 (CH), 
116.7 (CH), 121.6 (CH), 125.1 (CH), 138.2 (quat), 146.6 (quat), 147.7 (quat), 148.2 
(quat); HRMS [ES] (M+H+), C18H27N2O2S requires m/z 335.1788, found m/z 
335.1788. 
 
 
Preparation of 2-(1-benzo[1,3]dioxol-5-yl-1-tert-butylsulfanylethyl)-1-methyl-
1H-imidazole 
NMeN
S
O
O  
 
2-(Benzo[1,3]dioxol-5-yl-tert-butylsulfanylmethyl)-1-methyl-1H-imidazole (0.100 g, 
0.33 mmol) was stirred at -78oC in THF (5 ml). n-BuLi (2.5 M in hexane, 0.16 ml, 
0.40 mmol) was added dropwise and the mixture stirred for 20 min. Methyl iodide 
(0.056 g, 0.40 mmol) was added and the reaction allowed to warm to room 
temperature and stir for 24 h. Water (25 ml) was then added and the mixture extracted 
with DCM (3 x 25 ml). The combined organic fractions were further washed with 
water (25 ml), dried over MgSO4 then evaporated to dryness yielding 0.074 g (70%) 
of a yellow oil; νmax(film)/cm-1 2955, 2358, 2339, 1504, 1484, 1362, 1242, 1105, 
1037, 936, 807; δH (400 MHz CDCl3) 1.10 (9H, s, C(CH3)3), 2.16 (3H, s, SCCH3), 
3.32 (3H, s, NCH3), 6.56 (1H, d, J = 1.8 Hz, OCHHO), 6.57 (1H, d, J = 1.8 Hz, 
OCHHO), 6.60 (1H, dd, J = 2.0, 8.0 Hz, CHarom), 6.65 (1H, d, J = 8.0 Hz, CHarom), 
6.68 (1H, d, J = 2.0 Hz, CHarom), 6.81 (1H, d, J = 1.2 Hz, CH3NCH), 7.01 (1H, d, J = 
1.2 Hz, C=NCH); δC (100 MHz CDCl3) 30.9 (3 x CH3), 34.1 (CH3), 34.4 (CH3), 46.5 
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(quat), 51.2 (quat), 100.2 (CH2), 105.5 (CH), 107.1 (CH), 117.8 (CH), 121.9 (CH), 
124.1 (CH), 126.1 (quat), 145.4 (quat), 146.9 (quat), 148.1 (quat); HRMS [ES] 
(M+H+), C17H23N2O2S requires m/z 319.1475, found m/z 319.1474. 
 
 
Preparation of 2-[1-tert-butylsulfanyl-1-(3,4-dimethoxyphenyl)-but-3-enyl]-1-
methyl-1H-imidazole 
NMeN
OMe
MeO
S
 
 
2-[tert-Butylsulfanyl-(3,4-dimethoxyphenyl)-methyl]-1-methyl-1H-imidazole (0.160 
g, 0.5 mmol) was stirred in THF (2 ml) at -78oC. n-BuLi (2.5 M in hexane, 0.24 ml, 
0.6 mmol) was then added dropwise. The mixture was stirred for 15 min then allyl 
bromide (0.073 g, 0.6 mmol) was added. The reaction was then allowed to return to 
room temperature and stirred for 24 h. The reaction was then quenched with water (25 
ml) and extracted with DCM (3 x 25 ml). The combined organic fractions were then 
washed with water (25ml), dried over MgSO4, and evaporated to dryness yielding 
0.163 g of a crude orange oil. Column chromatography on silica gel was carried out 
using light petroleum:ethyl acetate (10:1) eluent, yielding the title compound in a 
yield of 0.038 g (22%) as a yellow oil; νmax(film)/cm-1 2956, 1513, 1463, 1408, 1362, 
1260, 1145, 1026, 915, 804, 765, 697; δH (400 MHz CDCl3) 1.06 (9H, s, C(CH3)3), 
3.18 (4H, m, NCH3 and CCHHCH=CH2), 3.52 (1H, q, J = 7.6 Hz, CCHHCH=CH2), 
3.72 (3H, s, OCH3), 3.79 (3H, s, OCH3), 4.76 (1H, dd, J = 2.0, 17.2 Hz, 
CCH2CH=CHH), 4.87 (1H, dt, J = 1.2, 10.0 Hz, CCH2CH=CHH), 5.79 (1H, m, 
CCH2CH=CH2), 6.59 (2H, m, 2 x CHarom), 6.67 (1H, d, J = 7.2 Hz, CHarom), 6.75 (1H, 
d, J = 1.2 Hz, CH3NCH), 6.94 (1H, d, J = 1.2 Hz, C=NCH); δC (100 MHz CDCl3) 
30.6 (3 x CH3), 33.7 (CH3), 46.3 (quat), 46.5 (CH2), 54.1 (quat), 54.7 (CH3), 54.9 
(CH3), 108.9 (CH), 109.3 (CH), 116.6 (CH2), 117.9 (CH), 121.6 (CH), 125.0 (CH), 
133.3 (CH), 134.9 (quat), 146.6 (quat), 147.4 (quat), 147.9 (quat); HRMS [ES] 
(M+H+), C20H29N2O2S requires m/z 361.1944, found m/z 361.1946. 
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Preparation of 2-[1-tert-butylsulfanyl-1-(3,4-dimethoxyphenyl)-2-phenylethyl]-1-
methyl-1H-imidazole 
NMeN
OMe
MeO
S
 
 
2-[tert-Butylsulfanyl-(3,4-dimethoxyphenyl)-methyl]-1-methyl-1H-imidazole (0.160 
g, 0.5 mmol) was stirred in THF (2 ml) at -78oC. n-BuLi (2.5 M in hexane, 0.24 ml, 
0.6 mmol) was then added dropwise. The reaction was stirred for 15 min then benzyl 
chloride (0.076 g, 0.6 mmol) was added. The reaction was then allowed to return to 
room temperature and stirred for a further 24 h. The reaction was then quenched with 
water (25 ml) and extracted with DCM (3 x 25 ml). The combined organic fractions 
were washed with water (25 ml), dried over MgSO4 and evaporated to dryness 
yielding 0.195 g of a crude dark orange oil. Column chromatography on silica gel was 
carried out using light petroleum:ethyl acetate (8:1) eluent, yielding 0.032 g (16%) of 
the title compound as a yellow oil; νmax(film)/cm-1 2954, 1601, 1511, 1462, 1409, 
1362, 1259, 1144, 1077, 1027, 912; δH (400 MHz CDCl3) 1.13 (9H, s, C(CH3)3), 3.16 
(3H, s, NCH3), 3.44 (3H, s, OCH3), 3.79 (4H, m, OCH3 and PhCHH), 3.98 (1H, m, 
PhCHH), 6.55 (1H, d, J = 8.0 Hz, CHarom), 6.74-7.02 (9H, m, 7 x CHarom and 
C=NCHCHNCH3); δC (100 MHz CDCl3) 30.9 (3 x CH3), 33.9 (NCH3), 46.9 (quat), 
47.4 (CH2), 54.7 (2 x CH3), 121.6 (CH), 121.9 (CH), 123.9 (CH), 124.8 (CH), 125.1 
(CH), 125.7 (CH), 125.8 (2 x CH), 130.9 (2 x CH), 134.6 (quat), 136.1 (quat), 147.9 
(quat), [3 x quat not detected]; HRMS [ES] (M+H+), C24H31N2O2S requires 411.2101, 
found 411.2097. 
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Preparation of 2-[benzo[1,3]dioxol-5-yl-(3-chloropropylsulfanyl)-methyl]-1-
methyl-1H-imidazole 
O
O
S
N
Me
N
Cl
 
 
Benzo[1,3]dioxol-5-yl-(1-methyl-1H-imidazol-2-yl)-methanol (0.348 g, 1.5 mmol), 3-
chloropropane-1-thiol (0.332 g, 3 mmol) and TFA (0.342 g, 3 mmol) were refluxed in 
chloroform (20 ml) for 24 h. The mixture was allowed to cool and basified with aq. 
NaHCO3. Diethyl ether (3 x 50 ml) was used to extract the mixture, and the combined 
organic layers were washed with water (50 ml). The organic phase was then dried 
over MgSO4 and evaporated to dryness yielding 0.61 g of a crude orange oil. Column 
chromatography using silica gel and light petroleum: ethyl acetate (5:1) eluent 
afforded 0.413 g (85%) of the title compound as a orange oil; νmax(film)/cm-1 2902, 
1501, 1486, 1366, 1243, 1197, 1124, 1095, 1037, 929, 793; δH (400 MHz CDCl3) 1.86 
(2H, m, SCH2CH2CH2Cl), 2.53 (2H, m, SCH2CH2CH2Cl), 3.38 (3H, s, NCH3), 3.52 
(2H, m, SCH2CH2CH2Cl), 5.08 (1H, s, SCH), 5.83 (1H, d, J = 1.2 Hz, OCHHO), 5.85 
(1H, d, J = 1.2 Hz, OCHHO), 6.64 (1H, d, J = 8.0 Hz, CHarom), 6.74 (2H, m,  
CH3NCH and CHarom), 6.89 (2H, m, CHarom and C=NCH); δC (100 MHz CDCl3) 27.6 
(CH2), 30.7 (CH2), 32.1 (CH3), 42.5 (CH2), 44.8 (CH), 100.1 (CH2), 106.5 (CH), 
107.6 (CH), 120.4 (CH), 121.2 (CH), 126.2 (CH), 130.9 (quat), 144.9 (quat), 146.2 
(quat), 147.1 (quat); HRMS [ES] (M+H+), C15H1835ClN2O2S requires m/z 325.0772, 
found m/z 325.0773. 
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Preparation of 3-chloro-1-(3,4-dimethoxyphenyl)-propan-1-one 74 
 
O
Cl
MeO
OMe  
 
Veratrole (1.38 g, 10 mmol), 3-chloropropionyl chloride (1.52 g, 12 mmol) and AlCl3 
(2.67 g, 20 mmol) were heated at 50oC for 2 h. Iced water (50 ml) was added and the 
mixture was extracted with DCM (3 x 50 ml). The combined organic layers were then 
washed with water (50 ml), dried over MgSO4 and evaporated to dryness yielding 
2.03 g of a crude yellow solid. Recrystallisation from diethyl ether yielded 1.17 g 
(51%) of the title compound as a white solid; νmax(film)/cm-1 1672 (C=O), 1587, 
1513, 1425, 1357, 1271, 1168, 1022; δH (400 MHz CDCl3) 3.34 (2H, t, J = 7.2 Hz, 
CH2CO), 3.83-3.89 (8H, m CH2Cl and 2 x OCH3), 6.83 (1H, d, J = 8.4 Hz, CHarom), 
7.46 (1H, d, J = 2.0 Hz, CHarom), 7.52 (1H, dd, J = 2.0, 8.4 Hz, CHarom); δC (100 MHz 
CDCl3) 39.1 (CH2), 40.8 (CH2), 56.0 (2 x CH3), 110.0 (2 x CH), 122.9 (CH), 129.7 
(quat), 149.2 (quat), 153.7 (quat), 195.3 (quat); HRMS [EI] (M+), C11H1335ClO3 
requires m/z 228.0548, found m/z 228.0550. 
 
 
Preparation of 3-chloro-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one 75 
 
O
Cl
HO
OMe  
 
Veratrole (0.69 g, 5 mmol), 3-chloropropionyl chloride (0.76 g, 6 mmol) and AlCl3 
(1.33 g, 10 mmol) were heated at 100oC for 5 h. Iced water (50 ml) was added and the 
mixture was extracted with DCM (3 x 50 ml). The combined organic layers were then 
washed with water (50 ml), dried over MgSO4 and evaporated to dryness yielding 
0.96 g (90%) of a yellow oil; νmax(film)/cm-1 3392 (O-H), 1669 (C=O), 1589, 1515, 
1426, 1348, 1275, 1187, 1030; δH (400 MHz CDCl3) 3.33 (2H, t, J = 6.8 Hz, 
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C=OCH2), 3.86 (5H, m, CH2Cl and OCH3), 6.83 (1H, d, J = 8.4 Hz, CHarom), 7.46 
(2H, m, CHarom) [OH not observed]; δC (100 MHz CDCl3) 36.3 (CH2), 39.7 (CH2), 
55.1 (CH3), 108.9 (CH), 113.1 (CH), 122.5 (CH), 128.3 (quat), 145.8 (quat), 149.9 
(quat), 194.4 (quat); HRMS [EI] (M+), C10H1135ClO3 requires m/z 214.0394, found 
m/z 214.0391. 
 
 
Preparation of 1-benzo[1,3]dioxol-5-yl-1-(1-methyl-1H-imidazol-2-yl)-but-3-en-1-
ol 
O
O
OH
NMeN
 
 
Benzo[1,3]dioxol-5-yl-(1-methyl-1H-imidazol-2-yl)-methanone (0.30 g, 1.3 mmol) 
was stirred in THF (5 ml) at 0oC. Allylmagnesium chloride solution (2.0 M in THF, 
1.30 ml, 2.6 mmol) was then added. The reaction was then stirred at room temperature 
for 24 h. Water (25 ml) was then added to quench the reaction and the mixture was 
extracted with diethyl ether (3 x 25 ml). The combined organic layers were then 
washed with brine (50 ml) and water (50 ml). The organic phase was then dried over 
MgSO4, filtered and evaporated to dryness yielding 0.243 g of a crude dark brown oil. 
Column chromatography on silica gel using light petroleum: ethyl acetate (10:1) as 
eluent afforded 0.173 g (49%) of the title compound as a yellow solid; mp = 163-
165oC; νmax(film)/cm-1 3124 (O-H), 2876, 1481, 1446, 1340, 1246, 1143, 1076, 1040, 
931, 903, 812, 740; δH (400 MHz CDCl3) 2.74 (1H, dd, J = 7.2, 14.0 Hz, 
CCHHCH=CH2), 3.18 (1H, dd, J = 7.2, 14.0 Hz, CCHHCH=CH2), 3.29 (3H, s, 
NCH3), 3.71 (1H, bs, OH), 5.08 (2H, m, CH=CH2), 5.77-5.88 (3H, m, OCH2O and 
CH=CH2), 6.64 (2H, m, 2 x CHarom), 6.66 (1H, d, J = 1.2 Hz, CH3NCH), 6.73 (1H, m, 
CHarom), 6.78 (1H, d, J = 1.2 Hz, C=NCH); δC (100 MHz CDCl3) 33.1 (CH3), 46.6 
(CH2), 73.1 (quat), 99.9 (CH2), 105.2 (CH), 106.7 (CH), 117.5 (CH), 119.3 (CH2), 
121.8 (CH), 124.8 (CH), 132.7 (CH), 137.1 (quat), 145.4 (quat), 146.5 (quat), 148.8 
(quat); HRMS [FAB] (M+H+), C15H17N2O3 requires  m/z 273.1239, found m/z 
273.1236. 
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Preparation of 1-(3,4-dimethoxyphenyl)-1-(1-methyl-1H-imidazol-2-yl)-prop-2-
en-1-ol 
NMeN
OMe
MeO
OH
 
 
(3,4-Dimethoxyphenyl)-(1-methyl-1H-imidazol-2-yl)-methanone (0.50 g, 2.0 mmol) 
was stirred in THF (7.5 ml) at 0oC. Vinylmagnesium bromide (1.0 M in THF, 10.0 
ml, 10.0 mmol) was added and the reaction was allowed to return to room temperature 
and stirred for 12 h. The reaction was then quenched with water (50 ml), and extracted 
with DCM (3 x 50 ml). The combined organic layers were then washed with water 
(100 ml), dried over MgSO4 and evaporated to dryness yielding 0.49 g (89%) of the 
title compound as a yellow oil; νmax(film)/cm-1 3107 (O-H), 2952, 1591, 1510, 1463, 
1410, 1258, 1234, 1136, 1026, 913, 741; δH (400 MHz CDCl3) 3.33 (3H, s, NCH3), 
3.84 (3H, s, OCH3), 3.89 (3H, s, OCH3), 5.26 (2H, m, CH=CH2), 6.68-6.94 (6H, m, 
CH=CH2 and 3 x CHarom and CH3NCHCHN) [OH not observed]; δC (100 MHz 
CDCl3) 34.2 (CH3), 55.8 (CH3), 55.9 (CH3), 75.7 (quat), 109.2 (CH), 110.6 (CH), 
113.5 (CH2), 118.3 (CH), 123.0 (CH), 126.1 (CH), 135.2 (quat), 141.7 (CH), 148.4 
(quat), 148.9 (quat), 149.8 (quat); HRMS [ES] (M+H+), C15H19N2O3 requires m/z 
275.1390, found m/z 275.1391; Elemental Analysis, requires C 65.68; H 6.61; N 
10.21, found C 65.33; H 6.29; N 10.21. 
 
 
Preparation of 1-(3,4-dimethoxyphenyl)-1-(1-methyl-1H-imidazol-2-yl)-but-3-en-
1-ol 
NMeN
OMe
MeO
OH
 
 
(3,4-Dimethoxyphenyl)-(1-methyl-1H-imidazol-2-yl)-methanone (0.50 g, 2.0 mmol) 
was stirred in THF (7.5 ml) at 0oC. Allylmagnesium bromide (2.0 M in THF, 5.0 ml, 
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10.0 mmol) was added and the reaction was allowed to return to room temperature 
and stirred for 12 h.  The reaction was then quenched with water (50 ml) and extracted 
with DCM (3 x 50 ml). The combined organic layers were then washed with water 
(100 ml), dried over MgSO4 and evaporated to dryness yielding 0.47 g (82%) as a 
yellow oil; νmax(film)/cm-1 3132 (O-H), 2869, 1476, 1459, 1329, 1285, 1171, 1044, 
1010, 962, 902, 815, 751; δH (400 MHz CDCl3) 2.75 (1H, dd, J = 8.0, 13.6 Hz, 
CCHHCH=CH2), 3.28 (4H, m, CCHHCH=CH2 and NCH3), 3.75 (3H, s, OCH3), 3.78 
(3H, s, OCH3), 5.15 (2H, m, CH=CH2), 5.81-5.90 (1H, m, CH=CH2), 6.68 (3H, m, 2 x 
CHarom and CH3NCH), 6.78 (1H, s, CHarom), 6.85 (1H, d, J = 0.8Hz, C=NCH) [OH not 
observed]; δC (100 MHz CDCl3) 34.1 (CH3), 47.7 (CH2), 55.8 (CH3), 55.9 (CH3), 74.1 
(quat), 108.5 (CH), 110.6 (CH), 117.4 (CH), 120.6 (CH2), 122.8 (CH), 125.9 (CH), 
133.9 (CH), 136.6 (quat), 147.9 (quat), 148.7 (quat), 149.8 (quat); HRMS [ES] 
(M+H+), C16H21N2O3 requires m/z 289.1547, found m/z 289.1551. 
 
 
Preparation of 1-(4-benzyloxy-3-methoxyphenyl)-propenone 
 
BnO
OMe
O
 
 
3-Chloro-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one (0.86 g, 4.0 mmol), benzyl 
bromide (0.68 g, 4.0 mmol) and K2CO3 (0.28 g, 2.0 mmol) were heated under reflux 
in acetone (15 ml) for 24 h. Water (50 ml) was added and then the mixture was 
extracted with chloroform (3 x 50 ml). The combined organic fractions were then 
washed with water (50 ml), dried over MgSO4 and evaporated to dryness yielding 
0.94 g of a crude orange oil. Column chromatography on silica gel using light 
petroleum: ethyl acetate (10:1) eluent afforded 0.29 g (27%) of the title compound as 
a clear colourless oil; νmax(film)/cm-1 1668 (C=O), 1587, 1566, 1502, 1475, 1436, 
1309, 1301, 1278, 1244, 1193, 1138, 1091, 1022; δH (400 MHz CDCl3) 3.95 (3H, s, 
OCH3), 5.24 (2H, s, PhCH2O), 5.86 (1H, dd, J = 1.6, 10.4 Hz, CH=CHH), 6.42 (1H, 
dd, J = 1.6, 17.2 Hz, CH=CHH), 6.91 (1H, d, J = 8.4 Hz, CHarom), 7.17 (1H, dd, J = 
10.4, 17.2 Hz, CH=CH2), 7.30-7.43 (5H, m, 5 x CHarom), 7.51 (1H, dd, J = 2.0, 8.4 
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Hz, CHarom), 7.59 (1H, d, J = 2.0 Hz, CHarom); δC (100 MHz CDCl3) 56.1 (CH3), 70.8 
(CH2), 111.1 (CH), 112.1 (CH), 123.2 (CH), 127.2 (2 x CH), 128.0 (CH), 128.8 (2 x 
CH), 129.1 (CH2), 130.6 (quat), 131.9 (CH), 136.2 (quat), 149.7 (quat), 152.5 (quat), 
189.2 (quat); HRMS [EI] (M+), C17H16O3 requires m/z 268.1100, found m/z 268.1104. 
 
 
Preparation of 1-(4-benzyloxy-3-methoxyphenyl)-2,3-dihydroxypropan-1-one 
 
BnO
OMe
O
OH
OH
 
 
1-(4-Benzyloxy-3-methoxyphenyl)-propenone (0.268 g, 1.0 mmol), AD-mix β (1.4 g 
per mmol of substrate), and methylsulfonamide (0.095 g, 1.0 mmol) were stirred in 
tBuOH/H2O (1:1, 10 ml) for 24 h. Sodium sulfite (1.5 g, 12.0 mmol) was then added 
and the reaction stirred for a further 30 min. The reaction was then extracted with 
chloroform (3 x 50 ml). The combined organic fractions were washed with aq. KOH 
(2.0 M, 50 ml), dried over MgSO4 and evaporated to dryness yielding 0.180 g of a 
crude dark orange oil. Column chromatography on silica gel using light petroleum: 
ethyl acetate (2:1) eluent yielded 0.065 g (22%) of the title compound as a yellow oil; 
νmax(film)/cm-1 3389 (O-H), 2924, 1670 (C=O), 1589, 1557, 1539, 1511, 1456, 1418, 
1267, 1108, 1016; δH (400 MHz CDCl3) 3.64 (1H, dd, J = 5.2, 11.6 Hz, CHHOH), 
3.90 (4H, m, CHHOH and OCH3), 5.02 (1H, m, CHOH), 5.16 (2H, s, PhCH2O), 6.85 
(1H, d, J = 8.4 Hz, CHarom), 7.24-7.31 (7H, m, 7 x CHarom) [2 x OH not observed]; δC 
(100 MHz CDCl3) 55.1 (CH3), 64.8 (CH2), 69.9 (CH2), 73.0 (CH), 109.9 (CH), 111.1 
(CH), 122.2 (CH), 125.5 (2 x CH), 126.2 (CH), 126.9 (quat), 127.2 (2 x CH), 134.9 
(quat), 148.8 (quat), 152.4 (quat), 196.5 (quat); HRMS [EI] (M+), C17H18O5 requires 
m/z 302.1154, found m/z 302.1151. 
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Preparation of 1-benzo[1,3]dioxol-5-yl-propenone 76 
 
O
O
O  
 
Benzo[1,3]dioxole (0.61 g, 5 mmol) and acryloyl chloride (0.45 g, 5 mmol) were 
dissolved in DCM (10 ml) and the mixture stirred at 0 oC. AlCl3 (1.0 g, 7.5 mmol) 
was then added in several small portions. The mixture was stirred for 15 min at 0 oC 
then allowed to return to room temperature overnight. The mixture was then filtered 
through a pad of celite, and the solid washed with DCM (3 x 25 ml). The combined 
organic layers were then reduced under vacuum to yield a crude yellow oil. 
Recrystallisation from diethyl ether yielded 0.80 g  (91%) of the title compound as a 
clear colourless oil; νmax(film)/cm-1 2356, 1737 (C=O), 1633, 1602, 1496, 1462, 1402, 
1334, 1292, 1231, 1142, 1112, 1059, 1015, 980; δH (400 MHz CDCl3) 5.76 (2H, s, 
OCH2O), 5.96 (1H, dd, J = 1.2, 10.4 Hz, CH=CHH), 6.25 (1H, dd, J = 10.4, 17.2 Hz, 
CH=CH2), 6.52 (1H, dd, J = 1.2, 17.2 Hz, CH=CHH), 7.17 (3H, m, 3 x CHarom); δC 
(100 MHz CDCl3) 77.3 (CH2), 116.0 (CH), 123.5 (CH), 127.4 (CH), 127.7 (CH), 
133.0 (CH2), 140.6 (quat), 147.5 (quat), 163.9 (quat), 171.2 (quat); HRMS [FAB] 
(M+H+), C10H9O3 requires m/z 177.0552, found m/z 177.0547. 
 
 
Preparation of 1-(3,4-dimethoxyphenyl)-prop-2-en-1-ol 77 
 
OH
OMe
MeO
 
 
3,4-Dimethoxybenzaldehyde (1.66 g, 10 mmol) was stirred in THF (10 ml) at -78oC. 
Vinylmagnesium bromide solution (1.0 M in THF, 20 ml, 20 mmol) was added 
dropwise and the mixture stirred at -78 oC for 30 min. The reaction was then allowed 
to warm to room temperature and stirred overnight. Water (25 ml) was added to 
quench, and the mixture extracted with DCM (3 x 50 ml). The combined organic 
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layers were washed with water (50 ml) and brine (50 ml), then dried over MgSO4, 
filtered and reduced under vacuum to yield 1.84 g (95%) of the title compound as a 
light yellow oil; νmax(film)/cm-1 3476 (O-H), 2935, 1514, 1462, 1260, 1233, 1138, 
1026, 922; δH (400 MHz CDCl3) 3.69 (6H, s, 2 x OCH3), 4.92 (1H, d, J = 5.2 Hz, 
CHOH), 5.01 (1H, dt, J = 1.4, 10.0 Hz, CH=CHH), 5.15 (1H, dt, J = 1.4, 17.2 Hz, 
CH=CHH), 5.87 (1H, m, CH=CHH), 6.67 (1H, d, J = 8.0 Hz, CHarom), 6.72 (1H, dd, J 
= 1.6, 8.0 Hz, CHarom), 6.76 (1H, d, J = 1.6 Hz, CHarom) [OH not observed]; δC (100 
MHz CDCl3) 55.6 (CH3), 55.8 (CH3), 74.4 (CH), 108.8 (CH), 110.3 (CH), 114.2 
(CH2), 118.5 (CH), 135.3 (quat), 140.5 (CH), 148.2 (quat), 148.8 (quat); HRMS [EI] 
(M+), C11H14O3 requires m/z 194.0937, found m/z 194.0937. 
 
 
Preparation of 1-benzo[1,3]dioxol-5-yl-prop-2-en-1-ol 78 
 
OH
O
O  
 
Piperonal (3.0 g, 20 mmol) was stirred in THF (10 ml) at -78oC. Vinylmagnesium 
bromide solution (1.0 M in THF, 30 ml, 30 mmol) was added dropwise and the 
mixture stirred at -78oC for 30 min. The reaction was then allowed to warm to room 
temperature and stirred overnight. Water (25 ml) was added to quench, and the 
mixture extracted with DCM (3 x 50 ml). The combined organic layers were washed 
with water (50 ml) and brine (50 ml), then dried over MgSO4, filtered and reduced 
under vacuum to yield 3.18 g (89%) of the title compound as a light yellow oil; 
νmax(film)/cm-1 3372 (O-H), 2890, 1501, 1487, 1442, 1246, 1092, 1038, 990; δH (400 
MHz CDCl3) 2.75 (1H, s, OH), 4.96 (1H, m, CHOH), 5.06 (1H, dt, J = 1.2, 10.4 Hz, 
CH=CHH), 5.19 (1H, dt, J = 1.2, 17.2 Hz, CH=CHH), 5.87 (3H, m, OCH2O and 
CH=CH2), 6.64 (1H, d, J = 7.6 Hz, CHarom), 6.69 (1H, dd, J = 1.6, 7.6 Hz, CHarom), 
6.73 (1H, d,  J = 1.6 Hz, CHarom); δC (100 MHz CDCl3) 74.7 (CH), 100.9 (CH2), 106.4 
(CH), 108.1 (CH), 114.9 (CH2), 119.5 (CH), 136.8 (quat), 140.3 (CH), 146.9 (quat), 
147.7 (quat); HRMS [FAB] (M+), C10H10O3 requires m/z 178.0630, found m/z 
178.0630. 
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Preparation of benzo[1,3]dioxol-5-yl-oxiranyl-methanone 
 
O
O
O
O
 
 
1-Benzo[1,3]dioxol-5-yl-prop-2-en-1-ol (0.534 g, 3 mmol) was dissolved in 
acetonitrile (2.5 ml) and NaOCl (5 ml, 10% aq. solution) was added. The reaction was 
then stirred at room temperature for 72 h. The mixture was then extracted with CHCl3 
(3 x 25 ml) and the combined organic layers were washed with water (50 ml), dried 
over MgSO4, filtered, and reduced under vacuum yielding 0.41 g (71%) of the title 
compound as a yellow oil; νmax(film)/cm-1 1678 (C=O), 1602, 1503, 1446, 1392, 
1350, 1257, 1109, 1036, 930, 896; δH (400 MHz CDCl3) 2.88 (1H, dd, J = 2.6, 6.4 Hz, 
CHCHH), 3.03 (1H, dd, J = 4.6, 6.4 Hz, CHCHH), 4.09 (1H, dd, J = 2.6, 4.6 Hz, 
CHCH2), 6.01 (2H, s, OCH2O), 6.80 (1H, d, J = 8.4 Hz, CHarom), 7.42 (1H, d, J = 1.8 
Hz, CHarom), 7.63 (1H, dd, J = 1.8, 8.4 Hz, CHarom); δC (100 MHz CDCl3) 47.5 (CH2), 
50.9 (CH), 102.1 (CH2), 108.0 (CH), 108.2 (CH), 125.0 (CH), 130.2 (quat), 148.4 
(quat), 152.6 (quat), 192.5 (quat); HRMS [FAB] (M+NH4+), C10H12NO4 requires m/z 
210.0761, found m/z 210.0759. 
 
 
Preparation of [1-(3-chloro-propylsulfanyl)-benzyl]-benzene 
 
S
Cl
 
 
Diphenylmethanol (0.276 g, 1.5 mmol) and 3-chloropropane-1-thiol (0.332 g, 3 
mmol) were stirred in CHCl3 (10 ml) in a RBF with a reflux condenser attached. TFA 
(0.342 g, 3 mmol) was added and the mixture was refluxed for 24 h. Aq. NaHCO3 (25 
ml) was then added and the mixture extracted with CHCl3 (3 x 25 ml). The combined 
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organic layers were washed with brine (50 ml), water (50 ml), dried over MgSO4, 
filtered and evaporated to dryness yielding 0.397 g (96%) of the title compound as a 
clear yellow oil; νmax(film)/cm-1 3023, 2914, 1949, 1887, 1804, 1597, 1492, 1448, 
1308, 1269, 1185, 1076, 1029, 748, 701; δH (400 MHz CDCl3) 1.85 (2H, m, 
SCH2CH2CH2Cl), 2.39 (2H, t, J = 6.8 Hz, SCH2CH2CH2Cl), 3.43 (2H, t, J = 6.8 Hz, 
SCH2CH2CH2Cl), 5.03 (1H, s, SCH), 7.06-7.32 (10H, m, 10 x CHarom); δC (100 MHz 
CDCl3) 29.4 (CH2), 31.8 (CH2), 43.2 (CH2), 54.3 (CH), 127.0 (2 x CH), 128.5 (4 x 
CH), 129.1 (4 x CH), 141.6 (2 x quat); HRMS [FAB] (M-H+), C16H1635ClS requires 
m/z 275.0661, found m/z 275.0657. 
 
 
Preparation of 1-(3,4-dimethoxy-phenyl)-but-3-en-1-ol 81 
 
OH
MeO
OMe  
 
3,4-Dimethoxybenzaldehyde  (5.0 g, 30 mmol) was stirred in THF (20 ml) at -78 oC. 
Allylmagnesium bromide (2.0 M in THF, 30 ml, 60 mmol) was added in several 
portions and the solution allowed to stir for 15 min. The reaction mixture was then 
allowed to warm to room temperature and stirred for 12 h. The reaction was quenched 
with iced water (50 ml), and the resulting mixture extracted with diethyl ether (3 x 75 
ml). The combined organic layers were washed with brine (2 x 150 ml), dried over 
MgSO4, filtered and reduced under vacuum to yield 4.91 g (79%) of the title 
compound as a yellow oil; νmax(film)/cm-1 3480 (O-H), 2933, 1515, 1463, 1417, 1262, 
1234, 1152, 1139, 1027, 916; δH (400 MHz CDCl3) 2.26 (1H, bs, OH), 2.41 (2H, t, J 
= 6.8 Hz), 3.77 (3H, s, OCH3), 3.79 (3H, s, OCH3), 4.58 (1H, t, J = 6.4 Hz, CHOH), 
5.04 (2H, m, CH=CH2), 5.71 (1H, m, CH=CH2), 6.79 (3H, m, 3 x CHarom); δC (100 
MHz CDCl3) 43.7 (CH2), 55.8 (2 x CH3), 73.1 (CH), 108.9 (CH), 110.8 (CH), 117.8 
(CH), 118.1 (CH2), 134.6 (CH), 138.9 (quat), 148.3 (quat), 149.0 (quat); HRMS [EI] 
(M+), C12H16O3 requires m/z 208.1094, found m/z 208.1092. 
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Preparation of [1-(3-chloro-propylsulfanyl)-ethyl]-benzene 
 
S Cl
 
 
1-Phenylethanol (0.183 g, 1.5 mmol) and 3-chloropropane-1-thiol (0.332 g, 3 mmol) 
were stirred in CHCl3 (10 ml) in a RBF with a reflux condenser attached. TFA (0.342 
g, 3 mmol) was then added, and the mixture was refluxed for 24 h. Aq. NaHCO3 (25 
ml) was added and the mixture extracted with CHCl3 (3 x 25 ml). The combined 
organic layers were washed with brine (50 ml), water (50 ml), dried over MgSO4, 
filtered and evaporated to dryness yielding 0.30 g (93%) of the title compound as a 
clear yellow oil; νmax(film)/cm-1 2922, 1941, 1884, 1809, 1599, 1445, 1308, 1269, 
1086, 1019, 753; δH (400 MHz CDCl3) 1.47 (3H, d, J = 6.5 Hz, CHCH3), 1.81 (2H, m, 
CH2CH2CH2), 2.39 (2H, m, SCH2CH2), 3.47 (2H, m, CH2CH2Cl), 3.89 (1H, q, J = 6.5 
Hz, CHCH3), 7.13 - 7.28 (5H, m, 5 x CHarom); HRMS [FAB] (M+H+), C11H1535ClS 
requires m/z 215.0656, found m/z 215.0658. 
 
 
Preparation of (±)-(2-bromo-1-methoxyethyl)-benzene 82 
 
OMe
Br
 
 
Styrene (2.0 g, 19.2 mmol) and NBS (6.83 g, 38.4 mmol) were stirred at room 
temperature in MeOH:H2O (25 ml, 4:1) for 2 h. Conc. sodium thiosulfate aq. solution 
(50 ml) was then added and the mixture was stirred for 10 min before being extracted 
with CHCl3 (3 x 50 ml). The combined organic layers were then washed with water 
(100 ml), dried over MgSO4, filtered and evaporated to dryness yielding 3.3 g (80%) 
of the title compound as a yellow oil; νmax(film)/cm-1 2933, 1683, 1453, 1209, 1111, 
765; δH (400 MHz CDCl3) 3.30 (3H, s, OCH3), 3.48 (1H, dd, J = 6.0, 10.6 Hz, 
CHHBr), 3.57 (1H, dd, J = 2.4, 10.8 Hz, CHHBr), 4.39 (1H, dd, J = 4.0, 8.4 Hz, 
 135
CHOCH3), 7.26 – 7.39 (5H, m, 5 x CHarom); δC (100 MHz CDCl3) 35.2 (CH2), 56.2 
(CH3), 82.4 (CH), 124.9 (2 x CH), 127.8 (2 x CH), 128.1 (CH), 138.0 (quat). 
 
 
Preparation of diphenyl-methylthiophenyl ether 83 
 
S
 
 
Diphenylmethanol (3.68 g, 20 mmol) and benzenethiol (2.20 g, 20 mmol), were 
stirred in CHCl3 (15 ml) and TFA (2.97 ml, 40 mmol) was added dropwise. The 
mixture was then refluxed for 24 h. Aq. NaHCO3 (25 ml) was added and the mixture 
extracted with CHCl3 (3 x 25 ml). The combined organic layers were washed with 
brine (50 ml), dried over MgSO4, filtered and evaporated to dryness yielding 4.72 g 
(86%) of a yellow solid; mp = 185 - 186 oC; νmax(film)/cm-1 3023, 1951, 1597, 1581, 
1490, 1445, 1402, 1191, 1075, 1029, 734, 698; δH (400 MHz CDCl3) 5.62 (1H, s, 
SCH), 7.30 – 7.46 (15H, m, 15 x CHarom); δC (100 MHz CDCl3) 56.4 (CH), 126.6 
(CH), 126.7 (2 x CH), 128.5 (2 x CH),  128.7 (4 x CH),  128.9 (2 x CH),  130.6 (4 x 
CH),  136.4 (quat), 141.3 (2 x quat); HRMS [FAB] (M+), C19H16S requires m/z 
276.0793, found m/z 276.0786. 
 
 
Preparation of 1-phenyl-ethanethiophenyl ether 84 
 
S
 
 
1-Phenylethanol (2.44 g, 20 mmol) and benzenethiol (2.20 g, 20 mmol), were stirred 
in CHCl3 (15 ml) and TFA (2.97 ml, 40 mmol) was added dropwise. The mixture was 
then refluxed for 24 h. Aq. NaHCO3 (25 ml) was added and the mixture extracted 
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with CHCl3 (3 x 25 ml). The combined organic layers were washed with brine (50 
ml), dried over MgSO4, filtered and evaporated to dryness yielding 4.12 g (96%) of a 
yellow oil; νmax(film)/cm-1 3024, 2965, 1599, 1581, 1491, 1450, 1371, 1220, 1087, 
1048, 1025, 832, 747, 697; δH (400 MHz CDCl3) 1.79 (3H, d, J = 6.5 Hz, CHCH3), 
4.20 (1H, q, J = 6.5 Hz, SCH), 6.89 – 7.27 (10H, m, 10 x CHarom); δC (100 MHz 
CDCl3) 22.3 (CH3), 44.5 (CH), 126.3 (CH), 127.3 (2 x CH), 127.7 (2 x CH), 128.5 
(CH), 128.8 (2 x CH), 132.6 (2 x CH), 143.4 (quat), 145.7 (quat); HRMS [FAB] (M+), 
C14H14S requires m/z 214.0816, found m/z 214.0819. 
 
 
Preparation of 1-benzo[1,3]dioxol-5-yl-2-ethoxy-prop-2-en-1-ol 
 
OH
O
O
O  
 
Ethyl vinyl ether (0.36 g, 5 mmol) was stirred in THF (5 ml) at -78 oC. t-BuLi (1.7 M 
in hexane, 2.94 ml, 5 mmol) was added dropwise and the mixture stirred for 30 min. 
Piperonal (0.30 g, 2 mmol) in THF (5 ml) was then added and the reaction mixture 
was stirred for 12 h at RT. The mixture was quenched with ethanol (2 ml) at 0 oC, 
then iced water (25 ml) was added to the mixture and extracted with diethyl ether (3 x 
25 ml). The combined organic layers were then washed with brine (50 ml), dried over 
MgSO4, filtered and evaporated to dryness yielding 0.27 g (61%) of the title 
compound as a clear light yellow oil; νmax(film)/cm-1 3455 (O-H), 2975, 2891, 1502, 
1487, 1441, 1244, 1094, 1038, 933, 810; δH (400 MHz CDCl3) 1.24 (3H, t, J = 7.2 Hz, 
OCH2CH3), 2.56 (1H, bs, OH), 3.74 (2H, q, J = 7.2 Hz, OCH2CH3), 4.06 (1H, d, J = 
2.0 Hz, C=CHH), 4.19 (1H, d, J = 2.0 Hz, C=CHH), 5.01 (1H, d, J = 4.8 Hz, CHOH), 
5.93 (2H, s, OCH2O), 6.77 (1H, d, J = 8.0 Hz, CHarom), 6.88 (1H, dd, J = 1.6, 8.0 Hz, 
CHarom), 6.93 (1H, d, J = 1.6 Hz, CHarom); δC (100 MHz CDCl3) 14.3 (CH3), 64.1 
(CH2), 74.6 (CH), 82.1 (CH2), 100.8 (CH2), 107.2 (CH), 108.5 (CH), 120.2 (CH), 
135.5 (quat), 146.6 (quat), 148.0 (quat), 162.7 (quat); HRMS [FAB] (M+), C12H14O4 
requires m/z 222.0892, found m/z 222.0893. 
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Preparation of 2-ethoxy-1,1-diphenyl-prop-2-en-1-ol 
 
OH
OEt  
 
Ethyl vinyl ether (0.14 g, 2 mmol) was stirred in THF (4 ml) at -78 oC. t-BuLi (1.7 M 
in hexane, 1.76 ml, 3 mmol) was added dropwise and the mixture was stirred for 15 
min. Benzophenone (0.36 g, 2 mmol) in THF (5 ml) was then added and the reaction 
was stirred for 24 h at RT. The mixture was quenched with methanol (2.5 ml) at 0 oC, 
then iced water (25 ml) and extracted with diethyl ether (3 x 25 ml). The combined 
organic layers were then washed with brine (25 ml), dried over MgSO4, filtered and 
evaporated to dryness yielding 0.39 g (77%) of the title compound as a clear 
colourless oil; νmax(film)/cm-1 3563 (O-H), 2976, 1490, 1446, 1256, 1170, 1066, 
1032, 972, 820, 761, 699; δH (400 MHz CDCl3) 1.14 (3H, t, J = 7.0 Hz, OCH2CH3), 
3.47 (1H, s, OH), 3.71 (3H, m, OCH2CH3 and C=CHH), 4.19 (1H, d, J = 2.8 Hz, 
C=CHH), 7.11 – 7.43 (10H, m, 10 x CHarom); δC (100 MHz CDCl3) 15.2 (CH3), 63.7 
(CH2), 81.2 (quat), 86.7 (CH2), 126.4 (2 x CH), 127.1 (4 x CH), 128.0 (4 x CH), 144.8 
(2 x quat), 164.1 (quat); HRMS [FAB] (M+), C17H18O2 requires m/z 254.1307, found 
m/z 254.1306. 
 
 
Attempted preparation of 1-benzo[1,3]dioxol-5-yl-2-ethoxy-1-(1-methyl-1H-
imidazol-2-yl)-prop-2-en-1-ol (189) 
 
OH
O
O
NMeN
EtO
OH
O
O
NMeN
189 193  
 
Ethyl vinyl ether (0.22 g, 3 mmol) was stirred in THF (5 ml) at -78 oC. t-BuLi (1.7 M 
in hexane, 1.76 ml, 3 mmol) was added dropwise and the mixture stirred for 15 min. 
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Benzo[1,3]dioxol-5-yl-(1-methyl-1H-imidazol-2-yl)-methanone (0.46 g, 2 mmol) in 
THF (7.5 ml) was then added and the mixture was stirred at -78 oC –> RT overnight. 
The reaction was quenched with ethanol (2 ml) at 0 oC followed by iced water (25 
ml). The mixture was extracted with diethyl ether (3 x 25 ml) and the combined 
organic layers further washed with water (50 ml). The organic was then dried over 
MgSO4, filtered and evaporated to dryness yielding 0.31 g of a crude mixture. 
Column chromatography on silica gel with a light petroleum: ethyl acetate (10:1) 
eluent gave a trace yield of the compound tentatively assigned as the t-butyl addition 
product (193); νmax(film)/cm-1 3482 (O-H), 2988, 1564, 1533, 1481, 1429, 1209, 
1078, 801, 763; δH (400 MHz CDCl3) 1.18 (9H, s), 3.13 (3H, s), 5.86 (1H, d, J = 1.5 
Hz), 5.88 (1H, d, J = 1.5 Hz), 6.47 – 6.79 (5H, m). No parent ion detected in mass 
spectrum. 
 
 
Preparation of 2-[(3,4-dimethoxy-phenyl)-phenylsulfanylmethyl]-1-methyl-1H-
imidazole 
N
Me
N
MeO
OMe
S
 
 
(3,4-Dimethoxyphenyl)-(1-methyl-1H-imidazol-2-yl)-methanol (0.49 g, 2 mmol), 
benzenethiol (0.44 g, 4 mmol) and TFA (0.46 g, 4 mmol) in CHCl3 (10 ml) were 
refluxed for 48 h. Water (20 ml) was then added and the mixture extracted with 
CHCl3 (3 x 20 ml). The combined organic layers were then washed with aq. NaHCO3 
(2 x 50 ml) then dried over MgSO4, filtered and evaporated to dryness yielding 0.67 g 
(98%) of the title compound as a orange oil; νmax(film)/cm-1 2932, 2359, 1582, 1512, 
1462, 1336, 1261, 1139, 1025, 740, 691; δH (400 MHz CDCl3) 3.19 (3H, s, NCH3), 
3.65 (3H, s, OCH3), 3.70 (3H, s, OCH3), 5.30 (1H, s, SCH), 6.60 (1H, d, J = 8.0 Hz, 
CHarom), 6.67(1H, d, J = 1.2 Hz, NCH), 6.69 (1H, dd, J = 2.0, 8.0 Hz, CHarom), 6.82 
(1H, d, J = 2.0 Hz, CHarom), 6.92 (1H, d, J = 1.2 Hz, NCH), 7.07 – 7.19 (5H, m, 5 x 
CHarom); δC (100 MHz CDCl3) 32.2 (CH3), 49.3 (CH), 55.0 (CH3), 55.1 (CH3), 109.9 
 139
(CH), 110.7 (CH), 119.8 (CH), 120.7 (CH), 126.3 (CH), 126.7 (CH), 128.0 (2 x CH), 
128.6 (2 x CH), 129.9 (quat), 133.6 (quat), 145.2 (quat), 147.7 (quat), 148.1 (quat); 
HRMS [FAB] (M+H+), C19H21N2O2S requires m/z 341.1324, found m/z 341.1322. 
 
 
Preparation of imidazole-1-carbothioic acid S-(3-benzo[1,3]dioxol-5-yl-allyl) 
ester 
S
O
O
O
N
N
 
 
1-Benzo[1,3]dioxol-5-yl-prop-2-en-1-ol (0.36 g, 2 mmol), TCDI (0.53 g, 3 mmol) and 
TEA (0.30 g, 3 mmol) in CHCl3 (10 ml) were refluxed for 24 h. Water (50 ml) was 
added and the mixture extracted with CHCl3 (3 x 25 ml). The combined organic layers 
were then washed with water (50 ml), dried over MgSO4, filtered and evaporated to 
dryness yielding 0.97 g of a crude dark orange oil. Silica gel column chromatography 
with a light petroleum: ethyl acetate (20:1) eluent yielded 0.11 g (19%) of a yellow 
solid tentatively assigned as the title compound; mp = 184 - 185 oC; νmax(film)/cm-1 
2358, 1600, 1485, 1443, 1248, 1035, 973; δH (400 MHz CDCl3) 4.18 (2H, dd, J = 0.8, 
7.6 Hz, CH2S), 5.94 (2H, s, OCH2O), 6.04 (1H, dt, J = 7.6, 15.6 Hz, CH=CHCH2), 
6.55 (1H, d, J = 15.6 Hz, CH=CHCH2), 6.73 (1H, d, J = 8.0 Hz, CHarom), 6.78 (1H, 
dd, J = 1.6, 8.0 Hz, CHarom), 6.89 (1H, d, J = 1.6 Hz, CHarom), [imidazole CH’s not 
observed]; δC (100 MHz CDCl3) 39.7 (CH2), 101.1 (CH2), 105.7 (CH), 108.3 (CH), 
120.3 (CH), 121.3 (CH), 130.8 (quat), 134.4 (CH), 147.5 (quat), 148.1 (quat), 222.6 
(quat), [imidazole Cs not observed]. 
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Preparation of (4-methoxy-phenyl)-thiocarbamic acid S-(3-benzo[1,3]dioxol-5-yl-
allyl) ester 
S
O
O
O
NH
OMe 
 
1-Benzo[1,3]dioxol-5-yl-prop-2-en-1-ol (0.36 g, 2 mmol) was stirred in THF (7.5 ml) 
at 0 oC. Sodium hydride (60% oil disp., 0.16 g, 4 mmol) was added and the mixture 
was stirred for 15 min. 1-Isothiocyanato-4-methoxybenzene (0.33 g, 2 mmol) was 
added and the mixture was allowed to stir at RT for 12 h. Water (25 ml) was then 
added and the mixture was extracted with diethyl ether (3 x 25 ml). The combined 
organic layers were washed with brine (50 ml) and water (50 ml), dried over MgSO4, 
filtered and evaporated to dryness yielding 0.42 g of the crude product. 
Recrystallisation from CHCl3 and hexane afforded 0.21 g (30%) of the title compound 
as a white solid; mp = 239 – 241 oC; νmax(film)/cm-1 1642, 1509, 1204, 1029, 966, 
929, 822; δH (400 MHz CDCl3) 3.70 (5H, m, CH2S and OCH3), 5.86 (2H, s, OCH2O), 
6.00 (1H, dt, J = 7.6, 15.6 Hz, CH=CHCH2), 6.40 (1H, d, J = 15.6 Hz, CH=CHCH2), 
6.66 (1H, d, J = 8.0 Hz, CHarom), 6.71 (1H, dd, J = 1.6, 8.0 Hz, CHarom), 6.77 (2H, m, 
2 x CHarom), 6.83 (1H, d, J = 1.6 Hz, CHarom), 6.95 (1H, bs, NH), 7.23 (2H, d, J = 8.8 
Hz, 2 x CHarom); δC (100 MHz CDCl3) 30.9 (CH2), 55.5 (CH3), 101.1 (CH2), 105.7 
(CH), 108.3 (CH), 114.3 (2 x CH), 121.4 (CH), 122.3 (2 x CH), 123.3 (CH), 131.1 
(quat), 132.6 (CH), 147.3 (quat), 148.0 (quat) [3 x quat not detected]; HRMS [ES] 
(M+H+), C18H18NO4S requires m/z 344.0951, found m/z 344.0948. 
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Preparation of carbonic acid tert-butyl ester 1-(3,4-dimethoxyphenyl)-allyl ester 
 
O
O
O
MeO
OMe  
Method A: 
1-(3,4-Dimethoxyphenyl)-prop-2-en-1-ol (0.29 g, 1.5 mmol), TEA (0.15 g, 1.5 mmol) 
and Boc2O (0.33 g, 1.5 mmol) were stirred in CHCl3 (5 ml) at RT for 5 days. Water 
(25 ml) was added and the mixture extracted with CHCl3 (3 x 25 ml). The combined 
organic layers were washed with water (50 ml), dried over MgSO4, filtered and 
reduced to dryness yielding 0.51 g of a crude mixture. Silica gel column 
chromatography with light petroleum: ethyl acetate (10:1) eluent yielded 0.19 g (43%) 
of the title compound as a white solid (see data overleaf). 
 
Method B: 
1-(3,4-Dimethoxy-phenyl)-prop-2-en-1-ol ol (0.291 g, 1.50 mmol) was stirred in THF 
(5 ml) at 0 oC. Sodium hydride (60% oil disp., 0.054 g, 2.25 mmol) was added and the 
mixture was stirred for 20 min. Boc2O (0.327 g, 1.5 mmol) was then added and the 
mixture was allowed to return to RT and stirred overnight. Iced water (20 ml) was 
added and the mixture extracted with diethyl ether (3 x 20 ml). The combined organic 
layers were washed with brine (20 ml) and water (20 ml), then dried over MgSO4, 
filtered and reduced to dryness yielding 0.41 g (93%) of the title compound as a white 
solid. (see data overleaf). 
 
νmax(film)/cm-1 2981, 2930, 2358, 1809, 1771, 1755, 1738, 1520, 1456, 1371, 1305, 
1260, 1212, 1119, 1070; δH (400 MHz CDCl3) 1.41 (9H, s, C(CH3)3), 3.78 (3H, s, 
OCH3), 3.80 (3H, s, OCH3), 5.17 (2H, m, CH=CH2), 5.90 (2H, m, CHCH=CH2), 6.75 
(1H, d, J = 8.0 Hz, CHarom), 6.80 (1H, d, J = 2.0 Hz, CHarom), 6.83 (1H, dd, J = 2.0, 
8.0 Hz, CHarom); δC (100 MHz CDCl3) 27.5 (3 x CH3), 55.7 (2 x CH3), 79.0 (CH), 
82.2 (quat), 110.2 (CH), 110.9 (CH), 116.7 (CH2), 119.8 (CH), 131.2 (quat), 136.2 
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(CH), 146.7 (quat), 148.9 (quat), 152.7 (quat); HRMS [FAB] (M+), C16H22O5 requires 
m/z 294.1467, found m/z 294.1460. 
 
 
Attempted preparation of 2-[1-tert-butylsulfanyl-1-(3,4-dimethoxyphenyl)-3,3-
dimethoxypropyl]-thiazole 
NS
S
OMe
OMeMeO
OMe  
 
2-[tert-Butylsulfanyl-(3,4-dimethoxy-phenyl)-methyl]-thiazole (0.162 g, 0.5 mmol) 
was stirred in THF (5 ml) at -78 oC. n-BuLi (2.5M in hexane, 0.24 ml, 0.6 mmol) was 
added dropwise and the mixture was stirred for 20 min. 2-Bromo-1,1-dimethoxy-
ethane (0.101 g, 0.6 mmol) was then added and the reaction was allowed to return to 
RT and stirred overnight. Water (20 ml) was added and the mixture was extracted 
with CHCl3 (3 x 20 ml). The combined organic layers were further washed with water 
(25 ml), dried over MgSO4, filtered and evaporated to dryness yielding 0.139 g of a 
crude mixture of products. Silica gel column chromatography using light petroleum: 
ethyl acetate (20:1) as eluent yielded 0.109 g (67% recovery) of the sulfide starting 
material, and a trace yield of an unidentifiable product; νmax(film)/cm-1 2957.4, 
1511.8, 1460.0, 1259.3, 1026.3, 798.5; δH (400 MHz CDCl3) 1.10 (9H, s), 2.46 (2H, 
m), 3.76 (3H, s), 3.88 (3H, s), 6.71 (1H, d), 7.05 (2H, m), 7.24 (1H, d), 7.64 (1H, d); 
LRMS (EI) m/z 290 (100%) 274 (12%). 
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5 - Appendices  
 
5.1 – X-ray crystal data and structure refinement for 2-(Benzo[1,3]dioxol-5-yl-
tert-butylsulfanyl-methyl)-1-methyl-1H-imidazole 
 
Table 1.   
 
Identification code  gw37dl-(PAR/ME) 
Chemical formula  C16H20N2O2S 
Formula weight  304.40 
Temperature  150(2) K 
Radiation, wavelength  synchrotron, 0.6911 Å 
Crystal system, space group  monoclinic, P21/c 
Unit cell parameters a = 28.261(3) Å α = 90° 
 b = 5.8269(6) Å β = 111.014(2)° 
 c = 20.3766(19) Å γ = 90° 
Cell volume 3132.3(5) Å3 
Z 8 
Calculated density  1.291 g/cm3 
Absorption coefficient μ 0.213 mm−1 
F(000) 1296 
Crystal colour and size colourless, 0.10 × 0.05 × 0.03 mm3 
Reflections for cell refinement 7909 (θ range 3.56 to 29.58°) 
Data collection method Bruker APEX 2 CCD diffractometer 
 ω rotation with narrow frames 
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θ range for data collection 1.49 to 25.00° 
Index ranges h −25 to 34, k −7 to 6, l −22 to 24 
Completeness to θ = 25.00° 98.3 %  
Intensity decay 3% 
Reflections collected 17195 
Independent reflections 5890 (Rint = 0.0620) 
Reflections with F2>2σ 5441 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.979 and 0.994 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.1500, 1.3313 
Data / restraints / parameters 5890 / 0 / 389 
Final R indices [F2>2σ] R1 = 0.0843, wR2 = 0.2079 
R indices (all data) R1 = 0.0874, wR2 = 0.2129 
Goodness-of-fit on F2 1.068 
Extinction coefficient 0.037(6) 
Largest and mean shift/su 0.001 and 0.000 
Largest diff. peak and hole 1.577 and −0.533 e Å−3 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters 
(Å2). Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
C(1) 0.19965(18) 0.5669(8) 0.1535(2) 0.0473(11) 
N(1) 0.21050(12) 0.3942(6) 0.20884(17) 0.0329(7) 
C(2) 0.18547(13) 0.3564(6) 0.25381(18) 0.0268(7) 
N(3) 0.20487(12) 0.1853(6) 0.29641(19) 0.0380(8) 
C(4) 0.24441(15) 0.1066(8) 0.2773(2) 0.0425(10) 
C(5) 0.24858(13) 0.2330(8) 0.2244(2) 0.0383(10) 
C(6) 0.13816(12) 0.4805(6) 0.24920(17) 0.0249(7) 
C(7) 0.13510(11) 0.5259(6) 0.32094(18) 0.0232(7) 
C(8) 0.11748(12) 0.3576(6) 0.35605(18) 0.0235(7) 
C(9) 0.11796(12) 0.4112(6) 0.42163(18) 0.0246(7) 
C(10) 0.13485(12) 0.6185(6) 0.45317(18) 0.0255(7) 
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C(11) 0.15259(13) 0.7847(6) 0.4202(2) 0.0286(8) 
C(12) 0.15200(12) 0.7378(6) 0.35339(19) 0.0250(7) 
O(1) 0.10308(11) 0.2736(5) 0.46631(15) 0.0373(7) 
C(13) 0.1118(2) 0.4087(8) 0.5266(2) 0.0529(12) 
O(2) 0.13096(10) 0.6260(5) 0.51851(14) 0.0350(6) 
S(1) 0.08664(3) 0.30088(15) 0.19081(4) 0.0265(3) 
C(14) 0.03393(12) 0.5003(6) 0.14834(18) 0.0281(7) 
C(15) 0.02028(14) 0.6420(7) 0.2012(2) 0.0337(8) 
C(16)  −0.00952(14) 0.3388(7) 0.1087(2) 0.0379(9) 
C(17) 0.04673(15) 0.6563(8) 0.0966(2) 0.0397(9) 
C(1') 0.29973(17) 0.5831(7)  −0.0384(2) 0.0429(10) 
N(1') 0.28987(11) 0.3996(5) 0.00341(16) 0.0294(7) 
C(2') 0.31640(12) 0.3509(6) 0.07215(17) 0.0239(7) 
N(3') 0.29677(12) 0.1770(6) 0.09485(17) 0.0339(7) 
C(4') 0.25530(13) 0.1100(7) 0.0368(2) 0.0380(9) 
C(5') 0.25088(12) 0.2452(8)  −0.0190(2) 0.0324(8) 
C(6') 0.36457(11) 0.4692(6) 0.11490(17) 0.0235(7) 
C(7') 0.36700(11) 0.5166(6) 0.18896(17) 0.0216(7) 
C(8') 0.38249(12) 0.3491(6) 0.24146(18) 0.0246(7) 
C(9') 0.38022(13) 0.4045(6) 0.30556(19) 0.0267(7) 
C(10') 0.36373(13) 0.6165(6) 0.31877(19) 0.0273(7) 
C(11') 0.34892(14) 0.7811(6) 0.2694(2) 0.0299(8) 
C(12') 0.35043(12) 0.7329(6) 0.20320(19) 0.0251(7) 
O(1') 0.39367(12) 0.2699(5) 0.36548(14) 0.0386(7) 
C(13') 0.3772(3) 0.3995(8) 0.4125(3) 0.0722(19) 
O(2') 0.36667(12) 0.6265(5) 0.38799(14) 0.0406(7) 
S(1') 0.41556(3) 0.28419(16) 0.10837(5) 0.0257(3) 
C(14') 0.46793(12) 0.4855(6) 0.11481(18) 0.0285(8) 
C(15') 0.48096(14) 0.6354(7) 0.1805(2) 0.0351(9) 
C(16') 0.51139(14) 0.3262(7) 0.1197(2) 0.0388(9) 
C(17') 0.45370(16) 0.6349(8) 0.0494(2) 0.0412(9) 
 
Table 3.   Bond lengths [Å] and angles [°] 
 
C(1)–N(1)  1.459(5) N(1)–C(2)  1.362(4) 
N(1)–C(5)  1.377(5) C(2)–N(3)  1.306(5) 
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C(2)–C(6)  1.493(5) N(3)–C(4)  1.387(5) 
C(4)–C(5)  1.345(6) C(6)–C(7)  1.518(5) 
C(6)–S(1)  1.841(3) C(7)–C(12)  1.401(5) 
C(7)–C(8)  1.406(5) C(8)–C(9)  1.368(5) 
C(9)–C(10)  1.371(5) C(9)–O(1)  1.387(4) 
C(10)–C(11)  1.371(5) C(10)–O(2)  1.376(4) 
C(11)–C(12)  1.383(5) O(1)–C(13)  1.404(5) 
C(13)–O(2)  1.410(5) S(1)–C(14)  1.842(3) 
C(14)–C(15)  1.513(5) C(14)–C(16)  1.528(5) 
C(14)–C(17)  1.530(5) C(1')–N(1')  1.455(5) 
N(1')–C(2')  1.361(4) N(1')–C(5')  1.368(5) 
C(2')–N(3')  1.316(4) C(2')–C(6')  1.496(4) 
N(3')–C(4')  1.390(5) C(4')–C(5')  1.352(6) 
C(6')–C(7')  1.511(5) C(6')–S(1')  1.842(3) 
C(7')–C(8')  1.398(5) C(7')–C(12')  1.410(5) 
C(8')–C(9')  1.369(5) C(9')–C(10')  1.380(5) 
C(9')–O(1')  1.385(4) C(10')–C(11')  1.344(5) 
C(10')–O(2')  1.384(4) C(11')–C(12')  1.393(5) 
O(1')–C(13')  1.423(5) C(13')–O(2')  1.408(6) 
S(1')–C(14')  1.856(3) C(14')–C(16')  1.514(5) 
C(14')–C(17')  1.520(5) C(14')–C(15')  1.528(5) 
 
C(2)–N(1)–C(5) 106.7(3) C(2)–N(1)–C(1) 128.0(3) 
C(5)–N(1)–C(1) 125.3(3) N(3)–C(2)–N(1) 112.0(3) 
N(3)–C(2)–C(6) 124.4(3) N(1)–C(2)–C(6) 123.3(3) 
C(2)–N(3)–C(4) 104.7(3) C(5)–C(4)–N(3) 110.8(4) 
C(4)–C(5)–N(1) 105.8(3) C(2)–C(6)–C(7) 112.5(3) 
C(2)–C(6)–S(1) 104.4(2) C(7)–C(6)–S(1) 114.6(2) 
C(12)–C(7)–C(8) 119.8(3) C(12)–C(7)–C(6) 118.7(3) 
C(8)–C(7)–C(6) 121.4(3) C(9)–C(8)–C(7) 117.2(3) 
C(8)–C(9)–C(10) 122.6(3) C(8)–C(9)–O(1) 127.6(3) 
C(10)–C(9)–O(1) 109.8(3) C(9)–C(10)–C(11) 121.3(3) 
C(9)–C(10)–O(2) 110.3(3) C(11)–C(10)–O(2) 128.4(3) 
C(10)–C(11)–C(12) 117.7(3) C(11)–C(12)–C(7) 121.4(3) 
C(9)–O(1)–C(13) 104.5(3) O(1)–C(13)–O(2) 110.9(3) 
C(10)–O(2)–C(13) 104.6(3) C(6)–S(1)–C(14) 105.30(16) 
C(15)–C(14)–C(16) 110.5(3) C(15)–C(14)–C(17) 110.5(3) 
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C(16)–C(14)–C(17) 110.2(3) C(15)–C(14)–S(1) 112.3(2) 
C(16)–C(14)–S(1) 102.8(2) C(17)–C(14)–S(1) 110.3(2) 
C(2')–N(1')–C(5') 106.6(3) C(2')–N(1')–C(1') 127.3(3) 
C(5')–N(1')–C(1') 126.0(3) N(3')–C(2')–N(1') 112.1(3) 
N(3')–C(2')–C(6') 124.1(3) N(1')–C(2')–C(6') 123.6(3) 
C(2')–N(3')–C(4') 104.5(3) C(5')–C(4')–N(3') 110.3(3) 
C(4')–C(5')–N(1') 106.4(3) C(2')–C(6')–C(7') 111.8(3) 
C(2')–C(6')–S(1') 105.1(2) C(7')–C(6')–S(1') 115.0(2) 
C(8')–C(7')–C(12') 120.2(3) C(8')–C(7')–C(6') 121.7(3) 
C(12')–C(7')–C(6') 118.0(3) C(9')–C(8')–C(7') 117.1(3) 
C(8')–C(9')–C(10') 122.1(3) C(8')–C(9')–O(1') 128.0(3) 
C(10')–C(9')–O(1') 109.9(3) C(11')–C(10')–C(9') 121.9(3) 
C(11')–C(10')–O(2') 128.5(3) C(9')–C(10')–O(2') 109.6(3) 
C(10')–C(11')–C(12') 118.1(3) C(11')–C(12')–C(7') 120.5(3) 
C(9')–O(1')–C(13') 103.9(3) O(2')–C(13')–O(1') 109.7(4) 
C(10')–O(2')–C(13') 104.5(3) C(6')–S(1')–C(14') 104.45(16) 
C(16')–C(14')–C(17') 111.2(3) C(16')–C(14')–C(15') 111.0(3) 
C(17')–C(14')–C(15') 110.2(3) C(16')–C(14')–S(1') 103.0(3) 
C(17')–C(14')–S(1') 110.3(2) C(15')–C(14')–S(1') 111.0(2) 
 
Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2)  
 
      x       y       z       U 
 
H(1A) 0.1654 0.5427 0.1191 0.071 
H(1B) 0.2244 0.5537 0.1301 0.071 
H(1C) 0.2019 0.7202 0.1742 0.071 
H(4) 0.2657  −0.0195 0.2986 0.051 
H(5) 0.2728 0.2149 0.2023 0.046 
H(6) 0.1376 0.6313 0.2255 0.030 
H(8) 0.1057 0.2128 0.3351 0.028 
H(11) 0.1649 0.9271 0.4425 0.034 
H(12) 0.1633 0.8516 0.3290 0.030 
H(13A) 0.1363 0.3300 0.5679 0.064 
H(13B) 0.0796 0.4280 0.5351 0.064 
H(15A) 0.0495 0.7349 0.2289 0.051 
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H(15B) 0.0107 0.5399 0.2326 0.051 
H(15C)  −0.0082 0.7432 0.1764 0.051 
H(16A)  −0.0180 0.2428 0.1425 0.057 
H(16B) 0.0008 0.2408 0.0771 0.057 
H(16C)  −0.0393 0.4292 0.0812 0.057 
H(17A) 0.0168 0.7471 0.0699 0.060 
H(17B) 0.0570 0.5623 0.0642 0.060 
H(17C) 0.0745 0.7595 0.1226 0.060 
H(1D) 0.2717 0.5922  −0.0838 0.064 
H(1E) 0.3314 0.5513  −0.0462 0.064 
H(1F) 0.3028 0.7292  −0.0135 0.064 
H(4') 0.2332  −0.0133 0.0364 0.046 
H(5') 0.2257 0.2350  −0.0647 0.039 
H(6') 0.3661 0.6193 0.0919 0.028 
H(8') 0.3941 0.2029 0.2330 0.030 
H(11') 0.3377 0.9263 0.2793 0.036 
H(12') 0.3402 0.8465 0.1674 0.030 
H(13C) 0.3464 0.3287 0.4161 0.087 
H(13D) 0.4040 0.3994 0.4599 0.087 
H(15D) 0.5088 0.7392 0.1829 0.053 
H(15E) 0.4913 0.5375 0.2224 0.053 
H(15F) 0.4511 0.7255 0.1783 0.053 
H(16D) 0.5013 0.2249 0.0786 0.058 
H(16E) 0.5201 0.2336 0.1625 0.058 
H(16F) 0.5409 0.4170 0.1211 0.058 
H(17D) 0.4830 0.7282 0.0511 0.062 
H(17E) 0.4255 0.7358 0.0476 0.062 
H(17F) 0.4435 0.5372 0.0075 0.062 
 
Table 5.  Torsion angles [°]  
 
C(5)–N(1)–C(2)–N(3) 0.2(5) C(1)–N(1)–C(2)–N(3) 179.2(4) 
C(5)–N(1)–C(2)–C(6)  −173.6(3) C(1)–N(1)–C(2)–C(6) 5.3(6) 
N(1)–C(2)–N(3)–C(4)  −0.7(5) C(6)–C(2)–N(3)–C(4) 173.1(4) 
C(2)–N(3)–C(4)–C(5) 0.9(5) N(3)–C(4)–C(5)–N(1)  −0.7(5) 
C(2)–N(1)–C(5)–C(4) 0.3(5) C(1)–N(1)–C(5)–C(4)  −178.7(4) 
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N(3)–C(2)–C(6)–C(7) 41.9(5) N(1)–C(2)–C(6)–C(7)  −145.0(3) 
N(3)–C(2)–C(6)–S(1)  −83.0(4) N(1)–C(2)–C(6)–S(1) 90.1(4) 
C(2)–C(6)–C(7)–C(12) 94.7(4) S(1)–C(6)–C(7)–C(12)  −146.2(3) 
C(2)–C(6)–C(7)–C(8)  −83.0(4) S(1)–C(6)–C(7)–C(8) 36.1(4) 
C(12)–C(7)–C(8)–C(9)  −0.2(5) C(6)–C(7)–C(8)–C(9) 177.5(3) 
C(7)–C(8)–C(9)–C(10)  −0.2(5) C(7)–C(8)–C(9)–O(1)  −179.3(3) 
C(8)–C(9)–C(10)–C(11)  −0.3(5) O(1)–C(9)–C(10)–C(11) 178.9(3) 
C(8)–C(9)–C(10)–O(2) 179.8(3) O(1)–C(9)–C(10)–O(2)  −1.0(4) 
C(9)–C(10)–C(11)–C(12) 1.2(5) O(2)–C(10)–C(11)–C(12)  −179.0(3) 
C(10)–C(11)–C(12)–C(7)  −1.6(5) C(8)–C(7)–C(12)–C(11) 1.1(5) 
C(6)–C(7)–C(12)–C(11)  −176.6(3) C(8)–C(9)–O(1)–C(13) 179.2(4) 
C(10)–C(9)–O(1)–C(13) 0.1(4) C(9)–O(1)–C(13)–O(2) 0.8(5) 
C(9)–C(10)–O(2)–C(13) 1.4(4) C(11)–C(10)–O(2)–C(13)  −178.5(4) 
O(1)–C(13)–O(2)–C(10)  −1.3(5) C(2)–C(6)–S(1)–C(14)  −151.9(2) 
C(7)–C(6)–S(1)–C(14) 84.5(3) C(6)–S(1)–C(14)–C(15)  −53.9(3) 
C(6)–S(1)–C(14)–C(16)  −172.6(2) C(6)–S(1)–C(14)–C(17) 69.9(3) 
C(5')–N(1')–C(2')–N(3')  −0.3(4) C(1')–N(1')–C(2')–N(3') 178.3(4) 
C(5')–N(1')–C(2')–C(6') 175.1(3) C(1')–N(1')–C(2')–C(6')  −6.3(6) 
N(1')–C(2')–N(3')–C(4') 0.4(4) C(6')–C(2')–N(3')–C(4')  −175.0(3) 
C(2')–N(3')–C(4')–C(5')  −0.3(5) N(3')–C(4')–C(5')–N(1') 0.1(5) 
C(2')–N(1')–C(5')–C(4') 0.1(4) C(1')–N(1')–C(5')–C(4')  −178.5(4) 
N(3')–C(2')–C(6')–C(7')  −44.9(4) N(1')–C(2')–C(6')–C(7') 140.3(3) 
N(3')–C(2')–C(6')–S(1') 80.5(4) N(1')–C(2')–C(6')–S(1')  −94.3(3) 
C(2')–C(6')–C(7')–C(8') 82.6(4) S(1')–C(6')–C(7')–C(8')  −37.2(4) 
C(2')–C(6')–C(7')–C(12')  −94.0(3) S(1')–C(6')–C(7')–C(12') 146.3(3) 
C(12')–C(7')–C(8')–C(9') 0.6(5) C(6')–C(7')–C(8')–C(9')  −175.9(3) 
C(7')–C(8')–C(9')–C(10')  −0.4(5) C(7')–C(8')–C(9')–O(1')  −179.5(3) 
C(8')–C(9')–C(10')–C(11') 0.0(6) O(1')–C(9')–C(10')–C(11') 179.3(3) 
C(8')–C(9')–C(10')–O(2')  −178.5(3) O(1')–C(9')–C(10')–O(2') 0.8(4) 
C(9')–C(10')–C(11')–C(12') 0.1(5) O(2')–C(10')–C(11')–C(12') 178.3(4) 
C(10')–C(11')–C(12')–C(7') 0.1(5) C(8')–C(7')–C(12')–C(11')  −0.5(5) 
C(6')–C(7')–C(12')–C(11') 176.1(3) C(8')–C(9')–O(1')–C(13')  −172.3(5) 
C(10')–C(9')–O(1')–C(13') 8.5(5) C(9')–O(1')–C(13')–O(2')  −14.8(6) 
C(11')–C(10')–O(2')–C(13') 171.8(5) C(9')–C(10')–O(2')–C(13')  −9.8(5) 
O(1')–C(13')–O(2')–C(10') 15.4(6) C(2')–C(6')–S(1')–C(14') 149.3(2) 
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C(7')–C(6')–S(1')–C(14')  −87.3(3) C(6')–S(1')–C(14')–C(16') 172.3(2) 
C(6')–S(1')–C(14')–C(17')  −68.9(3) C(6')–S(1')–C(14')–C(15') 53.5(3) 
 
 
 
5.2 – X-ray crystal data and structure refinement for (4-Benzyloxy-3-
methoxyphenyl)-(1H-imidazol-2-yl)-methanone 
 
Table 1.   
 
Identification code  gw38-(PAR/ME) 
Chemical formula  C18H16N2O3 
Formula weight  308.33 
Temperature  150(2) K 
Radiation, wavelength  MoKα, 0.71073 Å 
Crystal system, space group  monoclinic, P21/n 
Unit cell parameters a = 5.2011(3) Å α = 90° 
 b = 18.7666(10) Å β = 94.0830(9)° 
 c = 15.4067(8) Å γ = 90° 
Cell volume 1499.98(14) Å3 
Z 4 
Calculated density  1.365 g/cm3 
Absorption coefficient μ 0.094 mm−1 
F(000) 648 
Crystal colour and size colourless, 0.87 × 0.26 × 0.17 mm3 
Reflections for cell refinement 6499 (θ range 2.90 to 30.52°) 
Data collection method Bruker APEX 2 CCD diffractometer 
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 ω rotation with narrow frames 
θ range for data collection 1.71 to 30.55° 
Index ranges h −7 to 7, k −26 to 25, l −21 to 21 
Completeness to θ = 30.55° 99.5 %  
Intensity decay 0% 
Reflections collected 17552 
Independent reflections 4578 (Rint = 0.0222) 
Reflections with F2>2σ 3836 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.922 and 0.984 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0685, 0.2748 
Data / restraints / parameters 4578 / 0 / 213 
Final R indices [F2>2σ] R1 = 0.0427, wR2 = 0.1117 
R indices (all data) R1 = 0.0514, wR2 = 0.1184 
Goodness-of-fit on F2 1.042 
Extinction coefficient 0.0070(15) 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 0.422 and −0.234 e Å−3 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters 
(Å2). Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
N(1) 1.34379(17)  −0.10238(5) 0.46668(6) 0.02428(19) 
C(2) 1.14473(18)  −0.08247(5) 0.40961(6) 0.02084(19) 
N(3) 1.03789(18)  −0.13885(5) 0.36870(6) 0.0270(2) 
C(4) 1.1733(2)  −0.19626(6) 0.40209(8) 0.0310(2) 
C(5) 1.3639(2)  −0.17437(6) 0.46241(8) 0.0305(2) 
C(6) 1.08270(18)  −0.00636(5) 0.39901(6) 0.01963(18) 
O(1) 1.22228(14) 0.03713(4) 0.43987(5) 0.02492(17) 
C(7) 0.86497(18) 0.01835(5) 0.33912(6) 0.01938(18) 
C(8) 0.85951(19) 0.09155(5) 0.31835(6) 0.02098(19) 
C(9) 0.67023(19) 0.11852(5) 0.26021(6) 0.02039(19) 
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C(10) 0.48069(18) 0.07252(5) 0.22103(6) 0.01939(18) 
C(11) 0.47975(18) 0.00092(5) 0.24422(6) 0.02101(19) 
C(12) 0.67225(18)  −0.02597(5) 0.30310(6) 0.02037(18) 
O(2) 0.65070(15) 0.18779(4) 0.23361(5) 0.02626(17) 
C(13) 0.8625(2) 0.23335(6) 0.25883(8) 0.0306(2) 
O(3) 0.31358(14) 0.10381(4) 0.16053(4) 0.02286(16) 
C(14) 0.1449(2) 0.05673(5) 0.10904(6) 0.0234(2) 
C(15) 0.04629(19) 0.09649(5) 0.02876(6) 0.02132(19) 
C(16) 0.1688(2) 0.08857(6)  −0.04807(7) 0.0263(2) 
C(17) 0.0789(2) 0.12398(6)  −0.12336(7) 0.0302(2) 
C(18)  −0.1334(2) 0.16835(6)  −0.12234(7) 0.0295(2) 
C(19)  −0.2565(2) 0.17698(6)  −0.04615(7) 0.0296(2) 
C(20)  −0.1677(2) 0.14111(6) 0.02932(7) 0.0261(2) 
 
Table 3.   Bond lengths [Å] and angles [°]  
 
N(1)–C(5)  1.3570(14) N(1)–C(2)  1.3620(12)
C(2)–N(3)  1.3326(13) C(2)–C(6)  1.4708(13)
N(3)–C(4)  1.3674(14) C(4)–C(5)  1.3729(16)
C(6)–O(1)  1.2347(11) C(6)–C(7)  1.4832(13)
C(7)–C(12)  1.3876(13) C(7)–C(8)  1.4103(13)
C(8)–C(9)  1.3791(13) C(9)–O(2)  1.3648(11)
C(9)–C(10)  1.4131(13) C(10)–O(3)  1.3616(11)
C(10)–C(11)  1.3904(13) C(11)–C(12)  1.3966(13)
O(2)–C(13)  1.4261(12) O(3)–C(14)  1.4424(11)
C(14)–C(15)  1.5030(13) C(15)–C(16)  1.3915(15)
C(15)–C(20)  1.3934(14) C(16)–C(17)  1.3888(15)
C(17)–C(18)  1.3839(17) C(18)–C(19)  1.3862(17)
C(19)–C(20)  1.3936(14)  
 
C(5)–N(1)–C(2) 107.44(9) N(3)–C(2)–N(1) 111.08(9) 
N(3)–C(2)–C(6) 129.62(9) N(1)–C(2)–C(6) 119.26(9) 
C(2)–N(3)–C(4) 105.16(9) N(3)–C(4)–C(5) 110.28(10) 
N(1)–C(5)–C(4) 106.04(9) O(1)–C(6)–C(2) 117.96(8) 
O(1)–C(6)–C(7) 120.38(9) C(2)–C(6)–C(7) 121.63(8) 
C(12)–C(7)–C(8) 119.39(8) C(12)–C(7)–C(6) 124.00(8) 
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C(8)–C(7)–C(6) 116.61(8) C(9)–C(8)–C(7) 120.45(9) 
O(2)–C(9)–C(8) 125.39(9) O(2)–C(9)–C(10) 114.77(8) 
C(8)–C(9)–C(10) 119.82(9) O(3)–C(10)–C(11) 125.38(8) 
O(3)–C(10)–C(9) 114.89(8) C(11)–C(10)–C(9) 119.72(8) 
C(10)–C(11)–C(12) 120.04(9) C(7)–C(12)–C(11) 120.48(9) 
C(9)–O(2)–C(13) 116.72(8) C(10)–O(3)–C(14) 116.48(7) 
O(3)–C(14)–C(15) 107.88(8) C(16)–C(15)–C(20) 118.93(9) 
C(16)–C(15)–C(14) 119.80(9) C(20)–C(15)–C(14) 121.28(9) 
C(17)–C(16)–C(15) 120.80(10) C(18)–C(17)–C(16) 119.99(10) 
C(17)–C(18)–C(19) 119.80(10) C(18)–C(19)–C(20) 120.29(10) 
C(15)–C(20)–C(19) 120.18(10)  
 
Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2) 
 
      x       y       z       U 
 
H(1) 1.441(3)  −0.0728(8) 0.4966(9) 0.029 
H(4) 1.1401  −0.2444 0.3859 0.037 
H(5) 1.4854  −0.2037 0.4946 0.037 
H(8) 0.9871 0.1225 0.3446 0.025 
H(11) 0.3481  −0.0297 0.2200 0.025 
H(12) 0.6712  −0.0750 0.3186 0.024 
H(13A) 0.8738 0.2396 0.3221 0.046 
H(13B) 0.8366 0.2798 0.2305 0.046 
H(13C) 1.0225 0.2119 0.2412 0.046 
H(14A)  −0.0008 0.0417 0.1428 0.028 
H(14B) 0.2402 0.0136 0.0927 0.028 
H(16) 0.3157 0.0586  −0.0490 0.032 
H(17) 0.1631 0.1177  −0.1756 0.036 
H(18)  −0.1946 0.1928  −0.1737 0.035 
H(19)  −0.4021 0.2075  −0.0454 0.036 
H(20)  −0.2533 0.1471 0.0813 0.031 
 
Table 5.  Torsion angles [°] 
 
C(5)–N(1)–C(2)–N(3)  −0.35(12) C(5)–N(1)–C(2)–C(6)  −178.49(9) 
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N(1)–C(2)–N(3)–C(4) 0.67(12) C(6)–C(2)–N(3)–C(4) 178.55(10) 
C(2)–N(3)–C(4)–C(5)  −0.75(13) C(2)–N(1)–C(5)–C(4)  −0.12(13) 
N(3)–C(4)–C(5)–N(1) 0.54(14) N(3)–C(2)–C(6)–O(1)  −174.56(10) 
N(1)–C(2)–C(6)–O(1) 3.18(14) N(3)–C(2)–C(6)–C(7) 3.47(16) 
N(1)–C(2)–C(6)–C(7)  −178.79(9) O(1)–C(6)–C(7)–C(12)  −167.85(9) 
C(2)–C(6)–C(7)–C(12) 14.16(14) O(1)–C(6)–C(7)–C(8) 12.53(14) 
C(2)–C(6)–C(7)–C(8)  −165.46(9) C(12)–C(7)–C(8)–C(9)  −2.46(14) 
C(6)–C(7)–C(8)–C(9) 177.18(9) C(7)–C(8)–C(9)–O(2)  −178.06(9) 
C(7)–C(8)–C(9)–C(10)  −0.13(15) O(2)–C(9)–C(10)–O(3) 2.26(12) 
C(8)–C(9)–C(10)–O(3)  −175.88(8) O(2)–C(9)–C(10)–C(11)  −179.08(9) 
C(8)–C(9)–C(10)–C(11) 2.78(14) O(3)–C(10)–C(11)–C(12) 175.68(9) 
C(9)–C(10)–C(11)–C(12)  −2.83(14) C(8)–C(7)–C(12)–C(11) 2.41(14) 
C(6)–C(7)–C(12)–C(11)  −177.20(9) C(10)–C(11)–C(12)–C(7) 0.23(14) 
C(8)–C(9)–O(2)–C(13) 9.08(14) C(10)–C(9)–O(2)–C(13)  −168.94(9) 
C(11)–C(10)–O(3)–C(14)  −8.41(14) C(9)–C(10)–O(3)–C(14) 170.16(8) 
C(10)–O(3)–C(14)–C(15)  −160.78(8) O(3)–C(14)–C(15)–C(16) 95.79(11) 
O(3)–C(14)–C(15)–C(20)  −84.63(11) C(20)–C(15)–C(16)–C(17)  −0.51(15) 
C(14)–C(15)–C(16)–C(17) 179.08(9) C(15)–C(16)–C(17)–C(18) 0.67(16) 
C(16)–C(17)–C(18)–C(19)  −0.36(17) C(17)–C(18)–C(19)–C(20)  −0.09(17) 
C(16)–C(15)–C(20)–C(19) 0.05(15) C(14)–C(15)–C(20)–C(19)  −179.53(9) 
C(18)–C(19)–C(20)–C(15) 0.25(17)  
 
Table 6.  Hydrogen bonds [Å and °]. 
 
D–H...A d(D–H) d(H...A) d(D...A) <(DHA) 
 
N(1)–H(1)...O(1') 0.863(14) 2.055(15) 2.8641(11) 155.9(13) 
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5.3 – X-ray crystal data and structure refinement for Benzo[1,3]dioxol-5-yl-(1H-
imidazol-2-yl)-methanone  
 
Table 1.                
                                                                                
Identification code  gwdl3-(PAR/VM) 
Empirical formula  C11H8N2O3 
Formula weight  216.19 
Temperature  150(2) K 
Wavelength  0.84620 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 11.4689(14) Å α= 90°. 
 b = 22.714(3) Å β= 95.722(2)°. 
 c = 7.3010(9) Å γ = 90°. 
Volume 1892.5(4) Å3 
Z 8 
Density (calculated) 1.518 Mg/m3 
Absorption coefficient 0.113 mm-1 
F(000) 896 
Crystal size 0.31 x 0.16 x 0.05 mm3 
Crystal description yellow tablet  
Theta range for data collection 3.85 to 33.10°. 
Index ranges -14<=h<=14, -28<=k<=29, -9<=l<=9 
Reflections collected 6895 
Independent reflections 2020 [R(int) = 0.0528] 
Completeness to theta = 27.50° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.853846 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2020 / 0 / 145 
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Goodness-of-fit on F2 1.090 
Final R indices [I>2sigma(I)] R1 = 0.0441, wR2 = 0.0999 
R indices (all data) R1 = 0.0557, wR2 = 0.1064 
Largest diff. peak and hole 0.255 and -0.204 e.Å-3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103). U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
C(1) 8096(1) 544(1) -1759(2) 19(1) 
N(1) 7030(1) 630(1) -2611(2) 22(1) 
C(2) 6609(1) 77(1) -3016(2) 25(1) 
C(3) 7416(1) -339(1) -2407(2) 25(1) 
N(2) 8352(1) -40(1) -1623(2) 23(1) 
C(4) 8966(1) 973(1) -940(2) 20(1) 
O(1) 9860(1) 771(1) -78(2) 30(1) 
C(5) 8810(1) 1616(1) -1120(2) 17(1) 
C(6) 7919(1) 1879(1) -2292(2) 19(1) 
C(7) 7841(1) 2490(1) -2476(2) 20(1) 
C(8) 8669(1) 2817(1) -1461(2) 18(1) 
O(2) 8806(1) 3418(1) -1458(2) 24(1) 
C(9) 9722(1) 3542(1) -9(2) 24(1) 
O(3) 10291(1) 2995(1) 484(2) 24(1) 
C(10) 9556(1) 2564(1) -295(2) 17(1) 
C(11) 9655(1) 1969(1) -87(2) 19(1) 
________________________________________________________________________________  
 
Table 3.   Bond lengths [Å] and angles [°]  
_____________________________________________________  
C(1)-N(1)  1.330(2) 
C(1)-N(2)  1.3592(19) 
C(1)-C(4)  1.478(2) 
N(1)-C(2)  1.367(2) 
C(2)-C(3)  1.366(2) 
C(3)-N(2)  1.3494(19) 
C(4)-O(1)  1.2364(18) 
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C(4)-C(5)  1.476(2) 
C(5)-C(6)  1.399(2) 
C(5)-C(11)  1.416(2) 
C(6)-C(7)  1.397(2) 
C(7)-C(8)  1.366(2) 
C(8)-O(2)  1.3733(17) 
C(8)-C(10)  1.385(2) 
O(2)-C(9)  1.4417(19) 
C(9)-O(3)  1.4328(18) 
O(3)-C(10)  1.3768(17) 
C(10)-C(11)  1.363(2) 
 
N(1)-C(1)-N(2) 111.08(14) 
N(1)-C(1)-C(4) 130.09(14) 
N(2)-C(1)-C(4) 118.80(13) 
C(1)-N(1)-C(2) 104.71(13) 
C(3)-C(2)-N(1) 110.65(14) 
N(2)-C(3)-C(2) 105.90(14) 
C(3)-N(2)-C(1) 107.66(13) 
O(1)-C(4)-C(5) 120.03(14) 
O(1)-C(4)-C(1) 116.88(14) 
C(5)-C(4)-C(1) 123.08(13) 
C(6)-C(5)-C(11) 120.25(14) 
C(6)-C(5)-C(4) 123.45(14) 
C(11)-C(5)-C(4) 116.24(13) 
C(7)-C(6)-C(5) 121.25(14) 
C(8)-C(7)-C(6) 117.02(14) 
C(7)-C(8)-O(2) 127.97(14) 
C(7)-C(8)-C(10) 122.40(14) 
O(2)-C(8)-C(10) 109.58(13) 
C(8)-O(2)-C(9) 105.65(11) 
O(3)-C(9)-O(2) 107.19(11) 
C(10)-O(3)-C(9) 105.55(11) 
C(11)-C(10)-O(3) 128.16(13) 
C(11)-C(10)-C(8) 121.91(13) 
O(3)-C(10)-C(8) 109.87(13) 
C(10)-C(11)-C(5) 117.17(13) 
_____________________________________________________________  
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Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103). The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* 
U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
C(1) 18(1)  18(1) 23(1)  1(1) 2(1)  3(1) 
N(1) 17(1)  25(1) 24(1)  -2(1) -2(1)  -1(1) 
C(2) 20(1)  27(1) 26(1)  -4(1) 0(1)  -5(1) 
C(3) 25(1)  20(1) 30(1)  -4(1) 2(1)  -5(1) 
N(2) 18(1)  18(1) 31(1)  1(1) -1(1)  2(1) 
C(4) 17(1)  21(1) 23(1)  2(1) 2(1)  2(1) 
O(1) 21(1)  21(1) 46(1)  4(1) -11(1)  2(1) 
C(5) 14(1)  19(1) 19(1)  0(1) 3(1)  0(1) 
C(6) 13(1)  22(1) 22(1)  1(1) -1(1)  -1(1) 
C(7) 14(1)  23(1) 22(1)  3(1) -2(1)  4(1) 
C(8) 17(1)  17(1) 19(1)  2(1) 5(1)  3(1) 
O(2) 24(1)  16(1) 29(1)  0(1) -4(1)  1(1) 
C(9) 23(1)  20(1) 28(1)  -5(1) -3(1)  3(1) 
O(3) 21(1)  19(1) 30(1)  -5(1) -5(1)  1(1) 
C(10) 14(1)  21(1) 17(1)  -4(1) 2(1)  -1(1) 
C(11) 16(1)  21(1) 19(1)  1(1) 0(1)  4(1) 
______________________________________________________________________________  
 
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2x 10 3). 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(2) 5860 -6 -3637 30 
H(3) 7334 -754 -2513 30 
H(2A) 9010 -195 -1116 27 
H(6) 7357 1637 -2976 23 
H(7) 7238 2670 -3272 24 
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H(9A) 10290 3825 -443 29 
H(9B) 9385 3714 1068 29 
H(11) 10265 1798 718 23 
________________________________________________________________________________  
 
Table 6.  Torsion angles [°] 
________________________________________________________________  
N(2)-C(1)-N(1)-C(2) 0.08(17) 
C(4)-C(1)-N(1)-C(2) -177.80(15) 
C(1)-N(1)-C(2)-C(3) 0.20(18) 
N(1)-C(2)-C(3)-N(2) -0.41(18) 
C(2)-C(3)-N(2)-C(1) 0.44(17) 
N(1)-C(1)-N(2)-C(3) -0.34(18) 
C(4)-C(1)-N(2)-C(3) 177.81(13) 
N(1)-C(1)-C(4)-O(1) 173.71(15) 
N(2)-C(1)-C(4)-O(1) -4.0(2) 
N(1)-C(1)-C(4)-C(5) -6.6(3) 
N(2)-C(1)-C(4)-C(5) 175.66(14) 
O(1)-C(4)-C(5)-C(6) 170.07(14) 
C(1)-C(4)-C(5)-C(6) -9.6(2) 
O(1)-C(4)-C(5)-C(11) -7.2(2) 
C(1)-C(4)-C(5)-C(11) 173.10(13) 
C(11)-C(5)-C(6)-C(7) 0.1(2) 
C(4)-C(5)-C(6)-C(7) -177.06(14) 
C(5)-C(6)-C(7)-C(8) -0.1(2) 
C(6)-C(7)-C(8)-O(2) 177.16(13) 
C(6)-C(7)-C(8)-C(10) 0.1(2) 
C(7)-C(8)-O(2)-C(9) 173.90(15) 
C(10)-C(8)-O(2)-C(9) -8.74(15) 
C(8)-O(2)-C(9)-O(3) 14.22(15) 
O(2)-C(9)-O(3)-C(10) -14.32(15) 
C(9)-O(3)-C(10)-C(11) -173.60(15) 
C(9)-O(3)-C(10)-C(8) 9.14(15) 
C(7)-C(8)-C(10)-C(11) -0.1(2) 
O(2)-C(8)-C(10)-C(11) -177.68(13) 
C(7)-C(8)-C(10)-O(3) 177.31(13) 
O(2)-C(8)-C(10)-O(3) -0.23(16) 
O(3)-C(10)-C(11)-C(5) -176.80(13) 
 164
C(8)-C(10)-C(11)-C(5) 0.2(2) 
C(6)-C(5)-C(11)-C(10) -0.1(2) 
C(4)-C(5)-C(11)-C(10) 177.23(13) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 
Table 7.  Hydrogen bonds [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(2)-H(2A)...O(1)#1 0.88 1.98 2.8273(17) 160.9 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,-y,-z       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
